PCT Bibliography March 2009 - pingxiti.com · PCT_Bibliography_March_2009.doc, page 4 of 80 BDN 005 Nylen ES et al. And Becker KL. Serum procalcitonin as an index of inhalation injury

PCT_Bibliography_March_2009.doc, Page 1 of 80

PCT Procalcitonin

BIBLIOGRAPHY MARCH 2009

see also: http://www.procalcitonin.com

B·R·A·H·M·S Aktiengesellschaft• Neuendorfstr. 25 • 16761 Hennigsdorf, Germany Tel.: +49-3302 - 883-644, FAX: +49-3302 - 883-388

PCT_Bibliography_March_2009.doc, page 2 of 80

SUBJECT BDN NUMBER

Reviews 042, 100, 112, 120, 144, 157, 175, 177, 239, 241, 249, 268, 314, 316, 334, 354, 377, 387, 408, 411, 414, 416, 428, 449, 468, 469, 470, 488, 531, 535, 547, 565, 571, 572, 573, 605, 606, 610, 691, 683, 719, 732, 805, 813, 814, 883, 895, 905, 943, 944, 945, 946, 950, 957, 973, 1050, 1057, 1101, 1105, 1136, 1193, 1194, [1223], 1242, 1249,1253, 1257,1262, 1342, [1427 German], [1445 German], 1464, 1511

Guidelines 652, 1299, 1358, 1394, 1470

Infection / Sepsis/Bacteraemia

028, 035, 082, 107, 134, 146, 175, 241, 243, 249, 254, 270, 288, 314, 315, 317, 326, 338, 358,361, 362, 364, 365, 372, 374, 376, 379, 383,389, 390, 392, 393, 395, 397, 400, 403, 404, 407, 425, 431, 437, 454, 457, 458, 460, 461, 469, 470, 472, 480, 485, 491, 502, 510, 526, 528, 531, 533, 535, 536, 542, 548, 549, 550, 553, 556, 557, 565, 570, 577, 579, 580, 581, 587, 589, 592, 605, 611, 626, 627, 634, 639, 642, 645, 648, 651, 652, 655, 657, 658, 659, 660, 661, 665, 676, 678, 683, 685, 688, 709, 713, 715, 732, 744, 753, 760, 766, 772, 774, 776, 777, 779, 782, 784, 785, 787, 797, 801, 802, 807, 809, 813, 818, 820, 822, 835, 842, 848, 849, 850, 858, 863, 864, 865, 866, 871, 872, 873, 876, 877, 883, 886, 892, 893, 894, 869, 902, 904, 906, 907, 914, 922, 924, 926, 929, 930, 932,933, 936, 947, 949, 950, 969, 976, 977, 978, 982, 983, 989, 999, 1000, 1003, 1004, 1005, 1006, 1009, 1011, 1012, 1015, 1018, 1024, 1025, 1027, 1028, 1029, 1033, 1036, 1045, 1050, 1051, 1056, 1057, 1058, 1060, 1061, 1062,1064, 1066, 1069, 1075,1076, 1077, 1078, 1079, 1082, 1087, 1088, 1089, 1090, 1091, 1094, 1096, 1098, 1101, 1107, 1120, 1124, 1127, 1149, 1151, 1155, 1156, 1166, 1172, 1174, 1179, 1180, 1181, 1184, 1186, 1192, 1197, 1198, 1156, 1203, 1206, 1208, 1209(review urosepsis),1210, 1217, 1219, 1227, 1231, 1248,1252, 1258,1260, 1270, 1276, 1291, 1292, 1294, 1296, 1298, 1300, 1301, 1304, 1306, 1308, 1309, 1314, 1319, [1321, 1322], 1332, 1335, 1336, 1351, 1353, 1357, 1358, 1359, 1360, 1368, 1382, 1383, 1385, 1389, 1390, 1396, 1408, 1424, 1440, 1449, 1452, 1465, 1474, 1477, 1478, 1483, 1488, 1491, 1492, [1504 German], 1509

Differential Diagnosis 063, 078, 112, 148, 253, 340, 344, 358, 361, 367, 368, 369, 371, 389, 522, 530, 540, 566, 614, 670, 680, 688, 727, 729, 749, 761, 768, 785, 793, 801, 808, 816, 852, 902, 949, 981, 1007, 1069, 1084, 1087, 1102, 1110, 1116, 1121,1251

Surgery / Trauma / Polytrauma

129, 174, 180, 185, 203, 234, 236, 246, 247, 248, 249, 255, 261, 272, 319, 344, 346, 348, 370, 382, 384, 386, 389, 394, 415, 424, 427, 430, 434, 439, 453, 457, 498, 518, 527, 532, 537, 544, 552, 557, 569, 588, 593, 603, 609, 638, 641, 644, 647, 663, 669, 675, 681, 689, 715, 737, 738, 739, 745, 757, 759, 777, 778, 804, 819, 821, 837, 838, 847, 853, 860, 870, 874, 878, 882, 884, 887, 891, 896, 904, 906, 934, 939, 941, 942, 943, 948, 961, 966, 971, 974, 978, 984, 1005, 1013, 1014, 1016, 1020, 1021, 1034, 1047, 1049, 1062, 1077, 1081, 1089, 1099, 1105, 1131, 1122, 1130, 1143, 1147, 1198,1200, 1201, 1218, 1225, 1226,1268, 1269, 1316, 1327, 1346, 1352, 1441, 1462, [1472 Spain], 1484

Transplantation 036, 089, 090, 093, 108, 159, 235, 237, 238, 256, 269, 341, 352, 353, 354, 368, 369, 375, 439, 455, 475, 476, 477, 479, 490, 500, 541, 547, 623, 672, 711, 788, 791, 1033, 1177, 1188, 1295, 1297, 1303, 1340, 1395, 1399, 1430, 1439, 1480,

Paediatry / Neonatology 024, 076, 077, 078, 151, 153, 239, 257, 263, 293, 294, 331, 340, 347, 357, 358, 366, 367, 402, 410, 411, 418, 435, 436, 438, 458, 460, 478, 511, 522, 523, 544, 545, 559, 566, 567, 568, 596, 612, 613, 615, 616, 619, 649, 650, 654, 655, 666, 670, 673, 688, 724, 726, 740, 742, 747, 762, 775, 778, 790, 792, 794, 796, 798, 803, 808, 814, 824, 840, 841, 843, 844, 846, 861, 862, 879, 880, 888, 899, 897, 902, 908,910, 911, 915, 922, 923, 944, 961, 963, 968, 972, 977, 999, 1002, 1008, 1012, 1014, 1022, 1023, 1026, 1028, 1046, 1081, 1084, 1086, 1088, 1089, 1117, 1125, 1126, 1129, 1151, 1152, 1162, 1164, 1170, 1171, 1175, 1183, 1186, 1189, 1202, 1205, 1210, 1227, 1228, 1230, 1232, 1235, 1241,1251,1260,1263, 1284, 1286, [1313], 1315, 1349, 1355,1361, 1368, 1369, 1374, 1391, 1393, 1397, 1400, 1421, 1421a, 1429, 1436, 1443, [1450 French], 1482, 1501

Haematology / Oncology 119, 173, 228, 240, 264, 267, 327, 330, 372, 381, 399, 426, 433, 446, 459, 503, 512, 513, 515, 519, 564, 584, 632, 672, 717, 748, 758, 764, 765, 781, 789, 791, 800, 810, 879, 881, 887, 890, 922, 931, 991, 992, 996, 1028 , 1030, 1033, 1039, 1047, 1051, 1142, 1173,1222, 1277, 1281, 1369, 1423, 1476, 1499

Burn injury 005, 006, 007, 008, 141, 262, 351, 447, 494, 585, 586, 751, 1172, 1234, 1380

Kinetics, Biochemistry Pathophysiology

019, 030, 071, 116, 215,227, 260, 313, 318, 329, 332, 333, 336, 339, 349, 350, 373, 378, 379, 391, 401, 402, 406, 412, 441, 442, 444, 452, 456, 462, 463, 464, 465, 466, 467, 475, 480, 484, 495, 504, 509, 514, 516, 520, 534, 558, 562, 563, 574, 594, 595, 604, 607, 631, 633, 653, 667, 690, 720, 721, 723, 735, 746, 752, 763, 771, 786, 795, 868, 885, 917, 950, 985, 1097, 1159,1257, 1279, 1343, 1350, 1363, 1398, 1428, 1497

Laboratory aspects 176, 271, 316, 356, 432, 440, 553, 591, 686, 790a, 783, 826, 950, 1010, 1107 , 1283, 1489

Rapid test 355, 432, 440, 448, 624, 644, 688, 790a, 799, 878,902, 909, 917, 918, 935, 977, 1010, 1046, 1108, 1147, 1205, 1227, 1235, 1278, 1334, 1383, [1432],

PCT vs. Inflammatory parameters

024, 038, 089, 090, 141, 203, 245, 246, 247, 253, 256, 258, 261, 262, 264, 269, 270, 316, 326, 330, 335,337, 342, 347, 357, 365, 374, 397, 399, 402, 403, 404, 407, 412, 413, 418, 435, 438, 460, 474, 478, 479, 491, 521, 530, 542, 655, 662, 665, 668, 729, 767, 770, 776, 784, 802, 904, 906, 917, 1028, 1079, 1082, 1216, 1465, 1466, 1467, 1468

Influence by medication 490, 1038, 1188, 1285, 1290, 1344, 1366

Epidemiology 1051, 1053, 1054, 1071, 1085, 1095


Economic aspects Antibiotic use

403, 522, 578, 608,630, 640, 714, 731, 756, 780, 811, 924, 979, 1011, 1052, 1058, 1071, 1085, 1095, 1157, 1183, 1215, 1216, 1288, 1298, 1330, 1338, 1362, 1387, [1409], 1434, [1438 German], 1453, [1457 German], 1458, 1459, 1460, 1474, 1505, 1506

ER/ED, Prognosis 570, 1197, 1198, 1205, 1244, 1267, 1282, 1296, 1361,

Renal function, Dialysis 373, 456, 483, 662, 668, 864, 866, 994, 998, 1086, 1331, 1333,

SPECIAL INDICATIONS :

ARDS 343, 344, 417,1212

Autoimmune diseases 063, 181, 209, 244, 245, 302, 303, 371, 385, 429, 508, 747, 926, 1102, 1146, 1148, 1247, 1265, 1289, 1386, 1516

Immunosuppression 108, 136

Steroid therapy 1212

Malaria 033, 139, 178, 259, 380, 471, 518, 560, 736, 754, 1128,

Meningitis 078, 217, 253, 266, 328, 396, 409, 473, 489, 522, 530, 554, 597, 601, 617, 643, 657, 769, 825, 823, 830, 854, 875, 902, 913, 918, 963, 988, 1000, 1012, 1019, 1037, 1090, 1094, 1144, 1185, 1196, 1220, [1433 French], 1473, 1517

Neutropenia 327, 372, 519, 584, 781, 789, 791, 800, 810, 879, 881, 916, 1028, 1030, 1039, 1085, 1145, 1207,1251, 1271, 1287, 1411, 1422 (review), 1503

Pancreatitis 020, 156, 250, 251, 363, 382, 398, 443, 448, 482, 542, 583, 646, 656, 682, 712, 728, 734, 743, 793, 806, 812, 845, 878, 882, 912, 920, 927, 964, 987, 1007, 1017,1040, 1048, 1100, 1168, 1190, 1191, 1199, 1256, [1264], 1312, 1339 (review), 1442

Peritonitis 082, 128, 129, 304, 431, 496, 712, 896, 915, 1014, 1021, 1150, 1278, 1307, [1318], 1377, 1384, [1420],1483

Pneumonia/CAP, Respiratory Tract Infections/LRTI COPD

011, 038, 404, 418, 458, 486, 493, 551, 561, 567, 569, 618, 628, 664, 713, 756, 792, 794, 815, 836, 850, 859, 883, 886, 921, 924, 929, 950, 951, 960, 970, 975, 997, 1004, 1011, 1036, 1041, 1042, 1043, 1055, 1066, 1070, 1071, 1072, 1083, 1095, 1096, 1103, 1104, 1114, 1118, 1123, 1134, 1136, 1111, 1142, 1153, 1154, 1158, 1163, 1165, 1169, 1171, 1176, 1178, 1182, 1187, 1202, 1213; 1215, 1216, 1224, 1249, 1250, 1254,1255, 1267, 1273, 1275, 1282, 1302, 1305, 1310, 1317, 1325( review), 1326 (review VAP), 1341, 1345, 1347 (review VAP),1370, 1371, 1372, 1375, 1378, 1392, 1401, 1402, 1403, 1405, 1406, 1407, , [1417], 1418, 1419, 1425, 1435, 1448, 1469, [1475 German], 1479, 1485, [1500 German], 1510, [1514 Chin],

Pyelonephritis, UTI 252, 258, 456, 487, 493, 566, 670, 790, 899, 910, 923, 940, 968, 1008, 1080, 1131, 1133, 1134review, 1161, [1412], [1432], 1454, 1507, 1512

Shock 005, 038, 379, 484 , 848,

SARS 773

Dementia 1245

Cardiac 474, 860, 1105, 1200, 1218, 1266, 1323, 1354, 1361, 1462

HIV 142, 886

ECMO 1456

Others 1280, 1293, 1329,1379, 1444, 1461, [1463 German], [1494 Dut], 1515


BDN 005 Nylen ES et al. And Becker KL. Serum procalcitonin as an index of inhalation injury in burns Horm metab Res 1992, 24: 439-442

BDN 006 O´Neill WJ, Jordan MH, Lewis MS, Snider RH, Moor CF, Becker KL.

Serum Calcitonin may be a marker for inhalation injury in burns J Burn Care Rehabil. 1992, 13: 605-616

BDN 007 Becker KL et al. and Jordan MH.

Hypercalcitonemia in inhalation burn injury: a response of the pulmonary neuroendocrine cell? Anatomic Record (1993), 236: 136-138

BDN 008 Nylen ES et al. And Becker KH.

Late pulmonary sequela following burns: persistence of hyperprocalcitonemia using a 1-57 amino acid N-terminal flanking peptide assay Respirat Med 1995, 89: 41-46

BDN 011 Nylen E, Snider R, Thompson K, Rohatgi P, Becker K.

Pneumonitis-associated hyperprocalcitoninemia Am J Med Sci 1996, 312 (1): 12-18

BDN 019 Becker KL, Nylén ES, Cohen R, Snider RH.

Calcitonin: Stucture, Molecular Biology, and Actions in Principles of Bone Biology, Acad. Press, (1996), Chapt. 34, 471-494

BDN 020 Rau B, Steinbach G, Gansauge F, Mayer JM, Grunert A, Beger HG.

The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis Gut 1997, 41(6): 832-840

BDN 024 Monneret G, Labaune JM, Isaac C, Bienvenu F, Putet G, Bienvenu J.

Procalcitonin and C-reactive protein levels in neonatal infections Acta Paediatr 1997, 86: 209-212

BDN 028 Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C.

High serum procalcitonin concentrations in patients with sepsis and infection Lancet 1993, 341: 515-518

BDN 030 Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C.

Procalcitonin increase after endotoxin injection in normal subjects J Clin Endocrinol Metab 1994, 79 (6): 1605-1608

BDN 033 Davis TME, Assicot M, Bohuon C, St. John A, Li GQ, Anh TK.

Serum procalcitonin concentrations in acute malaria Trans R Soc Trop Med Hyg 1994, 88 (6): 670-671

BDN 035 Smith MD et al. and White NJ.

Elevated serum procalcitonin levels in patients with melioidosis Clin Infect Dis 1995, 20: 641-615

BDN 036 Gerard Y, Hober D, Petitjean S, Assicot M, Bohuon C, Mouton Q, Wattré P.

High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis Infection 1995, 23: 310-311

BDN 038 de Werra I et al. and Heumann D.

Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock and bacterial pneumonia Crit Care Med 1997, 25 (4): 607-613

BDN 042 Bohuon C, Assicot M.

Procalcitonin: A new innovative marker for sepsis and very severe inflammatory diseases The Immune Concequences of Trauma, Shock and Sepsis – Mechanism and Therapeutic Approaches. Eds. E. Faist, AE. Baue, FW. Schildberg, Pabst Science Publishers, (1997), 2 (1): 158-161

BDN 063 Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R.

Usefulness of Procalcitonin for differentiation between activity of systemic autoimmune disease and invasive bacterial infection Arthritis and Rheumatism 1997, 40 (7): 1250-1256

BDN 071 Rehli M, Luger K, Beier W, Falk W.

Molecular cloning and expression of mouse procalcitonin Biochem Biophys Res Commun 1996, 226 : 420-425


BDN 076 Gendrel D, Raymond J, Moulin F, Assicot M, Bohuon C.La Procalcitonine, un nouveau marqueur de l´infection bactérienne Flammarion Médicine-Sciences – J. Parisiennes de pédiatrie 1995, 23-29

BDN 077 Gendrel D, Assicot M, Raymond J, Moulin F, Francoual Ch, Badoual J, Bohuon C.

Procalcitonin as a marker for the early diagnosis of neonatal infection J Pediatr (1996), 128 (4): 570-573

BDN 078 Gendrel D, Raymond J, Assicot M, Moulin F, Iniguez J-L, Lebon P, Bohuon C.

Measurement of procalcitonin levels in children with bacterial or viral meningitis Clin Infect Dis. 1997 Jun;24(6):1240-2

BDN 082 Gramm HJ, Dollinger P, Beier W.

Procalcitonin – ein neuer Marker der inflammatorischen Wirtsantwort. Longitudinalstudien bei Patienten mit Sepsis und Peritonitis Chir Gastroentorol 1995, 11 (suppl 2): 51-54

BDN 089 Staehler M, Überfuhr P, Reichart B, Hammer C

[Differential diagnosis of acute rejection and infections in heart transplanted patients: new ways using cytokines and procalcitonin as markers] [in German] Transplantationsmedizin 1997, 9: 44-50

BDN 090 Staehler M, Hammer C, Meiser B, Fürst H, Reichhart B, Schildberg FW.

Differentialdiagnostik der akuten Abstoßreaktion und Infektion mittels Procalcitonin und Zytokinen Langenbecks Arch Chir I (Forumband 1997) 1997, 205-209

BDN 093 Staehler M, Hammer C, Meiser B, Reichart B.

Procalcitonin: A new marker of differential diagnosis of acute rejection and bacterial infection in heart transplantationTransplantation Proceedings 1997, 29: 584-585

BDN 100 Kämmerer W.

Procalcitonin – Ein neuer prognostischer Infektionsparameter bei septischen Infektionen Krankenhauspharmazie 1997, 18 (1): 11-15

BDN 107 Meisner M, Tschaikowsky K, Beier W, Schüttler J.

Procalcitonin (PCT) – a novel parameter for diagnosis and monitoring of bacterial inflammation and sepsis. [in German] Anästhesiologie und Intensivmedizin1996, 10 (37): 529-39

BDN 108 Meisner M, Tschaikowsky K, Schmidt J, Schüttler J

Procalcitonin (PCT) – Indications for a new diagnostic parameter of severe bacterial infection and sepsis in transplantation, immunosuppression and cardiac assist devices Cardiovascular Engineering 1996, 1 (1): 67-76

BDN 112 Meisner M.

Procalcitonin (PCT) [in German] in Lothar Thomas, Labor und Diagnose, Indikation und Bewertung von Laborbefunden für die medizinische Diagnostik, 5.Auflage, TH-Books 1998, 728-731

BDN 116 Le Moullec JM et al. And Moukhtar MS.

The complete sequence of human preprocalcitonin FEBS 1198 (1984),167 (1): 93-97

BDN 119 Zintl F, Sauer M, Fuchs D, Hermann J, Reinhart K.

High serum procalcitonin (PCT) concentrations in children and adults after hemopoietic stem cell transplantation (HSCT) – an indicator for poor prognosis in severe infections Blood 1996, 88 (Suppl 1): 266b (Abstract)

BDN 120 Reinhard K.

Neue Ansätze zur Diagnose von schweren Infektionen und Sepsis Journal für Anästhesie und Intensivbehandlung (7. Internationales Symposium für Intensivmedizin und Intensivpflege, Bremen, Feb 1997) 1997 I. Quartal, 107

BDN 128 Reith HB, Lehmkuhl P, Beier W, Högy B.

Procalcitonin – ein prognostischer Infektionsparameter bei der Peritonitis Chir Gastroenterol 1995, 11 (suppl. 2): 47-50

BDN 129 Kaman S, Reith HB, Mittelkötter U, Haarmann W, Kozuschek W.

Intensivmonitoring bei Peritonitis und Sepsis in Aktuelles in der Chirurgie. Kozuschek W, Reith H.B (Hrsg.), 8.Tagung der chirurgischen Kliniken der Krankenhäuser der Bundesknappschaft. Basel, Karger 1996, 157-163


BDN 134 Al-Nawas B, Krammer I, Shah PM.Procalcitonin in diagnosis of severe infections Eur J Med Res (1995/1996), 1: 331-333

BDN 136 Al-Nawas B, Shah PM.

Procalcitonin in patients with and without immunosuppression and sepsis Infection 1996, 24 (6): 434-436


Procalcitonin in acute malaria Eur J Med Res (1997), 2: 206-208

BDN 141 Carsin H, Assicot M, Feger F, Roy O, Pennacino I, Le Bever H, Ainaud P, Bohuon C.

Evolution and significance of circulating procalcitonin levels compared with IL-6, TNFa and endotoxin levels early after thermal injury Burns 1997, 23 (3): 218-224

BDN 142 Gerard Y et al. and Wattre P.

Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1 J Infection 1997, 35 : 41-46

BDN 144 Gendrel D, Bohuon C.

Procalcitonin, a marker of bacterial infection Infection 1997, 25 (3): 1-2

BDN 146 Karzai W, Meier-Hellmann A, Reinhart K.

Procalcitonin- An indicator of sepsis. In Yearbook of Intensive Care and Emergency Medicine 1998. Ed. J.-L. Vincent, Springer-Verlag 1998, 247

BDN 148 Hatherill M, Jones G, Lim E, Tibby SM, Murdoch IA.

Procalcitonin aids diagnosis of adrenocortical failure Lancet. 1997 Dec 13;350(9093):1749-50

BDN 151 Chiesa C, Panero A, Rossi N, Stegagno M, De Giusti M, Osborn JF, Pacifico L.

Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis (1998), 26: 664-672

BDN 153 Lapillonne A, Basson E, Monneret G, Bienvenu J, Salle BL.

Lack of specificity of procalcitonin for sepsis diagnosis in premature infants Lancet. 1998 Apr 18;351(9110):1211-2

BDN 156 Bertsch T, Richter A, Hofheinz H, Böhm C, Hartel M. Aufenanger J.

Procalcitonin – a new marker for the acute-phase reaction in acute pancreatitis Langenbeck Arch Chir 1997, 382: 367-372

BDN 157 Fabel H, Schulz A.

Parameter zur Diagnose und Verlaufsbeurteilung von Infektionen in der Intensivmedizin. Intensivmed (1997), 34: 466-471

BDN 173 Schwaner I et al. and Fekardt KU.

Procalcitonin concentrations during high dose therapy with autologous stem cell rescue Deutsche und österreichische Gesellschaft für Hämatologie und Onkologie. LINZ, 12-15 Oktober 1997 (Abstract)

BDN 174 Reith HB, Mittelkötter U, Debus ES, Küssner C, Thiede A.

Procalcitonin in early detection of postoperative complications Dig Surg (1998), 15: 260-265

BDN 175 Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K.

Procalcitonin – A New Indicator of the Systemic Response to Severe Infections Infection 1997, 25 (6): 329-334

BDN 176 Meisner M, Tschaikowsky K, Schnabel S, Schmidt J, Katalinic A, Schüttler J.

Procalcitonin – Influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations Eur J Clin Chem Clin Biochem 1997, 35 (8): 597-601

BDN 177 Pahlke K, Oberhoffer M, Karzai W, Meier-Hellmann A, Reinhart K.

Procalcitonin – Features of a new parameter in severe bacterial infections and sepsis Procalcitonin – Eigenschaften eines neuen Parameters bei schweren bakteriellen Infektionen und Sepsis.] Intensivmed 1997, 34: 381-387


BDN 178 Richard-Lenoble D et al. and Kombila M.Changes in procalcitonin and interleukin 6 levels among treated African patients with different clinical forms of malaria Trans R Soc Trop Med Hyg. 1997 May-Jun;91(3):305-6

BDN 180 Kiessling AH, Isgro F, Tran KH, Saggau W.

Procalcitonin serum levels in the postoperative phase after cardiac surgery 46th Annual Meeting Scand. Ass. For Thoracic Surgery (SATS), Sept. 1997, Stockholm

BDN 185 Gerlach M, Keh D. Ahlers 0, Kerner T, Spielmann S, Falke KJ, Gerlach H.

Increased procalcitonin levels in polytrauma patients Vienna Internat. Congress 1997, Anesthesiology & Intens. Care Med., Oct. 28-31: 335 (Abstract)

BDN 203 Mimoz O, Benoist JF, Edouard AR, Assicot M, Bohuon C, Samii K.

Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome Intensive Care Med. 1998 Feb;24(2):185-8

BDN 209 Stroehmann A, Cowell LG, Hiepe F, Krause A.

Zum Stellenwert von Procalcitonin in der rheumatologischen Diagnostik Med. Klinik 1998, 93: P-185 Abstract-Band1

BDN 215 Schmidt J, Meisner M, Brucker A, Tschaikowskv K.

Procalcitonin modulates the LPS-induced production of cytokines in vitro SHOCK Sixth Vienna Shock Forum, Vienna Austria 8-11.Nov.1997, 8 Suppl.: 29 (Abstract)

BDN 217 Gendrel D.

Biochemical markers in the diagnosis of bacterial meningitis. [Apport des données biochimiques dans le diagnostic des méningites purulentes communautaires.] Méd Mal Infect 1996, 26 : 1068-1072

BDN 227 Nylen ES, Whang KT, Snider RH, Steinwald PM, White JC, Becker KL.

Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsisCrit. Care Med. 1998, 26 (6): 1001-1006

BDN 228 Ghillani PP et al. and Bellet D.

Identification and measurement of calcitonin precursors in serum of patients with malignant diseases Cancer Res.Dec. 1989, 49(23): 6845-6851

BDN 229 Braithwaite SS.

Procalcitonin. Marker or Mediator? Crit Care Med 1998, 26 (6): 977-978

BDN 233 Brunkhorst FM, Heinz U, Forycki ZF,

Kinetics of procalcitonin in iatrogenic sepsis Intens. Care Med (1998) 24: 888-892

BDN 234 Kilger E et al. and Frey L.

Procalcitonin as a marker of systemic inflammation after conventional or minimally invasive coronary artery bypass grafting Thorac. Cardiovasc. Surgeon 1998, 46: 130-133

BDN 235 Eberhard OK et al. and Brunkhorst R.

Procalcitonin in the early phase after renal transplantation – will it add to diagnostic accuracy? Clin. Transplantation 1998, 12: 206-211

BDN 236 Hensel M, Volk T, Döcke WD, Kern F, Tschirna D, Egerer K, Konertz W, Kox WJ.

Hyperprocalcitoninemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass Anesthesiology 1998, 89: 93-104

BDN 237 Hammer C, Reichenspurner R, Meiser B, Reichart B.

Cytoimmunology in monitoring: the Munich experience Transplant. Proceed. 1998, 30: 873-874

BDN 238 Kunz D, Pross M, König W, Lippert H, Manger T.

Diagnostic relevance of procalcitonin, IL-6 and cellular immune status in the early phase after liver transplantation Transplant. Proceed. 1998, 30: 2398-2399

BDN 239 Chiesa C, Pacifico L, Mancuso G, Panero A.

Procalcitonin in pediatrics: Overview and challenge Infection 1998, 26(4): 236-241


BDN 240 Lestin F, Lestin H-G, Burstein C, Anders O, Freund M.Provisional experience with procalcitonin, C- reactive protein, neopterin, selected cytokines, and hemostatic parameters in patients with malignant hematological diseases and febrile neutropenia induced by cytostatic treatmentClin. Lab. 1998, 44: 451-461

BDN 241 Oberhoffer M, Karzai W, Meier-Hellmann A, Reinhart K.

Procalcitonin. Ein neuer diagnostischer Parameter bei schweren Infektionen und Sepsis Anaestesist 1998, 47: 581-587

BDN 243 Steinbach G, Grünert A.

Procalcitonin – a new indicator for bacterial infections Exp. Clin. Endocrinol. Diabetes 1998, 106 : 164-167

BDN 244 Moosig F, Csernok E, Reinhold-Keller E, Schmitt W, Gross WL.

Elevated procalcitonin levels in active Wegener’s granulomatosis J. Rheumatol. 1998, 25(8): 1531-1533

BDN 245 Schwenger V, Sis J, Breitbart A, Andrassy K.

CRP levels in autoimmune disease can be specified by measurement of procalcitonin Infection 1998, 26: 274-276

BDN 246 Benoist J-F, mimoz O, Assicot M, Edouard A.

Serum procalcitonin, but not C-reactive protein, indentifies sepsis in trauma patients Clin. Chem. 1998, 44(8): 1778-1779

BDN 247 Hergert M, Lestin H-G, Scherkus M, Brinker K, Klett I, Stranz G, Lestin F.

Procalcitonin in patients with sepsis and polytrauma Clin. Lab. 1998, 44: 659-670

BDN 248 Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schüttler J.

Postoperative plasma concentrations of procalcitonin after different types of surgery Intensive Care Med. 1998, 24: 680-684

BDN 249 Oczenski W, Fitzgerald RD, Schwarz S.

Procalcitonin: a new parameter for the diagnosis of bacterial infection in the peri-operative period Eur. J. Anaesthesiol. 1998, 15: 202-209

BDN 250 Oezcueruemez-Porsch M et al. and Kloer HU.

Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis Dig. Dis. Sci. 1998, 43(8): 1763-1769

BDN 251 Brunkhorst FM, Eberhard OK, Brunkhorst R.

Early identification of biliary pancreatitis with procalcitonin Am. J. Gastroenterol. 1998, 93(7): 1191-1192

BDN 252 Benador N et al. and Girardin E.

Procalcitonin is a marker of severity of renal lesions in pyelonephritis Pediatrics 1998, 102(6): 1422-1425

BDN 253 Gendrel D et al. and Bohuon C.

Procalcitonin, C-reactive protein and interleukin 6 in bacterial and viral meningitis in children [Procalcitonine, protéine C-réactive et interleukine 6 dans les méningites bactériennes et virales de l’enfant] Presse Med. 1998, 27(23): 1135-1139

BDN 254 Karzai W, Reinhart K.

Sepsis: definitions and diagnosis Int J Clin Pract Suppl 1998, 95: 448-449

BDN 255 Boeken U et al. and Gams E.

Diagnostic value of procalcitonin: the influence of cardiopulmonary bypass, aprotinin, SIRS, and sepsis Thorac Cardiovasc Surg 1998, 46(6): 348-351

BDN 256 Pross M, Manger Th, Weiss G, Lippers H, König W, Kunz D.

The diagnostic value of procalcitonin and IL-6 in combination with the cellular immune status for the therapeutic management after liver transplantation [in German] Tx Med 1998, 10: 195-201

BDN 257 Sachse C, Dressler F, Henkel E

Increased serum procalcitonin in newborn infants without infection Clin Chem 1998, 44 (6 Pt 1): 1343-1344


BDN 258 Gendrel D. Urinary tract infection and biological markers: C-reactive protein, interleukins and procalcitonin [in French] Arch Pediatr 1998, 5(Suppl3): 269S-273S

BDN 259 Hollenstein U et al. And Burgmann H.

Serum procalcitonin levels in severe Plasmodium falciparum malaria Am J Trop Med Hyg 1998, 59(6): 860-863

BDN 260 Monneret G, Laroche B, Bienvenu

Procalcitonin is not produced by circulating blood cells Infection 1998, 27(1): 34-35

BDN 261 Benoist JF, Mimoz O, Assicot M.

Procalcitonin in severe trauma [in French] Ann Biol Clin (Paris) 1998: 56(5): 571-574

BDN 262 von Heimburg D, Stieghorst W, Khorram-Sefat R, Pallua N.

Procalcitonin—a sepsis parameter in severe burn injuries Burns 1998, 24(8): 745-750

BDN 263 Petzold L et al. and Porquet D.

Determination of procalcitonin in the diagnosis of maternal-fetal infections [in French] Ann Biol Clin (Paris) 1998, 56(5): 599-602

BDN 264 Bernard L, Ferriere F, Casassus P, Malas F, Leveque S, Guillevin L, Lortholary O.

Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults Clin Infect Dis 1998, 27(4): 914-915

BDN 265 Lawn SD, Obeng J, Acheampong J W, Griffin GE.

Serum procalcitonin concentrations in patients with pulmonary tuberculosis Trans R Soc Trop Med Hyg 1998, 92(5): 540-541

BDN 266 Bohuon C, Assicot M, Raymond J, Gendrel D.

Procalcitonin, a marker of bacterial meningitis in children [in French] Bull Acad Natl Med 1998, 182(7): 1469-1475

BDN 267 Monneret G, Labaune JM, Isaac C, Bienvenu F, Putet G, Bienvenu J.

Increased serum procalcitonin levels are not specific to sepsis in neonates [letter] Clin Infect Dis 1998, 27(6): 1559-1561

BDN 268 Bohuon C, Gendrel D.

Procalcitonin: A new indicator for bacterial infections. Interest and perspectives Arch Pédiatr 1999, 6: 141-144

BDN 269 Hammer S et al. and Hammer C.

Procalcitonin: a new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation Transplant Immunology 1998, 6: 235-241

BDN 270 Schröder J, Staubach K-H, Zabel P, Stüber F, Kremer B.

Procalcitonin as a marker of severity in septic shock Langenbecks Arch Surg 1999, 384: 33-38

BDN 271 Meisner M.

Procalcitonin (PCT) in: Clinical Laboratory Diagnostics. Use and Assessment of Clinical Laboratory Results, L.Thomas (ed), 1st edition, TH-Books 1998, pp.710-714

BDN 272 Reinhart K, Karzai W.

Re: Procalcitonin: a new parameter for the diagnosis of bacterial infection in the perioperative period. Oczenski et al., Eur J Anaesthesiol 1998, 15 : 129-132 [letter] Eur J Anaesthesiol 1998, 15(5) : 618-619

BDN 284

Zéni F, Viallon A, Assicot M, Tardy B,Vindimian M, Page Y, Lafond P, Bertrand JC, Bohuon C. Procalcitonin Serum Concentrations and Severity of Sepsis 14th International Symposium on Intensive Care and Emergency Medicine

BDN 288 Whang KT et al. and Becker KL.

Serum calcitonin precursors in sepsis and systemic inflammation J Clin Endocrinol Metab 1998, 83(9): 3296-3301


BDN 293 Martin-Denavit T et al. And Bienvenu J.Usefulness of Procalcitonin in neonates at risk for infection [letter] Clin Chem 1999, 45(3): 440-441

BDN 294 Sachse C, Dressler F, Henkel E.

Re: Usefulness of procalcitonin in neonates at risk for infection. Martin-Denavit T. et al. Clin Chem 1999, 45(3). 441 BDN 302 Moosig F, Reinhold-Keller E, Csernok E, Gross WL.

Limitations on the usefulness of procalcitonin as a marker of infection in patients with systemic autoimmune disease: comment on the article by Eberhard et al [letter, comment] Arthritis Rheum 1998, 41(3): 566-567

BDN 303 Espinosa-Morales R, Escalant, A.

Use of procalcitonin as a diagnostic test: Comment on the article by Eberhard et al [letter, comment] Arthritis Rheum 1998, 41(3): 567-568

BDN 304 Mittelkötter U, Reith HB.

Procalcitonin im Infektionsmanagement Kankenhaus Spezial ”Peritonitis”, Reed Elsevier 1998, pp: 14-15

BDN 313 Oberhoffer M, Vogelsang H, Jäger L, Reinhart K.

Katacalcin and calcitonin immunoreactivity in different types of leukocytes indicate intracellular procalcitonin content J. Crit Care 1999, 14(1): 29-33


Procalcitonin, a new diagnostic and prognostic marker for severe infections Clin Micorbiol Infect 1998, 4(5): 237-241

BDN 315 Oberhoffer M, Vogelsang H, Rußwurm S, Hartung T, Reinhart K.

Outcome prediction by traditional and new markers of inflammation in patients with sepsis Clin Chem Lab 1999, 37(3): 363-368

BDN 316 Meisner M.

Procalcitonin: Experience with a new diagnsotic tool for bacterial infection and systemic inflammation [in German] J Lab Med 1999, 23(5): 263-272

BDN 317 Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent J-L.

Procalcitonin used as a marker of infection in the intensive care unit Crit Care Med 1999, 27(2): 498-504

BDN 318 Pugin J, Widmer M-C, Kossodo S, Liang C-M, Preas II HL, Suffredini AF.

Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators Am J Respir Cell Mol Biol 1999, 20: 458-464

BDN 319 Carlstedt F, Lind L, Joachimsson PO, Rastad J, Wide L, Ljunghall S.

Circulating ionized calcium and parathyroid hormone levels following coronary artery by-pass surgery Scand. J. Clin. Lab. Invest. 1999, 59: 47-54

BDN 322 Beaune G, Bienvenue F, Pondarré C, Monneret G, Benvienu J, Souillet G.

Serum procalcitonin rise is only slight in two cases of disseminated aspergillosis Infection 1998, 26(3): 168-169

BDN 326 Rothenburger M et al. and Weinhold C.

Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein Clin. Chem. Lab. Med. 1999, 37(3): 275-279

BDN 327 Engel A, Steinbach G, Kern P, Kern WV.

Diagnostic value of procalcitonin serum levels in neutropenic patients with fever Comparison with interleukin 8, Scand. J. Infect. Dis. 1999, 31: 185-189

BDN 328 Viallon A, Zeni F, Lambert C, Pozzetti B, Tardy B, Venet C, Bertrand J-C.

High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis Clin. Infect. Dis. 1999, 28 : 1313-1316

BDN 329 Russwurm S, Oberhoffer M, Zipfel PF, Reinhart K.

Procalcitonin – a novel biochemical marker for the mediator-directed therapy of sepsis Mol. Med. Today 1999, 5: 286-287

BDN 330 Ruokonen E, Nousiainen T, Pulkki K, Takala J.

Procalcitonin concentrations in patients with neutropenic fever Eur. J. Microbiol. Infect. Dis. 1999, 18: 283-285


BDN 331 Tollens M, Westerholt S, Oberhoffer M, Klare B, Emmrich P, Oberhoffer R. Procalcitonin bei Kindern mit hämolytisch-urämischem Syndrom (HUS) Monatsschr. Kinderheilkd 1999, 147(4): 373-376

BDN 332 Oberhoffer M et al. And Reinhart K.

Procalcitonin expression in human peripheral blood mononuclear cells and ist modulation by lipopolysaccharides and sepsis-related cytokines in vitro J. Lab. Clin. Med. 1999, 134(1): 49-55

BDN 333 Steinwald PM, Whang KT, Becker KL, Snider RH, Nylen ES, White JC

Elevated calcitonin precursor levels are related to mortality in an animal model of sepsis Crit. Care 1999, 3: 11-16

BDN 334 Mironov PI, Rudnov VA.

[Problems and perspective approaches to correction of mediator response in sepsis] (Review) [in Russian] Anesteziol Reanimatol. 1999 May-Jun,(3):54-59

BDN 335 Oberhoffer M, Karzai W, Meier-Hellmann A, Bögel D, Faßbinder J, Reinhart K.

Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor- and interleukin-6 in patients with sepsis Crit. Care Med. 1999, 27: 1814-1818

BDN 336 Silomon M, Bach F, Graeter T, Grundmann U, Larsen R.

Procalcitonin following cardiopulmonary bypass. Origin from hepatosplanchnicus? [German] Anaesthesist 1999, 48: 395-398

BDN 337 Bossink AWJ, Groeneveld ABJ.

Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-1-antitrypsin, and lactoferrin compared with clinical variables

Clin. Infect. Dis. 1999, 29: 398-407 BDN 338 Members of the American Association of Chest Physicians/ Society of Critical Care Medicine Consensus

Conference Committee American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit. Care Med. 1992, 20(6): 864-874

BDN 339 Whang KT, Vath SD, Nylen ES, Muller B, Qichang Li, Tamarkin L, White JC.

Procalcitonin and proinflammatory cytokine interactions in sepsis Shock 1999, 12(4): 268-273

BDN 340 Gendrel D et al. and Bohuon C.

Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon alpha for differentiation of bacterial vs viral infections Pediatr. Infect. Dis. 1999, 18: 875-881

BDN 341 Jaresová M, Striz I, Cermaková, Lácha J, Sedlácek J, Mudra K, Hána I, Vitko S.

Serum procalcitonin in transplant patients with acute rejection and bacterial infections Immunology Letters 1999, 69: 355-358

BDN 342 Erren M et al. and Cullen P.

Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral atheries Arteriovascul. Thrmob. Vasc. Biol 1999, 19: 2355-2363

BDN 343 Dalton H.

Procalcitonin: A predictor of lung injury attributable to sepsis? Crit. Care Med. 1999, 27(10): 2304-2305

BDN 344 Brunkhorst FM, Eberhard OK, Brunkhorst R.

Discrimination of infectious and nonoinfectious causes of early respiratory distress syndrome by procalcitonin Crit. Care Med. 1999, 27(10): 2172-2176

BDN 345 Brunkhorst FM, Clark AL, Forycki ZF, Anker SD.

Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation Int. J. Cardiol. 1999, 72: 3-10

BDN 346 Loebe M, Lodziewski S, Brunkhorst FM, Harke C, Hetzer R.

Procalcitonin (PCT) in cardiac surgery in: Current perspectives of the extracorporeal circulation, D. Baykut, A.Krian (eds), Darmstadt: Steinkopf, New York: Springer 2000, ISBN: 3-7985-1214-0 pp. 127-135


BDN 347 Hatherill M, Tibby M, Sykes K, turner C, Murdoch IA.Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leukocyte count Arch Dis Child 1999, 81: 417-421

BDN 348 Loebe M, Lodziewski S, Qedra N, Brunkhorst FM, Wagner F, Hetzer R.

Der Infektionsmarker Procalcitonin in der Herzchirurgie Z. Herz- Thorax- Gefäßchir 1999, 13: 215-220

BDN 349 Russwurm S, Wiederhold M, Oberhoffer M, Stonans I, Zipfel PF, Reinhart K.

Molecular aspects and natural source of procalcitonin Clin Chem Lab Med. 1999, 37(8): 789-797

BDN 350 Nishikura T.

The clearance of procalcitonin (PCT) during continuous venovenous hemofiltration (CVVHD) Int. Care Med. 1999, 25: 1198-1201

BDN 351 Nakae H, Inaba H, Endo S.

Usefulness of procalcitonin in Pseudomonas burn wound sepsis model Tohoku J. Exp. Med. 1999, 188: 271-273

BDN 352 Kuse ER, Langefeld I, Jaeger K, Külpmann WR

Procalcitonin in fever of unknown origin after liver transplantation: A variable to differentiate acute rejection from infection Crit. Care Med. 2000, 28(2): 555-559

BDN 353 Hammer S, Fraunberger P, Meiser B, Stangl M, Seidel D, Hammer C.

Procalcitonin, a new indicator for non-viral infections in heart, lung or liver transplant patients Ann. Tranplant. 1999, 4(2): 5-9

BDN 354 Hammer S, Meisner F, Hammer C, Seidel D.

Use of procalcitonin as indicator of nonviral infections in transplantation and related immunologic diseases Tranplant. Reviews 2000, 14(1): 52-63

BDN 355 Meisner M, Rotgeri A, Brunkhorst FM

[A semi-quantitative point-of-care test for the measurement of procalcitonin] [in German] J. Lab. Med. 2000, 24(2): 076-085

BDN 356 Reinke P, Döcke WD, Kox W, Zuckermann H, Volk HD

Neue Entwicklungen der Immundiagnsotik intensivmedizinischer Patienten Dtsch. Med. Wschr. 1999, 124: 1527-1529

BDN 357 Lorrot M et al. and Gendrel D

[Procalcitonin in pediatric emergency situations: comparison with C-reactive protein, interleukin 6 and alpha interferon for differentiating bacterial and viral infections] [in French] Presse Med. 2000, 29: 128-134

BDN 358 Hatherill M, Sykes K, McIntyre AG, Murdoch IA

Procalcitonin may help differentiate disseminated herpes simplex viral infection from bacterial sepsis in neonates Eur. J. Pediatr. 2000, 159: 168-169

BDN 359 Reinhart K, Carlet J

Procalcitonin – a new marker of severe infection and sepsis [Editorial] Intensive Care Med. 2000, 26(Suppl 2): S145

BDN 360 Bohuon C.

A brief history of procalcitonin Intensive Care Med. 2000, 26(Suppl 2): S146-147

BDN 361 Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R

Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock Intensive Care Med. 2000, 26(Suppl 2): S148-152

BDN 362 Cheval C et al. And Carlet J

Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients Intensive Care Med. 2000, 26(Suppl 2): S153-158

BDN 363 Rau B, Steinbach G, Baumgart K, Gansauge F, Grünert A, Beger HG

The clinical value of procalcitonin in the prediction of infected necrosis in acute pancreatitis Intensive Care Med. 2000, 26(Suppl 2): S159-164


BDN 364 Reith HB, Mittelkötter U, Wagner R, Thiede AProcalcitonin (PCT) in patients with abdominal sepsis Intensive Care Med. 2000, 26(Suppl 2): S165-169

BDN 365 Oberhoffer M, Rußwurm S, Bredle D, Chatziniculaou, Reinhart KDiscrimanative power of inflammatory markers for prediction of tumor necrosis factor- and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points Intensive Care Med. 2000, 26(Suppl 2): S170-174

BDN 366 Chiesa C, Pacifico L, Rossi N, Panero A, Matrunola M, Mancaso G

Procalcitonin as a marker of nosocomial infections in the neonatal intensive care unit Intensive Care Med. 2000, 26(Suppl 2): S175-177

BDN 367 Gendrel D, Bohuon C

Procalcitonin in pediatrics for differentiation of bacterial and viral infections Intensive Care Med. 2000, 26(Suppl 2): S178-181

BDN 368 Hammer S et al. and Hammer C

Procalcitonin for differential diagnosis of graft rejection and infection in patients with heart and/or lung grafts Intensive Care Med. 2000, 26(Suppl 2): S182-186

BDN 369 Kuse ER, Langefeld I, Jaeger K, Külpmann WR

Procalcitonin – a new diagnsotic tool in complications following liver transplantation Intensive Care Med. 2000, 26(Suppl 2): S187-192

BDN 370 Loebe M, Locziewski S, Brunkhorst FM, Harke C, Hetzer R

Procalcitonin in patients undergoing cardiopulmonary bypass in open heart surgery – first results of the procalcitonin in heart surgery study (ProHearts) Intensive Care Med. 2000, 26(Suppl 2): S193-198

BDN 371 Brunkhorst R, Eberhard OK, Haubitz M, Brunkhorst FM

Procalcitonin for discrimination between activity of systemic autoimmune diesease and systemic bacterial infection Intensive Care Med. 2000, 26(Suppl 2): S199-201

BDN 372 Fleischhack G, Cipic D, Juettner J, Hasan C, Bode U

Procalcitonin – a sensitive inflammation marker of febrile episodes in neutropenic children with cancer Intensive Care Med. 2000, 26(Suppl 2): S202-211

BDN 373 Meisner M, Schmidt J, Hüttner H, Tschaikowsky K

The natural elimination rate of procalcitonin in patients with normal and impaired renal function Intensive Care Med. 2000, 26(Suppl 2): S212-216

BDN 374 Herrmann W, Ecker D, Quast S, Klieden M, Rose S, Marzi I

Comparison of procalcitonin, sCD14 and interleukin-6 values in septic patients Clin Chem Lab Med 2000, 38(1): 41-46

BDN 375 Hammer S, Meisnera F, Beiras-Fernandez, Meiser B, Fraunberger P, Hammer C

[Procalcitonin: a new marker for the diagnosis of organ rejection and bacterial infections in patients receiving heart and lung transplants] [in Spanish] Transplantes 1999, 5:26-32

BDN 376 Wiedermann F, Innerhofer P, Margreiter J, Fuchs D, Schobersberger W

Procalcitonin and neopterin in infectious diseases Pteridines 1999, 10: 125-132

BDN 377 Meisner M

Procalcitonin (PCT) Ein neuer, innovativer Infektionsparameter. Biochemische und klinische Aspekte ISBN: 3-13-105473-5, Thieme Stuttgart, New York 2000

BDN 378 Wrenger S, Kähne T, Bohuon C, Weglöhner W, Ansorge S, Reinhold D.

Amino-terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV) FEBS Letters 2000, 466: 155-159

BDN 379 Price S, Evans T.

Bacterial translocation in cardiopenic shock: the gastrointestinal tract as the motor of sepsis? Int. J. Cardiol. 1999, 72: 11-12

BDN 380 Stoiser B et al. and Burgmann H.

Serum concentrations of granulocyte-colony stimulating factor in complicated falciparum malaria Eur. Cytokine News 2000, 11(1): 75-79


BDN 381 Südhoff T, Giagounidis A, Karthaus M.Evaluation of neutropenic fever: Value of Serum and Plasma Parameters in Clinical Practice Chemotherapy 2000, 46: 77-85

BDN 382 Müller CA, Uhl W, Printzen G, Gloor B, Bischofberger H, Tcholakov O, Büchler MW

Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis Gut 2000, 46: 233-238

BDN 383 Korczowska E.

Diagnostic usefulness of procalcitonin in internal medicine Polski Merkuriusz Lekarski 1999, VII(42): 251-252

BDN 384 Aouifi A et al. And Lehot JJ.

Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations Brit. J. Anaesth. 1999, 83(4): 602-607

BDN 385 Rüchardt A, Lydtin H.

Morbus Still des Erwachsenen DMW 1999, 124(50): 1541

BDN 386 Gürlich R, Maruna P, Cermak J.

[Use of procalcitonin in surgery] [in Czech] Rozhl. Chir. 1999, 78(6): 292-294

BDN 387 Ferriere F.

Procalcitonin, a new marker for severe infections [in French] Ann. Biol. Clin. 2000, 58(1): 49-59

BDN 388 Lind L et al. and Ljunghall S.

Hypocalcemia and parathyroid hormone secretion in critically ill patients Crit Care Med 2000, 28 (1): 93-99

BDN 389 Wanner GA., Keel M, Steckholzer U, Beier W, Stocker R, Ertel W.

Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients Crit Care Med 2000,.28 (4): 950-957

BDN 390 Müller B et al. And Ritz R.

Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit Crit Care Med 2000, 28(4): 977-983

BDN 391 Kettelhack C, Hohenberger P, Schulze G, Kilpert B, Schlag P.

Introduction of systemic serum procalcitonin and cardiocirculatory reactions after isolated limb perfusion with recombinant human tumor necrosis factor- and melphalan Crit Care Med 2000, 28 (4): 1040-1046

BDN 392 Boucher BA.

Procacitonin: Clinical tool or laboratory curiosity? Crit Care Med 2000,.28(4): 1224-1225

BDN 393 Vincent JL

Procalcitonin: THE marker of sepsis? Crit Care Med 2000, 28 (4): 1226-1227

BDN 394 Tamás S, Zsolt M, Tamás K, Miklós T.

[Inflammatory markers in the early postoperative period following oesophagectomies] [in Hungarian] Orvosi Hetilap 2000, 141(10):489-492

BDN 395 V. Zarka, Valat C, Lemarié E, Carré Ph, Besnard JC, Diot P.

[Serum calcitonin and respiratory tract infection] [in French] Rev. Pneumol. Clin., 1999, 55 (6): 365-369

BDN 396 Viallon A et al. and Bertrand JC

[Rapid differential diagnosis between bacterial and viral meningitis with serum procalcitonin assay in adult] [in French] Presse Med 2000, 29: 584-588

BDN 397 Petros S, Leonhardt U, Engelmann L.

Serum Procalcitonin and Proinflammatory Cytokines in a Patient with Acute Severe Leptospirosis Scand J Infect Dis 2000, 32 : 104-105


BDN 398 Melzi d’Eril GV, Merlini G, Finazzi G, Bosoni T, Barakat B, Pezzilli R.Procalcitonin is not a reliable marker for the assessment of Sevirity in Acute Pancreatis without Infectious Complications Clinical Chemistry 2000, 46 (3): 428-430

BDN 399 M. Sauer M, Tiede K, Volland R, Fuchs D, Zintl F.

[Procalcitonin and C-reactive protein: Comparison of two markers for sepsis-syndrom in severely immunocompromised children after bone-marrow transplantation] [in German] Klin Pädiatr 2000, 212: 10-15

BDN 400 Rußwurm S, Wiederhold M, Oberhofer M, Stonans I, Peiker G, Reinhart K.

[Procalcitonin as monocyte marker for early diagnosis of septic abortion] [in German] Z Geburtsh Neonatol 2000, 204: 34-38

BDN 401 Nijsten M et al. and Zwaveling JH.

Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro Crit Care Med 2000, 28 (2): 458-461

BDN 402 Delmas J et al. and Bienvenu J.

[Procalcitonin and C-reactive protein kinetics in neonates with group B s] [in French] Ann Biol Clin 2000, 58: 208-211

BDN 403 Angus, DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR.

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med. 2001, 29(7): 1303-1310

BDN 404 Hedlund J, Hansson LO.

Procalcitonin and C-Reactive Protein Levels in Community-Aquired Pneumonia: Correlation with Etiology and Prognosis Infection. 2000 Mar-Apr;28(2):68-73

BDN 405 Schmidt M, Burchardi C, Sitter T, Held E, Schiffl H.

Procalcitonin in Patients Undergoing Chronic Hemodialysis Nephron 2000, 84: 187-188

BDN 406 Braithwaite S.

Procalcitonin: New insights on regulation and origin Crit Care Med 2000, 28 (2): 586-588

BDN 407 Meisner M, Tschaikowsky K, Palmaers T, Schmidt J.

Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS Critical Care 1999, 3(1): 45-50

BDN 408 Meisner M.

Procalcitonin (PCT) A new, innovative infection parameter. Biochemical and clinical aspects ISBN: 3-13-105503-0, Thieme Stuttgart, New York 2000

BDN 409 Schwarz S, Bertram M, Schwab S, Andrassy K, Hacke W.

Serum procalcitonin levels in bacterial and abacterial meningitis Crit.Care Med 2000, 28(6): 1828-1832

BDN 410 Hatherill M, Tibby SM, Turner C, Ratnavel N, Murdoch IA

Procalcitonin and cytokine levels: Relationship to organ failure and mortality in pediatric septic shock Crit. Care Med. 2000, 28(7): 2591-2594

BDN 411 Gendrel D., Bohuon C.

Procalcitonin as a marker of bacterial infection Pediatr. Infect. Dis. J. 2000, 19: 679-688

BDN 412 Whang KT et al. and White JC.

Procalcitonin and proinflammatory cytokine interactions in sepsis Shock, 2000, 14(1): 73-78

BDN 413 Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Köhl J.

Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6 Crit. Care Med. 2000, 28(8): 2793-2798

BDN 414 Vincent JL and Mercan D.

Dear Sirs, what is your PCT? Intensive Care Med. 2000, 26: 1170-1171


BDN 415 Adamik B, Kübler-Kielb J, Golebiovska B, Gamian A, Kübler A.Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites Intensive Care Med. 2000, 26(9): 1259-1267.

BDN 416 Reinhart K, Karzai W, Meisner M.

Procalcitonin as a marker of the systemic inflammatory response to infection Intensive Care Med. 2000, 26: 1193-1200

BDN 417 Wichert A, Lukasewitz P, Hauser MH, Bittersohl J, Lennartz H.

ARDS in fulminant ornithosis and treatment with extracorporeal lung assist Int. J. Artif. Organs 2000, 23(6): 371-374

BDN 418 Toikka P, Irjala K, Juven T, Virkki R, Mertsola J, Leinonen M, Ruuskanen O.

Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children Pediatr. Infect. Dis. 2000, 19(7): 598-602

BDN 424 Aouifi A et al. and Lehot J

Usefulness of procalcitonin for diagnosis of infection in cardia surgical patients Critical Care Medizine 2000, 28(9): 3171-3176

BDN 425 Suprin E, Camus C, Gacouin A, Le Tulzo Y, Lavoune S, Feuillu A, Thomas R.

Procalcitonin: a valuable indicator of infection in a medical ICU? Intensive Care Med. 2000 , 26(9): 1232-1238

BDN 426 de Bont E, Kamps W, Vellenga E, Swaanenburg J.

Procalcitonin: A Diagnostic Marker of Bacterial Infection in Neutropenic Cancer Patients with Fever? Infection 2000, 28(6): 398-400

BDN 427 Bortone AS et al. and de Luca Tupputi Schinosa L.

Inflammatory response and angiogenesis after percutaneous transmyocardial laser revascularization Ann Thorac Surg 2000, 70: 1134-1138

BDN 428 Maruna P, Nedelnikova R, Gürlich R.

Physiology and Genetics of procalcitonin Physiol. Res. 2000, 49(Suppl.1): S57-S61

BDN 429 Andrassy K, Hänsch G.

[Vasculitis 1998: New insights into diagnossis and therapy] [in German] WMW 2000, 11: 230-232

BDN 430 Molnar Z.

Microalbuminuria and serum procalcitonin levels following oesophagotectomy Eur. J. Anaestesiol. 2000, 17: 464-465

BDN 431 Viallon A et al. and Bertrand J-C-

Serum and ascitic procalcitonin levels in patients with spontaneous bacterial peritonitis: diagnostic value and relationship to proinflammatory cytokines Intensive Care Med. 2000, 26: 1082-1088

BDN 432 Guerin S.

Evaluation of procalcitonin detection by immunochromatography: the PCT-Q test of BRAHMS Ann. Biol. Clin. 2000, 58: 613-614

BDN 433 Penel N, Degardin M, Frippiat F, Hachulla E.

Are there criteria for the diagnsosis of paraneoplastic fever? Rev. Med. Interne 2000, 21: 684-692

BDN 434 Bitkover K, Hansson L-O, Valen G, Vaage J.

Effects of cardiac surgery on some clinically used inflammation markers and procalcitonin Scand. Cardiovasc. 2000, 34: 307-314

BDN 435 Bonac B, Derganc M, Wraber B, Hojker S.

Interleukin-8 and procalcitonin in early diagnosis of early severe bacterial infection in critically ill neonates Pflügers Arch. – Eur. J. Physiol. 2000, 440(Suppl): R72-R74

BDN 436 Assumma M, Signore F, Pacifico L, Rossi N, Osborn JF, Chiesa C.

Serum procalcitonin concentrations in term delivering mothers and their healthy offspring: A longitudinal study. Clin. Chem. 2000, 46(10): 1583-1587


BDN 437 Choussat R et al. and Thomas D.Effect of prior exposure to chlamydia pneumonae, helicobacter pilory, or cytomegalovirus on the degree of inflammation and one- year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction Am. J. Cardiol. 2000, 86: 379-384

BDN 438 Marchini G, Berggren V, Djilali-Merzoug R, Hansson L-O.

The birth process initiates an acute phase reaction in the fetus-newborn infant Acta Paediatr. 2000, 89: 1082-1086

BDN 439 Boeken U, Feindt P, Micek M, schulte HD, Gams E.

Procalcitonin (PCT) in cardiac surgery: diagnostic value in systemic inflammatory response syndrome (SIRS), sepsis and after heart transplantation (HTX) Cardiovasc. Surg. 2000, 8(7): 550-554

BDN 440 Meisner M, Brunkhorst FM, Reith HB, Schmidt J, Lestin HG, Reinhart K.

Clinical experiences with a new, semiquantitative solid phase inmmunoassay for rapid measurement of procalcitonin Clin. Chem. Lab. Med. 2000, 38(10): 989-995

BDN 441 Redl H, Schlag G, Tögel E, Assicot M, Bohuon C.

Procalcitonin release pattern in a baboon model of trauma and sepsis: Relationship to cytokines and neopterin. Crit. Care 2000, 28(11): 3659-3663

BDN 442 Meisner M, Hüttemann E, Lohs T, Kasakov L, Reinhart K.

Elimination of procalcitonin and plasma concentrations during cotinuous veno-venous haemodiafiltration in septic patients. Eur. J. Anaesthesiol. 2000, 17: 665-671

BDN 443 Kylänpää-Bäck M-L et al. and Repo H.

Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis Crit. Care Med 2001, 29(1): 63-69

BDN 444 Hoffmann G, Totzke G, Seibel M, Smolny M, Wiedermann F.J, Schobersberger W.

In vitro modulation of inducible nitric oxide synthase gene expression and nitric oxide synthesis by procalcitonin Crit. Care Med 2001, 29(1): 112-116

BDN 445 Kissoon N.

Modulating nitric oxide synthesis: Another contender enters the ring Crit. Care Med 2001, 29(1): 214-215

BDN 446 Fleischhack G, Kambeck I, Cipic D, Hasan C, Bode U.

Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II British Journal of Haematology 2000, 111: 1093-1102

BDN 447 Sachse C, Machens H.G, Felmerer G, Berger A, Henkel E.

Procalcitonin as a marker for the early diagnosis of severe infection after thermal injury J Burn Care Rehabil. 1999 Sep-Oct;20(5):354-60

BDN 448 Kylänpää-Bäck M.L et al. and Repo H.

Procalcitonin strip test in the early detection of severe acute pancreatitis British Journal of Surgery 2001, 88: 1-6 Br J Surg. 2001 Feb;88(2):222-7

BDN 449 Casado Flores J, Blanco Quiros A.

[Procalcitonin: A new marker for bacterial infection] [in Spanish] An Esp Pediatr 2001, 54: 69-73

BDN 452 Müller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF

Ubiquitous expression of the calcitonin-1 Gene in multiple tissues in response to sepsis J. Clin. Endocrinol. Metab. 2001, 96(1): 396-404

BDN 453 Lecharny JB, Khater D, Bronchard R, Philip I, Durand G, Desmonts JM, Dehoux M.

Hyperprocalcitoninemia in patients with perioperative myocardial infarction after cardiac surgery Crit Care Med 2001, 29(2): 323-325

BDN 454 Van Langevelde P et aö. And van Dissel JT.

Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: Identification of subjects at high risk of mortality Clin Infect Dis 2000, 31: 1343-1348


BDN 455 Kornberg A et al. And Scheele J.

Differentiated therapy with prostaglandin E1 (Alprostadil) after orthotopic liver transplantation: the usefulness of procalcitonin (PCT) and hepatic artery resistive index (RI) for the evaluation of early graft function and clinical course. Clin Chem Lab Med 2000, 38(11): 1177-1180

BDN 456 Meisner M, Lohs T, Huettermann E, Schmidt J, Hueller M, Reinhart K.

The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function Eur. J. Anaesthesiol. 2001, 18: 79-87

BDN 457 Baykut D, Schulte-Herbrüggen J, Krian A.

The value of procalcitonin as an infection marker in cardiac surgery Eur J Med Res 2000, 5: 530-536

BDN 458 Moulin F, Raymond J, Lorrot M, Marc E, Coste J, Iniguez JL, Kalifa G, Bohuon C.

Procalcitonin in children admitted to hospital with community acquired pneumonia Arch Dis Child 2001, 84: 332-336

BDN 459 Blijlevens NMA, Donelly JP, Meis JFGM, de Keizer MH, de Pauw BE.

Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation Clin Diag Lab Immunol 2000, 7(6): 889-892

BDN 460 Galetto-Lacour A et al. and Suter S.

Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections with fever without localising signs Eur J Pediatr 2001, 160:95-100

BDN 461 Reinhart K.

Procalcitonin as a marker of the systemic inflammatory response to infections J Anaesth Intensivbehandliung 2001, 2: 41-43

BDN 462 Redl H, Boltzmann L.

Sources of procalcitonin – lessons learned from animal studies J Anaesth Intensivbehandliung 2001, 2: 54-55

BDN 463 Russwurm S, Stonans I, Stonane E, Zipfel PF, Deigner HP, Reinhart K.

Various human tissues express procalcitonin and CGRP-I mRNA J Anaesth Intensivbehandliung 2001, 2: 55-58

BDN 464 Nijsten MW, Olinga P, Hoekstra HJ.

In vitro and in vivo stimulation of procalcitonin by TNFα and IL-6 J Anaesth Intensivbehandliung 2001, 2: 58-60

BDN 465 Müller B et al. And Becker KL.

Calcitonin precursors: prototypes of hormokines J Anaesth Intensivbehandliung 2001, 2: 60-62

BDN 466 Bienvenu J, Monneret G, Debard AL, Arpin M.

The immunomodulatory role of procalcitonin (PCT) J Anaesth Intensivbehandliung 2001, 2: 62-63

BDN 467 Jorgensen PF, Wang JE, Solberg R, Thiemerman C, Foster SJ, Aasen AO.

Procalcitonin does not influence the surface expression on whole blood leukocytes Int Care Med 2001, 27: 430-433

BDN 468 Meisner M, Reinhart K.

Is procalcitonin really a marker of sepsis? Int J Intensive Care 2001, 8(1): 15-25

BDN 469 Matot I, Sprung CL.

Definition of sepsis Int Care Med 2001, 27: S3-S9

BDN 470 Llewelyn M, Cohen J.

Diagnosis of infection in sepsis Int Care Med 2001, 27: 10-32

BDN 471 Chiwakata CB, Manegold C, Bönicke L, Jülch C, Dietrich M.

Procalcitonin as a parameter of disease severity and risk of mortality in patients with Plasmodium falciparum malaria J Infect Dis 2001, 183 : 1161-1164


BDN 472 Tsokos M, Reichelt U, Nierhaus A, Puschel, K.

Serum procalcitonin (PCT): a valuable biochemical parameter for the post-mortem diagnosis of sepsis Int J Legal Med 2001, 114 (4-5): 237-243

BDN 473 Hoffmann, O, Reuter U, Masuhr F, Holtkamp, Kassim N, Weber JR.

Low sensitivity of serum procalcitonin in Bacterial meningitis in adults Scand J Infect Dis 2001, 33 : 215-218

BDN 474 Buratti F et al. and Wiedermann J.

Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction Inflammation 2001, 25(2):97-100

BDN 475 Kuse ER and Jaeger K.

Procalcitonin increases after anti-CD3 monoclonal antibody therapy does not indicate infectious disease Transpl Int 2001, 14: 55

BDN 476 Wagner FD, Jonitz B, Qedra N, Wegscheider K, Weinmann E, Loebe M, Hetzer R.

Procalcitonin: A donor-specific predictor of early graft failure and early graft failure mortality after heart transplantation J Heart Lung Transplant 2001, 20(2): 206

BDN 477 Qedra N, Wagner F, Jonitz B, Loebe M, Abraham K, Hetzer R.

Procalcitonin (PCT) is a new biological marker for the diagnosis of non-viral infections after transplantation of intrathoracic organs J Heart Lung Transplant 2001, 20(2): 239

BDN 478 Enguix A, Rey C, Concha A, Medina A, Coto D, Dieguez MA.

Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children Int Care Med 2001, 27: 211-2115

BDN 479 Cooper D, Sharples L, Cornelissen J, Wallwork J, Alexander G, Trull A.

Comparison betweem procalcitonin, serum amyloid A, and C-reactive protein as markers of serious bacterial and fungal infections after solid organ transplantation Transplant Proc 2001, 33(1-2): 1808-1810

BDN 480 Cohen J et al. and Opal S, on behalf of a UK Medical Research Council International Working Party

New strategies for clinical trials in patients with sepsis and septic shock Crit Care Med 2001, 29(4): 880-886

BDN 481 Meisner M, Huttemann E, Lohs T, Kasakov L, Reinhart, K.

Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients Shock 2001, 15(3): 171-175

BDN 482 Rau B, Steinbach G, Krüger C, Baumgart K, Grünert A, Beger HG.

Comparative analysis of procalcitonin (PCT) and lipopolysaccharide (LBP) in the prediction of infectious complications in acute pancreatitis Pancreatology 2001, 1: 143

BDN 483 Herget-Rosenthal S et al. and Kribben A.

Procalcitonin for accurate detection of infection in haemodyalysis Nephrol Dial Transplant 2001, 16: 975-979

BDN 484 Redl H, Schießer A, Tögel E, Assicot M, Bohuon C.

Possible role of TNF on procalcitonin release in a baboon model in sepsis Shock 2001, 16(1): 25-27

BDN 485 Zaborec R.

Definition for septic syndrome should be re-evaluated Intensive Care Med. 2000 Dec;26(12):1870

BDN 486 Korppi M, Remes S.

Serum procalcitonin in pneumococcal pneumonia in children Eur. Respir. 2001, 17: 623-627

BDN 487 Gervaix A, Galetto-Lacour A, Gueron T, Vadas L, Zamora S, Suter S, Girardin E.

Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection Pediatr Infect Dis J 2001, 20 : 507-512


BDN 488 Bohuon C. Cascade inflammatoire en réponse á la libération de toxines. Perspectives thérapeutiques [Inflammatory cascade response to toxin release: therapeutic perspectives] [in French] Ann Pharm Fr 2001, 59: 191-197

BDN 489 Jereb M, Muzlovic I, Hojker s, Strle F.

Predictive value of serum and cerebrospinal fluid procalcitonin levels for the diagnosis of bacterial meningitis Infection 2001, 29(4): 209-212

BDN 490 Sabat R et al. and Reinke P.

Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies Int Care Med 2001, 27: 987-991

BDN 491 Harbarth S et al. and Pugin J and the Geneva Sepsis Network

Diagnostic value of procalcitonin, interleukin-6 and interleukin-8 in critically ill patients admitted with suspected sepsis Am J Respir Crit Care Med 2001, 164: 396-402

BDN 492 Whicher J, Bienvenue J, Monneret G.

Procalcitonin as an acute phase marker Ann Clin Biochem 2001, 38: 483-493

BDN 493 Martinot M et al. and Christmann D.

[Procalcitonin in pyelonephritis and acute community-acquired pneumonia in adults] [In French] Press Med 2001, 30(22): 1091-1096

BDN 494 Ulrich D, Noah E-M, Pallua N.

[Plasma Endotoxin, procalcitonin, C-reactive protein, and organ function in patients with major burns] [ In German] Handchir mikrochir Plast Chir 2001, 33: 262-266

BDN 495 Russwurm S et al. and Reinhart K.

Procalcitonin and CGRP-I mRNA expression in various human tissues Shock 2001, 16(2): 109-112

BDN 496 Spahr L, Morard I, Hadengue A, Vadas L, Pugin J.

Procalcitonin is not an accurate marker of spontaneous bacterial peritonitis in patients with cirrhosis Hepato-Gastroenterology 2001, 48:502-505

BDN 497 Fernandez-Lopez A et al. and Pou Fernandez J.

[Use of procalcitonin in a paediatric emergency department in the early detection of invasive bacterial infection in infants] [in Spanish] An Esp Pediatr 2001, 55(4): 321-328

BDN 498 Stiletto RJ, Baacke M, Gotzen L, Lefering R, Renz H.

Procalcitonin versus interleukin-6 levels in bronchoalveolar lavage fluids of trauma victims with severe lung contusion Crit Care Med 2001, 29(9): 1690-1693

BDN 499 Lipsett PA.

Serum cytokines, proteins, and receptors in acute pancreatitis: mediators, markers, or more of the same? Crit Care Med 2001, 29(8): 1642-1644

BDN 500 Hammer C, Fraunberger P, Meiser B, Hammer S.

Procalcitonin: A new marker of diagnosis of acute rejection and nonviral infection of heart and lung transplant patients Transplant Proceed. 2001, 33:2204-2206

BDN 501 Preas HL, Nylen ES, Snider RH, Becker KL, White JC, Agosti JM, Suffredini F.

Effects of anti-inflammatory agents on serum levels of calicotinin precursors during human experimental endotoxemia J. Infect. Dis. 2001, 184 : 373-376

BDN 502 Liaudat s, Dayer E, Praz G, Bill J, Troillet N.

Uselfulness of procalcitonin serum level for the diagnosis of bacteremia Eur J Microbiol Infect Dis 2001, 20: 524-527

BDN 503 Svaldi M, Hirber J, Lanthaler AT, Mayr O, Faes S, Peer E, Mitterer M.

Procalcitonin-reduced sensitivity and specificity in heavily neutropenic and imnnuosuppressed patients Brit J Haematol. 2001, 115: 53-57


BDN 504 Hoffmann G, Schobersberger W.Modulatory effects of PCT during sepsis (Letter to the editors) Cytokine 2001, 14(2): 127-128

BDN 505 D’Herbomez M, Leclerc L, Vantyghem M-C, Fourrier F, Proye C, Wemeau JL.

Clinical evaluation of a new sensitive calcitonin assay: study of specificity Clin. Chim. Acta 2001, 311: 149-155

BDN 506 Hemmer CJ, Reisinger EC.

Procalcitonin levels in severe plasmodium falciparum malaria: predictor of outcome or reflection of athomechanism? J. Infect Dis 2001, 184: 1091

BDN 507 Eloy O, Vauloup C, Therónd P, Pina P, Allouch P, Pangon B, Bedos JP, Ghnassia JC.

[Procalcitonin level in deep-seated Candida infections] [in French] Ann. Biol. Clin. 2001, 59: 502-505

BDN 508 Shin KC, Lee YJ, Kang SW, Baek HJ, Lee EB, KIM HA, Song YW.

Serum procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE Ann Rheum. Dis. 2001 Oct;60(10):988-9

BDN 509 Beishuizen A, Thijs LG, Haanen C, Vermes I.

Macrophage migration factor and hypothalamo-pituitary-adrenal function during critical illness J. Clin. Endocrinol. Metab. 2001, 86(6): 2811-2816

BDN 510 Yukioka H, Yoshida G, Kurita S, Kato N.

Plasma procalcitonin in sepsis and organ failure Ann. Acad. Med. Singapore 2001, 30: 528-531

BDN 511 Janota J, Stranak Z, Belohlavkova S.

[Interleukin-6, procalcitonin, C-reactive protein and I/T ratio in diagnostics of early-onset sepsis in low birth weight infants] [in Czech] Ces. Gynek. 2000, 65 (Suppl.1): 29-33

BDN 512 Penel N, Fournier C, Degardin M, Kouto H, Guyen MN.

[Fever and solid tumour: diagnostic utility of procalcitonin and C-reactive protein] [in French] Rev. Méd Interne 2001, 22: 706-714

BDN 513 De Bont ESJM, Nijhuis CO, Kamps WA, Vellenga E.

Interpretation of inflammatory markers in feverish cancer patients with or without neutropenia at admission Brit. J. Haematol. 2001, 114: 485-491

BDN 515 Takubo T, Kumura T, Ohta K, Yamane T, Hino M, Kamitani T, Tatsumi N.

Elevation of serum procalcitonin level in a patient with chronic myelocytic leukemia Haematologia 2001, 31(2): 177-179

BDN 516 Janota J, Simak J, Stranak Z.

Procalcitonin – Marker of systemic infection and multiple organ dysfunction: Characteristics of gene and protein Ceskoslovenska fysiol. 2001, 50(3): 119-124

BDN 517 Level C et al. and Combe C.

Procalcitonin: a new marker of inflammation in haemodialysis patients? Nephrol Dial Transplant 2001, 16: 980-986

BDN 518 Pusch F, Wildling E, Freitag H, Weinstahl C.

Procalcitonin as a diagnostic marker in patients with aspiration after closed head injury Wien. Klin Wochenschr 2001, 113(17-18): 676-680

BDN 519 Giamarellos-Bourboulis EJ et al. and Giamarellou H.

Assessment of procalcitonin as a diagnositc marker of underlying infection in patients with febrile neutropenia CID 2001, 32: 1718-1725

BDN 520 Kretzschmar M, Krüger A, Schirrmeister W.

Procalcitonin following elective partial liver resection – origin from the liver Acta Anaesthesiol. Scand. 2001, 45: 1162-1167

BDN 521 Sablotzki A, Börgermann J, Baulig W, Friedrich I, Spillner J, Silber RE, Czeslick E.

Lipopolysaccharide-binding protein (LBP) and markers of acute-phase response in patients with multiple organ dysfunction syndrome (MODS) following open heart surgery Thorax Cardiov Surg 2001, 49: 273-278


BDN 522 Marc, E., C. Menager, F. Moulin, B. Stos, M. Chalumeau, S. Guerin, P. Lebon, F. Brunet, J. Raymond, and D. Gendrel. [Procalcitonin and viral meningitis: reduction of unnecessary antibiotics by measurement during an outbreak.] [in French] Arch Pédiatr 2002, 9:358-364

BDN 523 Janota J, Stranak Z, Belohlavkova S, Mudra K, Simak J.

Postnatal increase of procalcitonin in premature newborns is enhanced by chorioamnionitis and neonatal sepsis Eur J Clin Invest 2001, 31 : 978-983

BDN 524 Duflo F, Debon R, monneret G, Bienvenue J, Chassard D, Allaouchiche B.

Alveolar and serum procalcitonin Anaesthesiology 2002, 96: 74-79

BDN 525 Athhan F, Akagündüz B, Genel F, Bak M, Can D.

Procalcitonin: A marker of neonatal sepsis J Tropical Pediatr 2002, 48: 10-14

BDN 526 Müller B, Becker KL.

Procalcitonin: how a hormone became a marker and mediator of sepsis Swiss Med Wkly 2001, 131: 595-602

BDN 527 Hammer S et al. and Netz H.

Effect of cardiopulmonary bypass on myocardial function, damage and inflammation after cardiac surgery in newborns and children Thorac Cardiov Surg 2001, 49: 349-354

BDN 528 Van Leeuwen HJ, Voorbij HAM.

[Procalcitonin concentration in the diagnosis of acute inflammatory reactions] [in Dutch] Ned Tijdschr Geneeskd 2002, 146(2): 55-59

BDN 529 Sikora JP, Chlebna-Sokol D, Kryzanska-Oberbek.

Proinflammatory cytokines (IL-6, IL-8), cytokine inhibitors (IL-6sR, sTNFRII) and anti-inflammatory cytokines (IL-10, IL-13) in the pathogenesis of sepsis in newborns and infants Arch Immunol Ther Exper. 2001, 49: 399-404

BDN 530 Shimetani N, Shimetani K, Mori M.

Levels of three inflammation markers, C-reactive protein, serum amyloid A protein and procalcitonin, in the serum and cerebrospinal fluid of patients with meningitis Scand J Clin Invest 2001, 61: 567-574

BDN 531 Rintala EM, Aittoniemi J, Laine S, Nevalainen TJ, Nikoskelainen J.

Early identification of bacteremia by biochemical markers of systemic inflammation Scand J clin Lab Invest 2001, 61: 523-530

BDN 532 Kerbaul F, Guidon C, Lejeune PJ, Mollo M, Mesana T, Gouin F.

Hyperprocalcitoninemia is related to noninfectious postoperative systemic inflammatory distress syndrome associated with cardiovascular dysfunction after coronary artery bypass graft surgery J Cardiothoracic Vasc Anaesth 2002, 16(1): 47-53

BDN 533 Hausfater P, Garric S, Ben Ayed S, Rosenheim M, Bernard M, Riou B.

Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: A prospective study CID 2002, 34: 895-901

BDN 534 Weglöhner W et al. and Bergmann A.

Isolation and characterization of serum procalcitonin from patients with sepsis Peptides 2002, 2099-2103

BDN 535 Bayona OEN.

[Bacterial infection, sepsis and procalcitonin [in Spanish] Médica Sanitas 2001, 4(5): 19-21

BDN 536 Reinhart K.

Diagnosis of sepsis MINERVA Anaestesiol 2001, 67: 675-681

BDN 537 Di Filippo, Lombardi A, Ognibene A, Messeri G, Tonelli F.

Procalcitonin as an early marker of postoperative infectious complications MINERVA Chir 2002, 57: 59-62


BDN 538 Basler T, Meier-Hellmann A, Bredle D, Reinhart K.Amino acid imbalance early in septic encephalopathy Intensive Care Med 2002, 28: 293-298

BDN 539 Brunkhorst FM, Reinhart K, Loebe ME, DeBakey ME.

Hyperprocalcitoninemia in patients with perioperative myocardial infarction after cardiac surgery Crit Care Med 2002, 30(2): 491-492

BDN 540 Martinez R, Gaul C, Buchfelder M, Erbguth F, Tschaikowsky K.

Serum procalcitonin monitoring for differential diagnosis of ventriculitits in adult intensive care patients Intensive Care Med 2002, 28: 208-210

BDN 541 Stríz L, Jaresova M, Lácha J, Sedlácek J, Vitko S.

MRP 8/14 and procalcitonin serum levels in organ transplantations Ann Tranplant 2001, 6(2): 6-9

BDN 542 Savelyev VS et al. and Saganov VP.

Role of procalcitonin assay in diagnosis and evaluation of severity of infectious forms of pancreonecrosis [in Russian] Annaly Chirurgii 2001, 4: 44-49

BDN 543 Marik PE.

Definition of sepsis: Not quite time to dump SIRS? Crit Care Med 2002, 30(3): 706-708

BDN 544 Hövels-Gürich HH et al. and Seghaye MC.

Cytokine balance in infants undergoing cardiac operation Ann Thorac Surg 2002, 73: 600-609

BDN 545 Guibourdenche J et al. and Porquet D.Biochemical markers of neonatal sepsis: value of procalcitonin in the emergency setting Ann Clin Biochem 2002, 130-135

BDN 546 Claeys R, Vinken S, Spapen H, ver Elst K, Decochez K, Huygens L, Gorus K.

Plasma procalcitonin and C-reactive protein in acute septic shock: Clinical and biological correlates Crit Care Med. 2002, 30(4): 757-762

BDN 547 Hammer C., Höbel G., Hammer S., Fraunberger P., Meiser B.

Diagnosis and monitoring of inflammatory events in transplant patients Biomarkers of Disease. An Evidence-Based Approach, Trull AK et al (ed) Cambridge University Press 2002, pages 474-481

BDN 548 Ruokonen E, Ilkka L, Niskanen M, Takala J.

Procalcitonin and neopterin as indicators of infection in critically ill patients Acta Anaesthesiol Scand 2002, 46: 398-404

BDN 549 Guven H, Altintop L, Baydin A, esen S, Aygun D, Hokelek M, doganay Z, Bek Y.

Diagnostic values of procalcitonin levels as an early indicator of sepsis Am J Emerg Med 2002, 20: 202-206

BDN 550 Van Dissel JT.

Procalcitonin and other markers of infection. What should be their role in clinical practice? Clin Microbiol Infect 2002: 8: 70-73

BDN 551 Brunkhorst FM, Al-Nawas B, Forycki ZF, Shah PM.

Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia Clin Microbiol Infect 2002, 8: 93-100

BDN 552 Sablotzki A, Friedrich I, Mühling J, Dohne MG, Spillner j, Silber RE, Czeslik E.

The systemic inflammatory response syndrome following cardiac surgery: different expression of proinflammatory cytokines and procalcitonin in patients with and without multiorgan dysfunctions Perfusion 2002, 17: 103-109

BDN 553 Morgenthaler N, Struck J, Fischer-Schulz C, Seidel-Müller E, Beier W, Bergmann A.

Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA Clin Lab 2002, 48: 263-270

BDN 554 Carrol ED, Newland P, Riordan FAI, Thomson APJ, Curtis N, Hart CA.

Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash Arch Dis Child 2002, 86: 282-285


BDN 555 Morgenthaler N, Struck J, Fischer-Schulz C, Bergmann A.Sensitive immunoluminometric assay for the detection of procalcitonin Clin Chem 2002, 48(5): 788-790

BDN 556 Reinhart K, Bayer O, Brunkhorst F, Meisner M.

Markers of endothelial damage in organ dysfunction and sepsis Crit Care Med 2002, 30(5) Suppl: S302-S312

BDN 557 Tschaikowsky K et al. and Schüttler J.

Coincidence of pro- and anti- inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients Crit Care Med 2002, 30(5): 1015-1023

BDN 558 Wiedermann FJ et al. And Schobersberger W.

Migration of human monocytes in response to procalcitonin Crit Care Med 2002, 30(5): 1112-1117

BDN 559 Büscher U, Chen F, Dudenhausen JW.

Acute phase proteins and cytokines in cord blood for diagnosis of neonatal infection [in German] XVII. Akademische Tagung deutschsprechender Hochschullehrer in der Gynäkologie und Geburtshilfe, 3-5 Okt 2001, Leopoldskron, Salzburg, Abstract

BDN 560 Kirchgatter K, del Portillo HA.

Association of severe noncerebral plasmodium falciparum malaria in Brazil with expressed PfEMP1 DBL1α sequences lacking cysteine residues Molecular Med 2002, 8(1): 16-23

BDN 561 Andermahr J et al. And Neugebauer E.

Pneumonia in multiple injured patients: a prospective controlled trial on early prediction using clinical and immunological parameters Inflamm. Res. 2002, 51: 265-272

BDN 562 Dahaba AA, Elawady GA, Rehak PH, List WF.

Procalcitonin and proinflammatory cytokine clearance during continuous venovenous haemofiltration in septic patients Anaesth Intensive Care 2002, 30: 269-274

BDN 563 Bergmann A, Bohuon C.

Decrease of serum dipeptidylpeptidase activity in severe sepsis patients: relationship to procalcitonin Clin Chim Acta 2002, 321: 123-126

BDN 564 Hambach L et al. And Hertenstein B.

Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation Haemologica 2002, 87: 643-651

BDN 565 Brunkhorst FM, Karzai W, Reinhart K.

[Diagnostic approach to sepsis – State of the art] [in German] Zentralbl Chir 2002, 127: 165-173

BDN 566 Smolkin V, Koren A, Raz R, Colodner, Sakran W, Halevy R.

Procalcitonin as a marker of acute pyelonephritis in infants and children Pediatr. Nephrol. 2002, 17: 409-412

BDN 567 Gendrel D.

[Community-acquired pneumoniae in children: etiology and treatment] [in French] Arch Pédiatr 2002, 9: 278-288

BDN 568 Kunz D, Kohse KP.

[Diagnostik of inflammation in pediatric patients] [in German] J Lab Med 2002 26(5/6): 335-340

BDN 569 Oppert M, Reinicke A, Müller C, Barckow D, Frei U, Eckardt KU.

Elevations in procalcitonin but not in C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation Resuscitation 2002, 53: 167-170

BDN 570 Chirouze C et al. and Hoen B.

Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever CID 2002, 3582): 156-161


BDN 571 Vassilyev GA, Vassilyev AG, Shlapak IP, Mischenko DL.Plasma procalcitonin in diagnosis and monitoring of severe bacterial infection and sepsis (Review) 9th Congress of Slovak Anaesthesiologists, Piestany, 22-24 May 2002, Conference proceedings, 2002, pp. 5-30

BDN 572 Vassilyev GA, Mischenko DL, Shlapak IP, Vassilyev AG.

[Procalcitonin – A new parameter for diagnosis of severe infection (biochemistry, physiological properties, determination, comparison with other parameters] [in Russian] Ukrainian Med. J. 2001, 4(24): 129-138

BDN 573 Meisner M. Pathobiochemistry and clinical use of procalcitonin Clinica Chimica Acta 323 (2002) 17-29

BDN 574 Kiriyama Y, Nomura Y, and Tokumitsu Y.

Calcitonin gene expression induced by lipopolysaccharide in the rat pituitary Am J Physiol Endocrinol Metab 282: E1380-E1384, 2002

BDN 575 De Backer J et al. and De Backer G.

Parameters f inflammation and infection in a community based case-control study of coronary heart disease Atherosclerosis 160: 457-463, 2002

BDN 576 Struck J, de Almeida P, Bergmann A, Morgenthaler NG.

High concentrations of procalcitonin but not mature calcitonin in normal human milk Horm Metab Res 2002, 34: 460-465

BDN 577 Carrol ED, Thomson APJ, Hart CA.

Procalcitonin as a marker of sepsis International Journal of Antimicrobial Agents 20: 1-9, 2002

BDN 578 Schmid A et al. and Schobersberger W.

Economic burden of illness imposed by severe sepsis in Austria Wien Klein Wochenschr 114/15-16: 697-701, 2002

BDN 579 Pettilä V, Hynninen M, Takkunen O, Kuusela P, Valtonen M.

Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis Intensive Care Med 28: 1220-1225, 2002

BDN 580 Pugin J.

Biomarkers of sepsis: is procalcitonin ready for prime time? Intensive Care Med 28: 1203-1204, 2002

BDN 581 Giamarellos-Bourboulis EJ et al. and Giamarellou H.

Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 28: 1351-1356, 2002

BDN 582 Tsokos M.

Postmortem measurement of serum procalcitonin concentration in Waterhouse-Friderichsen syndrome Virchows Archiv 2002

BDN 583 Pezzilli R, Morselli-Labate AM, Romboli E, Dibenedetti F et al.

Pancreatic involvement during the early phase of shock JOP 2002, 3(4): 139-143

BDN 584 Barnes C, Ignatovic V, Newall F, Carlin J, Ng F, Hamilton S, Ashley D, Waters K, Monagle P.

Change in serum procalcitonin ( PCT) predicts the clinical outcome of children admitted with febrile neutropenia Brit J Haematol 2002, 118: 1190-1200

BDN 585 Dehne MG, Sablotzki A, Hoffmann A, Mühling J, Dietrich FE, Hempelmann G.

Alterations of acute phase reaction and cytokine production in patients following severe burn injury Burns 2002, 28: 535-542

BDN 586 Galstian GM, Berkovskii AL, Zueva VA, Kariakin AV, et al.

[Tumor necrosis factor, interleukin-6, endotoxin and procalcitonin in septic shock in patients with haematological malignancy] [in Russian] Terapevt. Arch. 2002, 7: 56-61

BDN 588 Meisner M, Rauschmayer C, Schmidt J, Feyrer R, Cesnjevar et al.

Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications Intensive Care Med 2002, 28: 1094-1102


BDN 589 Cabioglu N, Bilgic S, Gunnur D, Aktas E, Seyhun Y, Turna A, Gunay K, Esen F. Decreased cytokine expression in peripheral blood leukocytes of patients with severe sepsis Arch Surg 2002, 137: 1037-1042

BDN 590 Koszegi T.

Immunoluminometric detection of human procalcitonin J Biochem Biophys Methods 2002, 53: 157-164

BDN 591 Balog A, Ocsovski I, Mándi Y. Flow cytometric analysis of procalcitonin expression in human monocytes and granulocytes Immunology letters 2002, 84: 199-203

BDN 592 Tugrul S, Ozcan PE, Akinci O, Seyhun Y, Cagatay A, Cakar N, Esen F.

The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis Crit Care 2002, 6(4): 357-362

BDN 593 Hanes SD, Boucher BA.

Procalcitonin in bronchoalveolar lavage fluid after severe pulmonary contusion Crit Care Med 2002, 30(9): 2171-2172

BDN 594 Kaneider NC, Egger P, Wiedermann FJ, Ritter M, Wöll E, Wiedermann CJ.

Involvement of cyclic adenosine monophosphate-dependent protein kinase A and pertussis toxin-sensitive G proteins in the migratory response of human CD14+ mononuclear cells to katacalcin J Bone Mineral Res 2002, 17(10): 1872-1882

BDN 595 Wagner KE, Martinez JM, Vath SD, Snider RH, Nylen ES, Becker KL, Müller B, White JC.

Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs Crit Care Med 2002, 30(10): 2313-2321

BDN 596 Kordek A, Giedris-Kalemba S, Nikodemski T, Bartkowiak E, Trobe A, Czajka R.

[Procalcitonin as a marker of perinatal infection in newborn – preliminary data] [in Polish] GIN POL 2002, 73(8): 727-731

BDN 597 Van der Kaay DCM, De Kleijn ED, De Rijke YB, Hop WCJ, De Groot R, Hazelzet JA.

Procalcitonin as a prognostic marker in meningococcal disease Intensive Care Med 2002, 28: 1606-1612

BDN 598 Remskar M, Horvat M, Hojker S, Noc M.

Procalcitonin in patients with acute myocardial infarction Wien Klin Wochenschr 2002, 114(5-6): 205-210

BDN 599 Lotric-Furlan S, Maraspin-Carman V, Cimperman J, Ogrinc K, Stopar T, Strle F.

Procalcitonin levels in patients with Lyme borreliosis Wien Klin Wochenschr 2002, 2002(13-14): 530-532

BDN 600 Blommendahl J, Janas M, Laine S, miettinen A, Ashorn P.

Comparison of procalcitonin with CRP and differential white blood cell count for diagnosis of culture-proven neonatal sepsis Scand J Infect Dis 2002, 34 : 620-622

BDN 601 Leclerc F, Leteurtre S, Noizet O, Dorkenoo A, Sadik A, Cremer R, Fourier C. Procalcitonin as a prognostic marker in children with meningococcal septic shock Arch Dis Child 2002, 87(5): 450

BDN 602 Bach F, Grundmann U, Bauer M, Buchinger H, Soltesz S, Graeter T, Larsen R, Silomon M.

Modulation of the inflammatory response to cardiopulmonary bypass by dopexamine and epidural anaesthesia Acta Anaesthesiol Scand 2002, 46: 1227-1235

BDN 603 Jerin A, Pozar-Lukanovic N, Sojar V, Stanislavlevic D, Paver-Erzen V, Osredkar J.

Neopterin – an early marker of surgical stress and hypoxic reperfusion damage during liver surgery Clin Chem Lab Med 2002, 40(7): 663-666

BDN 604 Hoffmann G, Czechowski M, Schloesser M, Schobersberger W.Procalcitonin amplifies inducible nitric oxide synthase gene expression and nitric oxide production in vascular smooth muscle cells Crit Care Med 2002, 30(9): 2091-2095

BDN 605 Maccioli GA.

Sepsis and trials: Are we studying the right patients in the correct fashion? Crit Carre Med 2002, 30(11): 2594-2595

BDN 606 Vassilyev, GA, Mischenko, DL, Shlapak, IP, Vassilyev, AG.

Applications of procalcitonin concentration measurement in clinical practice [in Russian] Ukrainian Med J 2002, 30(4): 17-27


BDN 607 Tomita T.

Immunocytochemical localization of prohormone convertase 1/3 and 2 in thyroid C-cells and medullary carcinoma Endocrine Pathol. 2000, 11(2): 165-172

BDN 608 Teres D, Rapoport J, Lemeshow S, Kim S, Akhras K.

Effects of severity of illness on resource use by survivors and nonsurvivors of severe sepsis at intensive care unit admission Crit Care Med 2002, 30(11): 2413-2419

BDN 609 Lindberg M, Hole A, Johnsen H, Asberg A, Rydning A, Myrvold HE, Bjerve KS.

Reference intervals for procalcitonin and C-reactive protein after major abdominal surgery Scand J Clin Lab Invest 2002, 62: 189-192

BDN 610 Bayona ON, Fernandez Lopez A, Luaces Cubells C.

Procalcitonin: a new diagnostic tool in bacterial infections Med Clin (Barc) 2002,119(18): 706-14

BDN 611 D’Escrivan T, Kipnis E, Robriquet L.

Assessment of procalcitonin levels in emergency department patients CID 2002, 35:1275-1276

BDN 612 Chiesa C, Pellegrini G, Panero A, Osborn JF, Signore F, Assumma M, Pacifico L.

C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: Influence of illness severity, risk status, antenatal and perinatal complications, and infection Clin Chem 2003, 49(1): 60-68

BDN 613 Escobar GJ.

Effect of the systemic inflammatory response on biochemical markers of neonatal bacterial infection: A fresh look at old confounders Clin Chem 2003, 49(1): 21-22

BDN 614 Sitter T, Schmidt M, Schneider S, Schiffl H.

Differential diagnosis of bacterial infection and inflammatroy response in kidney diseases using procalcitonin J Nephrol 2002, 15: 297-301

BDN 615 Han YY, Doughty LA, Kofos D, Sasser H, Carcillo JA.

Procalcitonin is persistently increased among children with poor outcome from bacterial sepsis Pediatr Crit Care Med 2003, 4(1):21-25

BDN 616 Mariscaldo MM.

Is plasma procalcitonin ready for prime time in the pediatric intensive care unit? Pediatr Crit Care Med 2003, 4(1): 118-119

BDN 617 Flieger R. R., Winkler M., Werdan K.

[24-year old patient under suspected meningococcal meningitis caused sepsis] [in German] Intensiv-News 2003, 1: 19-21

BDN 618 Delévaux I, André M, Aumaitre O et al.

Procalcitonin measurement for differential diagnosis between pulmonary embolism and pneumonia Crit Care Med 2003 ,31(2): 661

BDN 619 Schennach H, Murr C, Larcher C et al.

Neopterin concentrations in cord blood: a single-cohort study of paired samples from 541 pregnant women and their newborns Clin Chem 2002 , 48(11): 2059-2206

BDN 623 Grebe SO, Mueller TF.

Immune Monitoring in Organ Transplantation Using Neopterin Current Drug Metabolism 2002, 3, 189-202

BDN 624 Pinkola K, Darvas K.

Application of procalcitonin quick test at surgical patients treated in the intensive care unit [in Hungarian, English abstract] Hungarian J Surg, Magyar Sebészet 54, 2001, 368-370

BDN 626 Tugrul S, Esen F, Celebi S et al.

Reliability of Procalcitonin as a Severity Marker in Critically Ill Patients with Inflammatory Response Anaesth Intensive Care 2002, 30, 747-754

BDN 627 Christofilopoulou S, Charvalos E, Petrikkos G.

Could procalcitonin be a predictive biological marker in systemic fungal infections? Study of 14 cases Eur J Internal Med 2002, 13: 493-495


BDN 628 Korppi M, Remes S, Heiskanen-Kosma T.

Serum Procalcitonin Concentrations in Bacterial Pneumonia in Children: A Negative Result in Primary Healthcare Settings Ped Pulmonol 2003, 35: 56-61

BDN 630 Moerer O, Schmid A, Hofmann A.Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use Intensive Care Med. 2002, 28: 1440-1446

BDN 631 Meisner M, Müller V, Khakpour Z et al.

Induction of procalcitonin and proinflammatory cytokines in an anhepatic baboon endotoxin shock model SHOCK, 19 (2): 187-190

BDN 632 Schüttrumpf S, Binder L, Hagemann T et al.

Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients? Ann Hematol 2003, 82: 98-103

BDN 633 Martinez JM, Wagner KE, Snider RH et al.

Late Immunoneutralization of procalcitonin arrests the progression of lethal porcine sepsis Surg Infections 2001, 2 (3): 193-203

BDN 634 Balci C, Sungurtekin H, Gürses E et al.

Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit Critical Care 2003, 7: 85-90

BDN 636 Hatzistilianou M, Hitoglou S, Gougoustamou D et al.

Serum procalcitonin adenosine deaminase and its isoenzymes in the aetiological diagnosis of pneumonia in children Intern J Immunopathology Pharmacol 2002, 15( 2): 119-127

BDN 637 Molnár Z, Szakmány T, Heigl P.

Microalbuminuria does not reflect increased systemic capillary permeability in septic shock Intensive Care Med 2003, 29: 391-395

BDN 638 Sablotzki A, Dehne MG, Friedrich I et al.

Different expression of cytokines in suvivors and non-survivors from MODS following cardiovascular surgery Eur J Med Res 2003, 8: 71-76

BDN 639 Connert S, Stremmel W, Elsing C.

Procalcitonin is a valid marker of infection in decompensated cirrhosis Z Gastroenterol 2003: 41: 165-170

BDN 640 Martin GS, Mannino DM, Eaton S, Moss M.

The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med 2003, 348 (16): 1546-1554

BDN 641 Maruna P, Gürlich R, Fraško R et al.

[Procalcitonin in diagnosis of post-operative complications] [in Czech] Sborník lékaĭský 2002, 103 (2): 283-295

BDN 642 Hryniewiecki T, Sitkiewicz D, Rawczyńska-Englert I.

[Role of procalcitonin in diagnosis of uncomplicated infective endocarditis] [in Polish] Przeglad Lekarski 2002, 59 (10): 793-795

BDN 643 Mary R, Veinberg F, Couderc R.

[Bacterial meningitis, inflammatory proteins and procalcitonin] [in French] Ann Biol Clin 2003, 61 (2) : 127-137

BDN 644 Pelinka LE, Sendova K, Mauritz W et al.

Quantitative versus semiquantitative procalcitonin measurement Europ Journal of Trauma 2003, No. 2: 81-84

BDN 645 Kocazeybek B, Küçükoğlu S, Öner YA.

Procalcitonin and c-reactive protein in infective endocarditis: correlation with etiology and prognosis Chemotherapy 2003, 49: 76-84

BDN 646 Riché FC, Cholley BP, Laisné MJC et al.

Inflammatory cytokines, C- reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis Surgery 2003, 133 (3): 257-262


BDN 647 Molter GP, Soltész S, Kottke R et al.[Procalcitonin plasma concentrations and systemic inflammatory response following different types of surgery] [in German] Anaesthesist 2003, 52 : 210-217

BDN 648 Delèvaux I, André M, Colombier M et al.

Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 2003, 62: 337-340

BDN 649 Resch B, Gusenleitner W, Müller WD.

Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate Acta Paediatr 2003, 92: 243-245

BDN 650 Leclerc F, Cremer R, Noizet O.

Procalcitonin as a diagnostic and prognostic biomarker of sepsis in critically ill children Pediatr Crit Care Med 2003, 4 (2): 264-266

BDN 651 Carlet J.

Rapid diagnostic methods in the detection of sepsis Bacterial Sepsis and Septic Shock 1999, 13 (2): 483-494

BDN 652 Levy MM, Fink MP, Marshall JC et al.

2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference Crit Care Med 2003, 31 (4): 1250-1256

BDN 653 Ittner L, Born W, Rau B et al.

Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma Europ Journal of Endocrinology 2002, 147: 727-731

BDN 654 Czyzewska M, Lachowska M, Gajewska E.

[Evaluation of diagnostic value of procalcitonin (PCT) as a marker of congenital infection in newborns] [in Polish] Przeglad Lekarski 2002, 59 (Suppl 1): 46-49

BDN 655 Casado-Flores J, Blanco-Quirós A, Asensio J et al.

Serum procalcitonin in children with suspected sepsis: a comparison with c-reactive protein and neutrophil count Pediatr Crit Care Med 2003, 4 (2): 190-195

BDN 656 Werner J, Hartwig W, Uhl W, Müller Ch.

Useful markers for predicting severity and monitoring progression of acute pancreatitis Pancreatology 2003, 3: 115-127

BDN 657 Villanueva JL, Cervin RJ.

Serum procalcitonin levels and empirical antibiotic treatment of patients with community-acquired febrile syndromesClin. Infect. Dis. 2003, 36 (6) 822

BDN 658 Nylen E, Muller B, Becker KL, Snider R.

The future diagnostic role of procalcitonin levels: the need for improved sensitivity Clin. Infect. Dis. 2003, 36 (6) : 823-824

BDN 659 van Dissel JT.

Procalcitonin: what should be its role in the clinical management of febrile patients admitted to the hospital? Clin. Infect. Dis. 2003, 36 (6) : 824-825

BDN 660 Debard AL, Vautrin C, Pariset C et al.

High serum procalcitonin levels do not predict bacteremia in adult patients with acute fever Clin. Infect. Dis. 2003, 36 (6) : 825-826

BDN 661 Chirouze C. and Hoen B.

High serum procalcitonin levels do not predict bacteremia Clin. Infect. Dis. 2003, 36 (6): 825-826 in adult patients with acute fever Clin. Infect. Dis. 2003, 36 (6) : 826-827

BDN: 662 Dahaba AA, Rehak PH, List WF.

Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis Intensive Care Med 2003, 29: 579-583

BDN 663 Schinkel C, Zedler S, Faist E et al.

Clinical relevance of biochemical markers for the diagnosis, prognosis and therapy of polytraumtized patients [in German] Intensivmed 2002, 39: 327-333


BDN 664 Polzin A, Pietz M, Erbes R, Raffenberg M, Mauch H, Wagner S, Arndt G, Lode H. Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis Eur Resp J 2003, 21: 939-943

BDN 665 Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A.

Comparison of procalcitonin and C-reactive protein as markers of sepsis Crit Care Med 2003, 31(6): 1737-1741

BDN 666 Kordek A, Giedrys-Kalemba S, Pawlus B, Podraza W, Czajka R.

Umbilical cord serum procalcitonin concentration in the diagnsosis of early neonatal infection J Perintology 2003, 23: 148-153

BDN 667 Hoffmann G, Schobersberger W.

Procalcitonin as a marker Acta Anaesthesiol Scand 2003, 47: 237

BDN 668 Chauveau P, Level C, Lasseur C, Bonarek H, Peuchant E, Montaudon D, Vendrely B, Combe C.

C-reactive protein and procalcitonin as markers of mortality in hemodialysis patients : A 2-year prospective study J Renal Nutrition 2003, 13(2): 137-143

BDN 669 Boeken U, Feindt P, Schulte HD, Gams E.

Elastase release following myocardial ischemia during extracorporeal circulation (ECC) . Marker of ongoing systemic inflammation? Thorac Cardiov Surg 2002, 41: 136-140

BDN 670 Prat C, Dominguez J, Rodrigo C, Gimenz M, Azuara M, Jimenez O, Gali N, Ausina V.

Elevated serum procalcitonin values correlate with renal scarring in children with urinary tract infection Pediatr Infect Dis J 2003, 22: 438-442

BDN 671 Gattas DJ, Cook DJ.

Procalcitonin as diagnostic test for sepsis: Health technology assessment in the ICU J Crit Care 2003, 18(1): 52-58

BDN 672 Sauer M, Tiede K, fuchs D, Gruhn B, Berger D, Zintl F.

Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbiditiy and mortality from sepsis Bone Marrow Transplantation 2003, 31: 1137-1142

BDN 673 Koskenvuo MM, Irjala K, Kinnala A, Ruuskanen O, Kero P.

Value of monitoring serum procalcitonin in neonates at risk of infection Eur J Microbiol Infect Dis 2003, 22 : 377-378

BDN 674 Marx C, Petros S, Bornstein SR, Weise M, Wendt M, Menschikowski M, Engelmann L, , Höffken G.

Adrenocortical hormones in survivors and nonsurvivors of severe sepsis: Diverse time course of dehydroepiandrostenone, dehydroepiandrostenone-sulfate and cortisol Crit Care Med 2003, 31 (5): 1382-1388

BDN 675 Holzheimer RG.

Oral antibiotic prohpylaxis can influence the inflammatory response in aortic aneurism repair: Results of a randomised clinical study J Chemotherapy 2003, 15 (2): 157-164

BDN 676 Hohenberger P, Latz E, Kettelhack C, Rezaei A-H, Schumann R, Schlag PM.

Pentoxifyllin attenuates the systemic inflammatory response induced during isolated limb perfusion with recombinant human tumor necrosis factor-α and Melphalan Ann Surg Oncol 2003, 10(5): 562-568

BDN 677 Gerlach H, Dhainaut JF, Harbarth S, Reinhart K, Marshall JC, Levy M.

The PIRO concept: R is for response Critical Care 2003, 7(3): 256-259

BDN 678 Reinhart K, Brunkhorst FM, Bloos F.

New considerations in the treatment of sepsis [in German] Deutsches Ärzteblatt 2003, 100 (31-32): A2080-A2086

BDN 680 Heinemann A, Tsokos M, Püschel K.

Medico-legal aspects of pressure scores Legal Medicine 2003, 5: 263-266

BDN 681 Kin H, Kawazoe K, Nakajima T et al.

Perioperative serum procalcitonin concentrations in patients with acute aortic dissection European Surgical Research 2003, 35: 451-454


BDN 682 Frasquet J, Sáez J, Trigo C et al.Early measurement of procalcitonin does not predict severity in patients with acute pancreatitis British Journal of Surgery 2003, 90: 1129-1130

BDN 683 Kabir K, Keller H, Grass G et al.

Cytokines and chemokines in serum and urine as early predictors to identify septic patients on intensive care unit Intern Journal of Molecular Medicine 2003, 12: 565-570

BDN 684 Gessner Ch, Hammerschmidt S, Kuhn H et al.

Exhaled breath condensate nitrite and its relation to tidal volume in acute lung injury Clinical Investigations in Critical Care CHEST 2003, 124(3): 1046-1052

BDN 685 Galstyan GM, Gorodetsky VM, Berkovsky AL et al.

Procalcitonin as a marker of infection inflammation: clinical value and application [in Russian] Kon ABTOPOB 2003, 2: 26-31

BDN 686 Hubl W, Kraßler J, Zingler Ch et al.

Evaluation of a fully automated procalcitonin chemiluminescence immunoassay“ Clin Lab 2003, 49: 319-327

BDN 687 Scirè CAS, Caporali R, Perotti C, Montecucco C.

Plasma procalcitonin in rheumatic diseases [Italian] Reumatismo 2003, 55(2):113-118

BDN 688 Fernandez Lopez A, Cubells L, García G et al.Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker Pediatr Infect Dis J 2003, 22: 895-903

BDN 689 Molnar Z, Szakmany T, Koszegi T.

Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial Intensive Care Med 2003, 29: 749-755

BDN 690 Monneret G, Arpin M, Venet F et al.

Calcitonin gene related peptide and N-procalcitonin modulate CD11b upregulation in lipopolysaccharide activated monocytes and neutrophils Intensive Care Med 2003, 29: 923-928

BDN 691 Riedemann NC, Guo RF, Ward PA.

The enigma of sepsis J Clin Invest 2003, 112: 460-467

BDN 692 Vincent JL, Jacobs F.

Infection in critically ill patients: clinical impact and management Cur Opin Infect Dis 2003, 16: 309-313

BDN 711 Fazakas J, Gondos T, Varga M et al.

Analysis of systemic and regional procalcitonin serum levels during liver transplantation Transpl Int 2003, 16: 465-470

BDN 712 Ammori BJ, Becker KL, Kite P, Snider RH, Nylen ES, White JC, Barclay GR, Larvin M, McMahon MJ

Calcitonin precursors: Early markers of gut barrier dysfunction in patients with acute pancreatitis Pancreas 2003, 27(3): 239-243

BDN 713 Kandemir Ö, Uluba B, Polat G, Sezer C, Camdeviren H, Kaya A.

Elevation of procalcitonin level in patients with pulmonary tuberculosis and in medical staff with close patient contact. Arch Med Res 2003, 34: 3111-314

BDN 714 Brun-Buisson, Roudot-Thoraval, Girou E, Grenier-Sennelier C, Durand-Zaleski I.

The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis Intensive Care Med 2003, 29: 1464-1471

BDN 715 Hensler T, Sauerland S, Lefering R et al.

The clinical value of procalcitonin and neopterin in predicting sepsis and organ failure after major trauma SHOCK 2003, 20 (5): 420-426

BDN 716 Bihan H, Becker KL, Snider RH et al.Calcitonin precursor levels in human medullary thyroid carcinoma THYROID 2003, 13 (8): 819-822


BDN 717 Dornbusch HJ, Strenger V, Kerbl R et al.Procalcitonin and C-reactive protein do not discriminate between febrile reaction to anti-T-lymphocyte antibodies and gram-negative sepsis Bone Marrow Transplantation 2003, 32: 941-945

BDN 718 Yaoi Y, Suzuki M, Tomura H et al.

Expression and localization of prohormone convertase PC1 in the calcitonin-producing cells of the bullfrog ultimobranchial gland The Journal of Histochemistry & Cytochemistry 2003, 51 (11): 1459-1466

BDN 719 Meisner M.

Drotrecogin alfa (activated): increased survival in severe sepsis Advances in Sepsis 2003, 3 (2): 34-44

BDN 720 Feezor RJ, Oberholzer C, Baker HV et al.

Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria Infection and Immunity Oct. 2003, 71 (10): 5803-5813

BDN 721 Linscheid P, Seboek D, Nylen ES et al.

In vitro and in vivo calcitonin-I gene expression in parenchymal cells: a novel product of human adipose tissue Endocrinology 2003, 144(12): 5578-5584.

BDN 722 Siassi M, Hohenberger W, Riese J.

Mannan-binding lectin (MBL) serum levels and post-operative infections Biochemical Society Transactions 2003, 31 (4): 774-775

BDN 723 Morgenthaler NG, Struck J, Chancerelle Y et al.

Production of procalcitonin (PCT) in non-thyroid tissue after LPS injection Hormon Metab Res 2003, 35 (5): 290-295

BDN 724 Beghetti M, Rimensberger PC, Kalangos A et al.

Kinetics of procalcitonin, interleukin 6 and C-reactive protein after cardiopulmonary-bypass in children Cardiol Young 2003, 13: 161-167

BDN 725 Kretzschmar M, Krüger A, Schirrmeister W.

Hepatic ischemia-reperfusion syndrome after partial liver resection (LR): hepatic venous oxygen saturation, enzyme pattern, reduced and oxidized glutathione, procalcitonin and interleukin-6* Exp Toxic Pathol 2003, 54: 423-431

BDN 726 Engle WD, Jackson GL, Sendelbach DM et al.

Pneumonia in term neonates: laboratory studies and duration of antibiotic therapy Journal of Perinatology 2003, 23: 372-377

BDN 727 Geppert A, Steiner A, Delle-Karth G. et al.

Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock Intensive Care Med 2003, 29: 1384-1389

BDN 728 Makay R, Issekutz A, Banga P et al.

Clinical value of procalcitonin quick test to differentiate steril and infected forms of acute pancreatitis [in Hungarian]Magyar Sebészet 2003, 56: 31-33

BDN 729 Prucha, M, Herold I, Zazula R et al.

Comparison of procalcitonin, interleukin-6 and C-reactive protein in the differential diagnosis of patients with sepsis syndrome in intensive care units [in Czech] Vnitr Lek 2003, 49 (7): 541-7

BDN 731 Moerer O und Burchardi H.

Sepsis – Epidemiologie und ökonomische Aspekte Intensiv- und Notfallbehandlung 28 (1) 2003, 4-19

BDN 732 Reinhart K, Meisner M, Hartog C.

Diagnosis of sepsis: novel and conventional parameters ADVANCES in Sepsis 2001, 1 (2): 42-49

BDN 733 Engelmann L. Patienten mit Sepsis versterben am “second hit” Intensiv-News 9/2003, 2-3

BDN 734 Lempinen M, Kylänpää M, Kemppainen E.

Laboratory tests in acute pancreatitis CLI September 2003: 8-10


BDN 735 Kettelhack C, Hohenberger P, Furchtbar S et al.Procalcitonin as a marker for the systemic inflammatory reaction after isolated limb perfusion [in German] Langenbecks Arch Chir (Forumband 1998), 399-402

BDN 736 Scott LK, Grier LR, Arnold TC et al.

Serum procalcitonin concentrations as a negative predictor of serious bacterial infection in acute sickle cell pain crisis Med Sci Monit 2003, 9 (10): CR426-431

BDN 737 Fritz HG, Brandes H, Bredle DL et al.

Post-operative hypoalbuminaemia and procalcitonin elevation for predicition of outcome in cardiopulmonary bypass surgery Acta Anaesthesiol Scand 2003, 47: 1276-1283

BDN 738 Fries M, Kunz D, Gressner AM et al.

Procalcitonin serum levels after out-of-hospital cardiac arrest Resuscitation 2003, 59: 105-109

BDN 739 Sauerland S, Hensler T, Bouillon B et al.

Plasma levels of procalcitonin and neopterin in multiple trauma patients with or without brain injury Journal of Neurotrauma 2003, 20 (10): 953-960

BDN 740 Galetto-Lacour A, Zamora SA, Gervaix A.

Bedside procalcitonin and C-reactive protein tests in children with fever without localizing of infection seen iin a referral center Pediatrics 2003, 112 (5): 1054-1060

BDN 741 Nierhaus A, Montag B, Timmler N et al.

Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis Intensive Care Med 2003, 29: 646-651

BDN 742 Matesanz JL, Fernandez E, Fernandez JM, Viejo G.

Plasma procalcitonin and C-reactive protein concentrations in pediatric patients with Epstein-Barr virus infection Clin Chem 2003, 49 (12): 2103-2104

BDN 743 Rau B, Steinbach G, Krüger CM et al.

Clinical value of lipopolysaccharide-binding protein (LBP) determinations in acute pancreatitis Langenbecks Arch Surg 2003, 388: 181-188

BDN 744 Wahl HG, Herzum I, Renz H.

Sepsis und Sepsismarker – Update J Lab Med 2003: 27 (11/12): 431-439

BDN 745 Berger C, Schwarz S, Schaebitz WR et al.

Serum procalcitonin in cerebral ventriculitis Crit Care Med 2002, 30 (8): 1778-1781

BDN 746 Bolko P, Manuszewska-Jopek E, Michalek K et al.

Efficacy of procalcitonin measurement in patients after total thyroidectomy due to medullary thyroid carcinoma Archivum Immunologiae et Therapiae Experimentalis 2003, 51: 415-419

BDN 747 Okada Y, Minakami H, Tomomasa T et al.

Serum procalcitonin concentration in patients with Kawasaki disease Journal of Infection 2004, 48: 199-205

BDN 748 Albrecht M, Doroszewicz J, Gillen S et al.

Proliferation of prostate cancer cells and activity of neutral endopeptidase is regulated by Bombesin and IL-Iß with IL-Iß acting as a modulator of cellular differentiation The Prostate 2004, 58: 82-94

BDN 749 van Haelst PL, Liem A, van Boven AdJ et al.

Usefulness of elevated neopterin and c-reactive protein levels in predicting cardiovascular events in patients with non-q-wave myocardial infarction The American Journal of Cardiology 2003, 92: 1201-1203

BDN 750 Casoni F, Merelli E, Bedin R et al.

Is serum neopterin level a marker of responsiveness to interferon beta-1° therapy in multiple sclerosis? Acta Neurol Scand 2004, 109: 61-65


BDN 751 Neely AN, Fowler LA, Kagan RJ, Warden GD.Procalcitonin in pediatric burn patients: an early indicator of sepsis? Journal of Burn Care & Rehabilitation 2004, 25 (1): 76-80

BDN 752 Giamarellos-Bourboulis EJ, PlachourasD, Tzivra A et al.Stimulation of innate immunity by susceptible and multidrug-resistant pseudomonas aeruginosa : an in vitro and in vivo study Clin Exp Immunol 2004, 135: 240-246

BDN 753 Bell K, Wattie M, Byth K et al.

Procalcitonin: a marker of bacteraemia in SIRS Anaesth Intensive Care 2003, 31 (6): 629-636

BDN 754 Braun N, Marfo Y, von Gärtner C et al.

CTLA-4 positive T cells in contrast to procalcitonin plasma levels discriminate between severe and uncomplicated plasmodium falciparum malaria in Ghanaian children Tropical Medicine and International Health 2003, 8 (11): 1018-1024

BDN 755 D’Intini V, Bordoni V, Fortunato A et al.

Longitudinal study of apoptosis in chronic uremic patients Seminars in Dialysis 2003, 16 (6): 467-473

BDN 756 Christ-Crain M, Jaccard-Stolz D, Bingisser R et al.

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infectiions: cluster-randomised, single-blinded intervention trial THE LANCET- Lancet 2004, 363(9409) : 600-607.

BDN 757 Szakmany T, Molnar Z.

Procalcitonin levels do not predict mortality following major abdominal surgery Can J of Anesth 2003, 50 (10): 1082-1083

BDN 758 Ilhan Nevin, Ilhan Necip, Ilhan Y et al.

C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer World J Gastroenterol 2004, 10 (8): 1115-1120

BDN 759 Lendemans S, Kreuzfelder E, Waydhas C et al.

Clinical course and prognostic significance of immunological and functional parameters after severe trauma [in German] Unfallchirurg 2004, 107: 203-210

BDN 760 Müller-Werdan U.

Septic shock and systemic inflammatory response syndrome – diagnostics [in German] Dtsch Med Wochenschr 2003, 128: 2368-2371

BDN 761 Dörge H, Schöndube FA, Dörge P et al.

Procalcitonin is a valuable prognostic marker in cardiac surgery but not specific for infection Thorax Cardiov Surg 2003, 51: 322-326

BDN 762 Prat C, Dominguez J, Rodrigo C et al.

Procalcitonin, c-reactive protein and leukocyte count in children with lower respiratory tract infection Pediatr Infect Dis J 2003, 22 (11): 963-967

BDN 763 Becker KL, Nylen ES, Snider RH et al.

Immunoneutralization of procalcitonin as therapy of sepsis Journal of Endotoxin Research 2003, 9 (6): 367-374

BDN 764 Oude Nijhuis CSM, Vellenga E, Daenen SMGJ et al.

Lipopolysaccharide-binding protein : a possible diagnostic marker for gram-negative bacteremia in neutropenic cancer patients Intensive Care Med 2003, 29: 2157-2161

BDN 765 Ciaccio M, Fugardi G, Titone L et al.

Procalcitonin levels in plasma in oncohaematologic patients with and without bacterial infections Clinica Chimica Acta 2004, 340: 149-152

BDN 766 Lee YJ, Park CH, Yun JW et al.

Predictive comparisons of procalcitonin (PCT) level, arterial ketone body ratio (AKBR), APACHE III score and multiple organ dysfunction score (MODS) in systemic inflammatory response syndrome (SIRS) Yonsei Med J 2004, 45 (1): 29-37


BDN 767 Korczowski B, Szybist W. Serum procalcitonin and c-reactive protein in children with diarrhoea of various aetiologies Acta Paediatr 2004, 93: 169-173

BDN 768 Müller C, Huber P, laifer G et al.

Procalcitonin and the early diagnosis of infective endocarditis Circulation April 13, 2004: 1707-1710

BDN 769 Boutoille D, Struillou L, Kourt Del et al.

[Meningitis with direct negative bacteriological examination – prospective assessment of a decision making tree] [in French] Presse Med 2004, 33 (4): 235-240

BDN 770 Korczowski B.

Procalcitonin and c-reactive protein in vaccination-associated adverse reactions The Pediatric Infectious Disease Journal 2004, 23 (3): 283

BDN 771 Odamaki M, Kato A, Kumagai H et al.

Counter-regulatory effects of procalcitonin and indoxyl sulphate on net albumin secretion by cultured rat hepatocytes Nephrol Dial Transplant 2004, 19: 797-804

BDN 772 Chan YL, Tseng CP, Tsay PK et al.

Procalcitonin as a marker of bacterial infection in the emergency department: an observational study Critical Care 2004, 8 (1): R12-R20

BDN 773 Chua AP, Lee KH

Procalcitonin in severe acute respiratory syndrome (SARS) Journal of Infection 2004, 48: 303-306

BDN 774 Caterino JM, Scheatzle MD, Forbes ML et al.

Bacteremic elder emergency department patients: procalcitonin and white count ACAD EMERG MED 2004, 11 (4): 393-396

BDN 775 Distefano G, Curreri R, Betta P et al.

Procalcitonin serum levels in perinatal bacterial and fungal infection of preterm infants Acta Paediatr 2004, 93:216-219

BDN 776 Wunder C, Eichelbrönner O, Roewer N.

Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II Inflamm res 2004, 53: 158-163

BDN 777 Rau B, Krüger CM, Schilling MK.

Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis Langenbecks Arch Surg 2004, 389: 134-144

BDN 778 Arkader R, Troster EJ, Abellan DM et al.

Procalcitonin and C-reactive protein kinetics in postoperative pediatric cardiac surgical patients Journal of Cardiothoracic and Vascular Anesthesia 2004, 18 (2): 160-165

BDN 779 Engelmann L, Gundelach K, Leonhardt U et al.

Sepsis – Gesichertes in Diagnostik und Therapie Medizin im Dialog, 2001, Sep 24

BDN 780 Sandek A, Springer J, Habedank D et al.

Procalcitonin-guided antibiotic treatment in heart failure The Lancet 2004, 363: 1555-1556

BDN 781 Von Lilienfeld-Toal M, Dietrich MP, Glasmacher A et al.

Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than CRP Eur J Microbiol Infect Dis 2004, 23: 539-544

BDN 782 Vedrine C, Caralon C, Lambert C, Genin C.Cytometric bead assay of cytokines in sepsis: a clinical evaluation Cytometry Part B (Clin Cytometry) 2004, 608: 14-22

BDN 783 Steinbach G, Rau B, Debard A-L et al.

Multicenter evaluation of a new immunoassay for procalcitonin measurement on the KRYPTOR system Clin Chem Lab Med 2004, 42(4): 440-449


BDN 784 Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J.Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis CID 2004, 39(2): 206-217

BDN 785

Shimetani N, Shimetani K, Mori M.Clinical evaluation of the measurement of serum procalcitonin: comparative study of procalcitonin and serum amyloid A protein in patients with high and low concentrations of serum C-reactive protein Scand J Clin Lab Invest 2004, 64 : 469-474

BDN 786 Russwurm S, Reinhart K.

Procalcitonin mode of action: New pieces in a complex puzzle Crit Care Med 2004, 32(8): 1801-1802

BDN 787 Rauchschwalbe SK, Maseizik T, Mittelkötter U et al.

Effect of the LT-α (+250G/A) polymorphism on markers of inflammation and clinical outcome in critically ill patients J Trauma Injury, Infection Crit Care 2004, 56(4): 815-822

BDN 788 Potapov EV, Wagner FD, Loebe M et al.

Elevated donor cardiac troponin T and procalcitonin indicate two independent mechanisms of early graft failure after heart transplantation Int J Cardiol 2003, 92: 163-167

BDN 789 Persson L, Engervall P, Magnuson A et al.

Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia Scand J Infect Dis 2004, 36 : 365-371

BDN 790 Pecile P, Miorin E, Romanello C et al.

Procalcitonin: A marker of severity of acute pyelonephritis among children Pediatrics 2004, 114(2): e249-e254

BDN 790a Canning, D. A.

Procalcitonin: a marker of severity of acute pyelonephritis among children. J Urol. 2005 Dec;174(6): 2371

BDN 791 Ortega M, Rovina M, Filella X et al.

Prospective evaluation of procalcitonin in adults with febbrile neutropenia after haemopoietic stem cell transplantation Brit J Haematol 2004, 126: 372-376

BDN 792 Michelow IC, Olsen K, Lozano J et al.

Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalised children Pediatrics 2004, 113(4): 701-707

BDN 793 Rau B, Kemppainen E, Gumbs A, Uhl W, Büchler MW, Wegscheider K, Bassi C, Puolakkainen P, Beger

HG, Schilling MK Clinical value of procalcitonin PCT) in predicting infectious complications and overall prognosis in severe acute pancreatitis: A prospective international multicenter study ISICEM 2003, Oral presentation, Abstract

BDN 794 Garcia-Zarza Martinez E, Ramos Amador JT, Rubio Gribble B, Corrales del Rio E, Zeballos Sarrato

G,Herrera Montes J. Utility of serum procalcitonin as a diagnostic guide in children with community-acquired pneumonia [in Spanish] An Pediatr (Barc). 2004, 60(3):279-281.

BDN 795 Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Müller B.

Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med. 2004, 32(8): 1715-1721

BDN 796 Leclerc F, d’Herbomez M.

Procalcitonin in the pediatric ICU [in French] Arch Pediatr. 2004 Jun;11(6): 587-9.

BDN 797 Le Roy F, Barbier S, Passos EM, Godin M.

Inflammation markers in daily practice [in French] Nephrologie. 2003 ;24(7) :347-350

BDN 798 Kuhn P, Escande B, Rivera S, Langlet C, Messer J.

Procalcitonin and neonatal infection [in French] Arch Pediatr. 2004 Jun;11(6): 585-586


BDN 799 Korczowski B, Malek U, Kowalczyk JR, Rybak A, Zinkiewicz A, Chmielewska A. Two diagnostic assays for serum procalcitonin measurement in clinical practice [in Polish] Przegl Lek. 2003;60(5): 345-348

BDN 800 Jimeno A, Garcia-Velasco A, del Val O, Gonzalez-Billalabeitia E, Hernando S, Hernandez R, Sanchez-

Munoz A, Lopez-Martin A, Duran I, Robles L, Cortes-Funes H, Paz-Ares L. Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia. Cancer. 2004 Jun 1;100(11): 2462-2469

BDN 801 Herrlinger KR, Dittmann R, Weitz G, Wehkamp J, Ludwig D, Schwab M, Stange EF, Fellermann K.

Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis. Inflamm Bowel Dis. 2004 May;10(3): 229-33.

BDN 802 Gibot S, Kolopp-Sarda MN, Bene MC, Cravoisy A, Levy B, Faure GC, Bollaert PE.

Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med. 2004 Jul 6;141(1): 9-15.

BDN 803 Gendrel D.

Use of procalcitonin at the pediatric emergency room [in French] Arch Pediatr. 2004 Jun;11(6): 582-4.

BDN 804 Egger G, Aigner R, Glasner A, Hofer HP, Mitterhammer H, Zelzer S.

Blood polymorphonuclear leukocyte migration as a predictive marker for infections in severe trauma: comparison with various inflammation parameters. Intensive Care Med. 2004 Feb;30(2): 331-4

BDN 805 Carvalho PR, Trotta Ede A.

Advances in sepsis diagnosis and treatment (Review) Pediatr (Rio J). 2003 Nov;79 Suppl 2: S195-204.

BDN 806 Yonetci N, Sungurtekin U, Oruc N, Yilmaz M, Sungurtekin H, Kaleli I, Kaptanoglu B, Yuce G, Ozutemiz

O. Is procalcitonin a reliable marker for the diagnosis of infected pancreatic necrosis? ANZ J Surg. 2004 Jul;74(7): 591-5.

BDN 807 Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L.

Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004 Aug;8(4): R234-242

BDN 808 Resch B, Gusenleitner W, Muller W.

Procalcitonin, interleukin-6, C-reactive protein and leukocyte counts in infants with bronchiolitis Pediatr Infect Dis J. 2003 May;22(5): 475-476

BDN 809 Struck J, Ühlein M, Bergmann A.

New markers of sepsis using proteome analysis Immuno-analyse & Biologie spécialisée 2004, 19: 131-137

BDN 810 Giamarellou H, Giamarellos-Bourboulis EJ, Repoussis P, Galani L, et al.

Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study Clin Microbiol Infect. 2004 Jul;10(7): 628-633.

BDN 811 Carrigan SD, Scott G, Tabrizian M.

Toward resolving the challenges of sepsis diagnosis Clin Chem. 2004 Aug;50(8): 1301-1314

BDN 812 Bihari D.

Monitoring procalcitonin is of value in acute pancreatitis. BMJ. 2004 Jul 24;329(7459): 232

BDN 813 Esen F.

From bench to bedside: is intensive care immunology of any use? “Sepsis, SIRS, Immune, Response – Concepts, Diagnostics and Therapy” Pabst 2003, ISBN 3-89967-101-5 (Europe), ISBN 1-59326-066-0 (USA)


BDN 814 Van Rossum AM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis. 2004 Oct;4(10): 620-630

BDN 815 Luyt CE, Guerin V, Combes A, Trouillet JL, Ben Ayed S, Bernard M, Gibert C, Chastre J.

Procalcitonin Kinetics as a Prognostic Marker of Ventilator-Associated Pneumonia Am J Respir Crit Care Med, 2005. 171(1): p. 48-53

BDN 816 Kadar J, Petrovicz E.

Adult-onset Still’s disease. Best Pract Res Clin Rheumatol. 2004 Oct;18(5): 663-676

BDN 817 Simon A, Bijzet J, Voorbij HA, Mantovani A, Van Der Meer JW, Drenth JP.

Effect of inflammatory attacks in the classical type hyper-IgD syndrome on immunoglobulin D, cholesterol and parameters of the acute phase response. J Intern Med. 2004 Sep;256(3): 247-253

BDN 818 Florianczyk B.

Structure and diagnostic value of procalcitonin. Ann Univ Mariae Curie Sklodowska [Med]. 2003;58(1):338-342.

BDN 819 Chachkhiani I.

Benefit of assessment of cytokines in inflammatory postoperative complications [in Czech] Sb Lek. 2003;104(4):303-312

BDN 820 Reingardiene D.

Procalcitonin as a marker of the systemic inflammatory response to infection [in Lithuanian] Medicina (Kaunas). 2004;40(7): 696-701.

BDN 821 Hajek T, Bartunek L, Topolcan O, Polivkova V, Hess Z, Holubec L Jr.

The role of procalcitonin in the patient assessment after surgical procedures [in Czech] Rozhl Chir. 2004 Jul;83(7): 337-341.

BDN 822 Munoz P, Simarro N, Rivera M, Alonso R, Alcala L, Bouza E.

Evaluation of procalcitonin as a marker of infection in a nonselected sample of febrile hospitalized patients. Diagn Microbiol Infect Dis. 2004 Aug ;49(4) :237-241.

BDN 823 Bugden SA, Coles C, Mills GD

The potential role of procalcitonin in the emergency department management of febrile young adults during a sustained meningococcal epidemic. Emerg Med Australas. 2004 Apr;16(2): 114-119.

BDN 824 Torbe A, Czajka R.

Maternal plasma procalcitonin concentrations in patients with preterm labor and intact membranes—prediction of preterm delivery and admission-to-delivery interval. J Perinat Med. 2004;32(4): 332-336

BDN 825 Bender A, Elstner M, Paul R, Straube A.

Severe symptomatic aseptic chemical meningitis following myelography: The role of procalcitonin. Neurology. 2004 Oct 12;63(7): 1311-1313.

BDN 826 Barassi A, Pallotti F, D’Eril GM.

Biological variation of procalcitonin in healthy individuals. Clin Chem. 2004 Oct;50(10):1878.

BDN 827 Erten, N., et al.

The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients. J Chin Med Assoc, 2004. 67(5) : p. 217-221.

BDN 828 Miyakis, S., et al.

Serial serum procalcitonin changes in the prognosis of acute stroke. Clin Chim Acta, 2004. 350(1-2) : p. 237-239.

BDN 829 Cojocaru, I.M., et al.

Investigation of TNF-alpha, IL-6, IL-8 and of procalcitonin in patients with neurologic complications in sepsis. Rom J Intern Med, 2003. 41(1): p. 83-93.

BDN 830 Taskin, E., et al.

Serum procalcitonin and cerebrospinal fluid cytokines level in children with meningitis. Mediators Inflamm, 2004. 13(4): p. 269-273.


BDN 831 Torbe, A. and R. Czajka

Proinflammatory cytokines and other indications of inflammation in cervico-vaginal secretions and preterm delivery. Int J Gynaecol Obstet, 2004. 87(2) : p. 125-130

BDN 832 Liu XL., et al.

[Significance of soluble intercellular adhesion molecule-1 and procalcitonin in diagnosis of neonatal septicemia] [in Chinese]. Zhonghua Er Ke Za Zhi, 2004. 42(9): p. 654-658.

BDN 833 Reith, H.B., et al.

IgM-enriched immunoglobulin (pentaglobin) positively influences the course of post-surgical intra-abdominal infections. Eur J Med Res, 2004. 9(10): p. 479-84.

BDN 834 Aalto, H., et al.

Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. Eur J Clin Microbiol Infect Dis, 2004. 23(9): p. 699-704.

BDN 835 Giamarellos-Bourboulis, E.J., et al.

Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis? J Crit Care, 2004. 19(3): p. 152-157.

BDN 836 Korppi, M.

Non-specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the most accurate combination? Pediatr Int, 2004. 46(5): p. 545-550.

BDN 837 Kerbaul, F., et al.

High concentrations of N-BNP are related to non-infectious severe SIRS associated with cardiovascular dysfunction occurring after off-pump coronary artery surgery. Br J Anaesth, 2004. 93(5): p. 639-644.

BDN 838 Torbe, A. and R. Czajka

Procalcitonin in cervicovaginal secretion in pregnancies complicated by preterm labor—a preliminary report. Eur J Obstet Gynecol Reprod Biol, 2004. 116(2): p. 177-181.

BDN 839 Eletr, D., et al.

Arteriovenous carboxyhemoglobin difference is not correlated to TNF-alpha, IL-6, PCT, CRP and leukocytes in critically ill patients. Clin Chim Acta, 2004. 349(1-2) : p. 75-80.

BDN 840 Ballot, D.E., et al.

Serum procalcitonin as an early marker of neonatal sepsis. S Afr Med J, 2004. 94(10): p. 851-854.

BDN 841 Torbe, A., E. Bartkowiak, and R. Czajka

Maternal serum procalcitonin concentrations in preterm labour complicated by premature rupture of membranes [in Polish]. Med Wieku Rozwoj, 2003. 7(3 Suppl 1): p. 335-341.

BDN 842 Tvede, M. Procalcitonin—acute inflammatory marker in infections [in Danish]. Ugeskr Laeger, 2004. 166(43): p.

BDN 843 Pavcnik-Arnol, M., S. Hojker, and M. Derganc

Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein. Intensive Care Med, 2004. 30(7): p. 1454-1460.

BDN 844 Schroder, H. and D. Lodahl

Procalcitonin as a marker of severe bacterial infection in children [in Danish]. Ugeskr Laeger, 2004. 166(43): p. 3804-7.

BDN 845 Papachristou, G.I. and D.C. Whitcomb

Predictors of severity and necrosis in acute pancreatitis. Gastroenterol Clin North Am, 2004. 33(4): p. 871-890.

BDN 846 Kawczynski, P. and A. Piotrowski

Procalcitonin and C-reactive protein as a markers of neonatal sepsis [in Polish]. Ginekol Pol, 2004. 75(6): p. 439-444.


BDN 847 Hammer, S., et al.

Interleukin-6 and procalcitonin in serum of children undergoing cardiac surgery with cardiopulmonary bypass. Acta Cardiol, 2004. 59(6): p. 624-629.

BDN 848 Clec’h, C., et al.

Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med, 2004. 32(5) : p. 1166-9.

BDN 849 Müller B., et al.

Limits to the use of the procalcitonin level as a diagnostic marker. Clin Infect Dis, 2004. 39(12): p. 1867-1868.

BDN 850 Müller B.

Procalcitonin and ventilator-associated pneumonia: yet another breath of fresh air. Am J Respir Crit Care Med, 2005. 171(1) : p. 2-3.

BDN 851 Blab, E., et al.

Advancements in the diagnosis of acute appendicitis in children and adolescents. Eur J Pediatr Surg, 2004. 14(6): p. 404-409.

BDN 852 Mitaka, C.

Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta, 2005. 351(1-2) : p. 17-29.

BDN 853 Ayten, R., O. Dogru, et al.

Predictive Value of Procalcitonin for the Diagnosis of Bowel Strangulation. World J Surg, 2005, 29(2): 187-189.

BDN 853a Papaziogas B, Anthimidis G, Koutelidakis I, Atmatzidis S and Atmatzidis K.

Predictive Value of Procalcitonin for the Diagnosis of Bowel Strangulation. World J Surg 2008

BDN 854 Carrol, E.D., et al.

Prognostic value of procalcitonin in children with meningococcal sepsis. Crit Care Med, 2005. 33(1): p. 224-225.

BDN 855 Bernhardt, H. and M. Knoke

Frühsignale systemischer Mykosen Leitlinien fürTherapieentscheidungen? [in German]. Mycoses, 2004. 47(s1): p. 60-65.

BDN 856 Zahorec, R., et al.

Renal rescue therapy in early stage of severe sepsis: a case study approach. Bratisl Lek Listy, 2004. 105(10-11) : p. 345-352.

BDN 857 Lateef, A., S. M. Khoo, et al.

Procalcitonin in hypoxic brain damage. Intensive Care Med 2005, 31(3): 494.

BDN 858 Kurihara, T, Fujishima S, Aikawa N.

[Evaluation of severity for systemic inflammatory response syndrome and sepsis.] [in Japanese] Nippon Rinsho, 2004. 62(12): 2291-2295.

BDN 859 Rello J et al.

De-escalation therapy in ventilator associated pneumonia. Crit Care Med 2004, 32 (11): 2183-2190

BDN 860 Müller C, Christ-Crain M, Müller B.

What cardiologists do nee to know about Procalcitonin. Clin Lab 2005, 51(1-2) : 1-4.

BDN 861 Volante E et al.

Early diagnosis of bacterial infection in the neonate. J Matern Fetal Neonatal Med, 2004. 16 Suppl 2: p. 13-6.

BDN 862 Hsiao AL, Baker MD.

Fever in the new millennium: a review of recent studies of markers of serious bacterial infection in febrile children. Curr Opin Pediatr, 2005. 17(1) : p. 56-61.

BDN 863 Oconnor E et al.

Serum procalcitonin and C-reactive protein as markers of sepsis and outcome in patients with neurotrauma and subarachnoid haemorrhage. Anaesth Intensive Care, 2004. 32(4): p. 465-470.


BDN 864 Herget-Rosenthal S et al.

Modulation and source of procalcitonin in reduced renal function and renal replacement therapy. Scand J Immunol, 2005. 61(2): p. 180-186.

BDN 865 Morgenthaler NG et al.

Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit Care, 2005. 9(1): p. R37-45.

BDN 866 Steinbach G et al.

Procalcitonin in patients with acute and chronic renal insufficiency. Wien Klin Wochenschr, 2004. 116(24) : p. 849-853.

BDN 867 Mosheimer B A, Kaneider NC et al.

Syndecan-1 is involved in OPG-induced chemotaxis in human peripheral blood monocytes. J Clin Endocrinol Metab 90(5): 2964-71.

BDN 868 Müller B, Peri G, Doni A, Perruchoud AP, Landmann R, Pasqualini F, Mantovani A.

High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration. J Leukoc Biol. 2002 Oct;72(4):643-649.

BDN 869 Rivers E, Nguyen B et al.

Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001. 345(19): 1368-1377.

BDN 870 Merle C et al.

Surgery for mesenteric infarction: Prognostic factors associated with early death within 72 hours. J Cardiothorac Vasc Anesth, 2004. 18(6) : p. 734-741.

BDN 871 Cakir E et al.

Pleural fluid and serum procalcitonin as diagnostic tools in tuberculous pleurisy. Clin Biochem, 2005. 38(3): p. 234-238.

BDN 872 Franzin L, Cabodi D

Legionella pneumonia and serum procalcitonin. Curr Microbiol, 2005. 50(1) : p. 43-46.

BDN 873 Axer H et al.

Procalcitonin as a marker for severe sepsis in an immunosuppressed patient [in German] Anasthesiol Intensivmed Notfallmed Schmerzther, 2005. 40(2): p. 97-102.

BDN 874 Sarbinowski R et al.

Plasma concentration of procalcitonin and systemic inflammatory response syndrome after colorectal surgery. Acta Anaesthesiol Scand, 2005. 49(2): p. 191-196.

BDN 876 Madhi SA, et al.

Use of Procalcitonin and C-Reactive Protein to Evaluate Vaccine Efficacy against Pneumonia. PloS Med, 2005. 2(2): p. 147-151.

BDN 877 Schmidt H et al.

[Reversible autonomic dysfunction in a young woman with septic multiple organ dysfunction syndrome.] [in German] Dtsch Med Wochenschr, 2005. 130(12) : p. 648-651.

BDN 878 Olah A et al.

Value of procalcitonin quick test in the differentiation between sterile and infected forms of acute pancreatitis. Hepatogastroenterology, 2005. 52(61): p. 243-245.

BDN 879 Stryjewski GR et al.

Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children. Pediatr Crit Care Med, 2005. 6(2) : p. 129-135.

BDN 880 Kouame DB et al.

Is procalcitoninable to help in pediatric appendicitis diagnosis ? [in French] Ann Chir, 2005. 130(3): p. 169-174.

BDN 881 Persson L et al.Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia. Eur J Haematol, 2005. 74(4): p. 297-303.


BDN 882 Rau B, Schilling MK and Beger HG.Laboratory markers of severe acute pancreatitis. Dig Dis, 2004. 22(3): p. 247-257.

BDN 883 Wroblewski T, Marcisz C, and Kurzawska G.

[Diagnostic utility of procalcitonin in community-acquired respiratory tract infections—a literature review.] [in Polish] Postepy Hig Med Dosw (Online), 2004. 58: p. 495-505.

BDN 884 Pasnik J.

Participation of procalcitonin in inflammatory response after cardiovascular surgery [in Polish] Postepy Hig Med Dosw (Online), 2004. 58: p. 522-529.

BDN 885 Linscheid, P., D. Seboek, et al.

Autocrine/paracrine role of inflammation-mediated Calcitonin Gene-Related Peptide and Adrenomedullin expression in human adipose tissue. Endocrinology 2005, 146(6): 2699-2708.

BDN 886 Schleicher, G.K., et al.

Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia. Eur Respir J, 2005. 25(4): p. 688-692.

BDN 887 Mokart, D., M. Merlin, et al.

Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 2005, 94(6): 767-773.

BDN 888 Vazzalwar, R., E. Pina-Rodrigues, et al.

Procalcitonin as a Screening Test for Late-Onset Sepsis in Preterm Very Low Birth Weight Infants. J Perinatol 2005, 25(6): 397-402.

BDN 889 Lepe Jimenez, J., A. Vazquez Florido, et al.

[Utility of procalcitonin, C-reactive protein and leukocyte count in the detection of meningococcal disease during an epidemic cluster.] [in Spanish] An Pediatr (Barc) 2005. 62(4): 328-332.

BDN 890 Ito, S., N. Sato, et al.

Serum procalcitonin levels are elevated in esophageal cancer patients with postoperative infectious complications. Eur Surg Res 2005. 37 (1): 22-28.

BDN 891 Szakmany, T., I. Toth, et al.

Effects of volumetric vs. pressure-guided fluid therapy on postoperative inflammatory response: a prospective, randomized clinical trial. Intensive Care Med 2005, 31(5): 656-663.

BDN 892 Gibot, S., A. Cravoisy, et al.

Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med 2005. 33(4) : 792-6.

BDN 893 Petrikkos, G. L., S. A. Christofilopoulou, et al.

Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections. Eur J Clin Microbiol Infect Dis 2005, 24(4) : 272-275.

BDN 894 Yukioka, H.

[Infection and plasma procalcitonin.] [in Japanese] Clin Calcium, 2005. 15(3): p. 472-7.

BDN 895 Kusnierz-Cabala, B. and D. Galicka-Latala

[Diagnostic value of procalcitonin (PCT) determination.] [in Polish] Przegl Lek 2005. 61(9) : 978-980.

BDN 896 Wojtacha, A., J. Juszczyk, et al.

[Spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis based on bacteriological and biochemical results] [in Polish] Przegl Epidemiol 2005. 58(4): 597-607.

BDN 897 Buzurnaya, M., V. Melnikova and V.M. Yurevich

[Optimization of antibacterial therapy in operated neonates on the basis of early diagnosis of septic complications.] [in Russian] Anesteziol Reanimatol 2005. (1): 46-50.


BDN 898 Prucha, M., I. Herold, et al. Significance of lipopolysaccharide-binding protein (an acute phase protein) in monitoring critically ill patients. Crit Care 2003. 7(6): R154-159.

BDN 899 Leroy, S., C. Adamsbaum, E. Marc, F. Moulin, J. Raymond, D. Gendrel, G. Breart and M. Chalumeau

Procalcitonin as a Predictor Vesicoureteral Reflux in Children with a first Febrile Urinary Tract Infection Pediatrics 2005. 2004-1631

BDN 901 Oberholzer, A., S. M. Souza, et al.

Plasma Cytokine Measurements Augment Prognostic Scores As Indicators Of Outcome In Patients With Severe Sepsis. Shock 2005, 23(6): 488-493.

BDN 902 Prat, C., J.Dominguez, C. Rodrigo, M. Gimenez, M. Azuara, S.Blanco,V. Ausina

Use of Quantitative and Semiquantitative Procalcitonin Measurements to Identify Children with Sepsis and Meningitis Eur J Clin Microbiol Infect Dis. 2004 Feb ;23(2) :136-138

BDN 903 Gerlach, H.

[Sepsis: New Markers – obsolete definitions ?] [in German] Chir. Praxis 2005, 64: 399-401.

BDN 904 Falcoz, P. E., F. Laluc, et al.

Usefulness of procalcitonin in the early detection of infection after thoracic surgery. Eur J Cardiothorac Surg 2005, 27(6) : 1074-1078.

BDN 905 Meisner, M.

[Are there new markers for the early recognition of sepsis?] [in German] (Review) Chir. Praxis 2005, 64 : 403-418.

BDN 906 Aikawa, N., S. Fujishima, et al.

Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 2005, 11(3): 152-159.

BDN 907 Gervaix, A. and J. Pugin

[Usefulness of procalcitonin in adults and children.] [in French] Rev Med Suisse, 2005. 1(13): p. 872-874, 877

BDN 908 Gervaix, A.

[Inflammatory markers in pediatric emergency care centers.] [in French] Arch Pediatr, 2005. 12(6): p. 694-696.

BDN 909 Desvignes, P. and A. Boutib

[Semi quantitative determination of blood procalcitonin by the immunochromatographic BRAHMS PCT-Q test: false positive result.] [in French] Ann Biol Clin (Paris), 2005. 63(3): p. 358-359.

BDN 910 Bigot, S., P. Leblond, et al.

[Usefulness of procalcitonin for the diagnosis of acute pyelonephritis in children] [in French] Arch Pediatr 2005, 12(7): 1075-1080.

BDN 911 Melnikova, V., M. Buzurnaya et al.

[Modern technologies in pediatric diagnostics and intensive care.] [in Russian] Vestn Ross Akad Med Nauk, 2005(5): p. 36-38.

BDN 912 Olczyk, P., E. M. Kozma, et al. [Biochemical diagnostics in acute pancreatitis recognition and outcome predicition.] [in Polish] Przegl Lek 2004, 61(12): 1420-1427.

BDN 913 Viallon A., et al.Decrease in serum procalcitonin levels over time during treatment of acute bacterial meningitis. Crit. Care 2005, 9(4): R344-R350

BDN 914 Al-Nakeeb, S. and G. Clermont Procalcitonin testing has the potential to reduce unnecessary antibiotic use in patients with suspected lower respiratory tract infections. Crit Care, 2005. 9(3): p. E5.

BDN 915 Schneider, A., U. Sack, et al. Peritoneal taurolidine lavage in children with localised peritonitis due to appendicitis. Pediatr Surg Int, 2005. 21(6): p. 445-448.


BDN 916 Robinson, J. O., T. Calandra, et al. Utility of procalcitonin for the diagnosis and the follow-up of infections in febrile neutropenic patients [in French] Rev Med Suisse 2005, 1(13): 878-882, 885-886.

BDN 917 Ballieux B.E.P.B. et al.

[Difference between procalcitonin and CRP in a patient with POMC deficiency and high doses of corticosteroids.] [in Dutch] Ned Tijdschr Klin Chem Labgeneesk 2004, 29: 267-268

BDN 918 Van der Kaay D.C.M. et al. [BRAHMS PCT-Q semiquantitative test method to determine procalcitonin in children with meningococcal disease.] [in Dutch] Ned Tijdschr Klin Chem Labgeneesk 2004, 29: 308-313

BDN 919 Thayyil S. et al.Is procalcitonin useful in early diagnsosis of serious bacterial infections in children? Acta Paediatrica 2005, 94: 155-158

BDN 920 Shafiq, N., S. Malhotra, et al. Estimating the diagnostic accuracy of procalcitonin as a marker of the severity of acute pancreatitis: a meta-analytic approach Jop 2005, 6(3): 231-237.

BDN 921 Boussekey, N., O. Leroy, H. Georges, P. Devos, T. d’Escrivan, and B. Guery Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit Infection 2005, 33(4) : 257-263.

BDN 922 Hitoglou-Hatzi, S., M. Hatzistilianou, et al. Serum adenosine deaminase and procalcitonin concentrations in neutropenic febrile children with acute lymphoblastic leukaemia Clin Exp Med 2005, 5(2): 60-65.

BDN 923 Gurgoze, M. K., S. Akarsu, et al. Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis. Pediatr Nephrol. Pediatr Nephrol. 2005 Oct;20(10):1445-8

BDN 924 Briel, M., M. Christ-Crain, J. Young, P. Schuetz, P. Huber, P. Periat, H. C. Bucher, and B. Muller Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners BMC Fam Pract 2005, 6(1): 34.

BDN 925 Puder, J. J., S. Vargas, M. Kraenzlin, C. De Geyter, U. Keller, and B. Muller Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance J Clin Endocrinol Metab. 2005, 90 (11): 6014-6021

BDN 926 Martinot, M., C. Sordet, M. Soubrier, X. Puechal, A. Saraux, F. Liote, P. Guggenbuhl, V. Legre, B.

Jaulhac, J. F. Maillefert, M. Zeisel, G. Coumaros, and J. Sibilia Diagnostic value of serum and synovial procalcitonin in acute arthritis: a prospective study of 42 patients. Clin Exp Rheumatol 2005, 23(3): 303-310.

BDN 927 Modrau, I. S., A. K. Floyd, and O. Thorlacius-UssingThe clinical value of procalcitonin in early assessment of acute pancreatitis. Am J Gastroenterol2005, 100(7): 1593-1597.

BDN 928 Sedlackova, L., M. Prucha, et al. [Immunological monitoring of sepsis using flow cytometry—quantitation of monocyte HLA-DR expression and granulocyte CD64 expression.] [in Czech] Epidemiol Mikrobiol Imunol 54(2): 54-61

BDN 929 Prat, C., J. Dominguez, F. Andreo, S. Blanco, A. Pallares, F. Cuchillo, C. Ramil, J. Ruiz-Manzano, and V. Ausina. Procalcitonin and neopterin correlation with aetiology and severity of pneumonia J Infect. 2006 Mar;52(3):169-77

BDN 930 Laifer, G., M. Wasner, P. Sendi, P. Graber, O. Gratzl, P. Huber, U. Fluckiger, and W. Zimmerli. Dynamics of serum procalcitonin in patients after major neurosurgery Clin Microbiol Infect 2005, 11(8): 679-681


BDN 931 Ek, T., M. Pinkava, and J. AbrahamssonAra-C fever and infections after high-dose ara-C treatment in pediatric lymphoid malignancies J Pediatr Hematol Oncol 2005, 27(7): 364-369

BDN 932 Jeena, P. The role of HIV infection in acute respiratory infections among children in sub-Saharan Africa Int J Tuberc Lung Dis 2005, 9(7):708-15.

BDN 933 Sorbera, L. A. Procalcitonin as an effective biomarker for the diagnosis and prognosis of severe sepsis Drugs Today (Barc) 2005, 41(4): 253-256

BDN 934 Macrina, F., L. Tritapepe, F. Pompei, A. Sciangula, E. Evangelista, F. Toscano, A. Criniti, G. Brancaccio, and P. E. Puddu Procalcitonin is useful whereas C-reactive protein is not, to predict complications following coronary artery bypass surgery Perfusion 2005, 20(3):169-175

BDN 935 Visvardis, G., I. Griveas, et al. Relevance of procalcitonin levels in comparison to other markers of inflammation in hemodialysis patients Ren Fail 2005, 27(4): 429-434

BDN 936 Stucker, F., F. Herrmann, J. D. Graf, J. P. Michel, K. H. Krause, and G. Gavazzi. Procalcitonin and infection in elderly patients J Am Geriatr Soc 2005, 53(8): 1392-1395

BDN 936a Christ-Crain M and Muller B. Procalictonin-you only find what you look for, and you only look for what you know. J Am Geriatr Soc 2006;54 (3): 546; author reply 547-8.

BDN 937 Ilhan, F., H. Akbulut, I. Karaca, A. Godekmerdan, E. Ilkay, and V. Bulut. Procalcitonin, c-reactive protein and neopterin levels in patients with coronary atherosclerosis Acta Cardiol 2005, 60(4): 361-365

BDN 938 Conti, G., A. Amore, M. Chiesa, D. Mancuso, P. Cirina, G. Mengozzi, A. Santoro, and R. Coppo. Procalcitonin as a marker of micro-inflammation in hemodialysis J Nephrol 2005, 18(3): 282-288

BDN 939 Siassi M., J.R., R. Steffensen, M. Meisner, S. Thiel, W. Hohenberger, J. Schmidt Mannan binding lectin and procalcitonin measurement for prediction of postoperative infection. Critical Care, 2005. 9: p. 483-489

BDN 940 Tuerlinckx, D., T. Vander Borght, Y. Glupczynski, L. Galanti, V. Roelants, B. Krug, G. de Bilderling, and

E. Bodart. Is procalcitonin a good marker of renal lesion in febrile urinary tract infection? Eur J Pediatr. 2005 Oct;164(10):651-2

BDN 941 Marton, S., T. Szakmany, A. Papp, L. Cseke, and P. O. Horvath. Does transthoracic compared to transhiatal resection alter the early postoperative course of oesophagectomy? Dis Esophagus 2005, 18(3): 155-159

BDN 942 Franke, A., W. Lante, V. Fackeldey, H. P. Becker, E. Kurig, L. G. Zoller, C. Weinhold, and A. Markewitz.Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know? Eur J Cardiothorac Surg. 2005 Oct;28(4):569-75

BDN 943 Hladik, M., A. Olosova, J. Neiser, and T. Zaoral. Procalcitonin—a marker and mediator of inflammation Acta Chir Plast 2005, 47(2) : 51-54

BDN 944 Kafetzis, D. A., G. S. Tigani, and C. Costalos. Immunologic markers in the neonatal period: diagnostic value and accuracy in infection. Expert Rev Mol Diagn2005, 5(2): 231-239

BDN 945 Davis, B. H. Improved diagnostic approaches to infection/sepsis detection. Expert Rev Mol Diagn 2005, 5(2): 193-207

BDN 946 Taboulet, P. and J. P. Feugeas [Acute dyspnea in the emergency room: the utility of troponin, natriuretic, procalcitonin and D-dimers] [in French] Ann Biol Clin (Paris) 2005, 63(4): 377-384


BDN 947 Liu, X. L., B. Du, J. Q. Pan, Y. Xu, and B. L. Hua[Role of procalcitonin in the differentiation and surveillance of systemic inflammatory response syndrome.] [in Chinese] 2005, Zhongguo Yi Xue Ke Xue Yuan Xue Bao 27(1): 48-52

BDN 948 Kindberg Boysen, A., J.S. Madsen, and P.E. JorgensenProcalcitonin as a marker of postoperative complications Scand J Clin Lab Invest, 2005. 65(5): p. 387-394

BDN 949 Dornbusch, H. J., V. Strenger, R. Kerbl, H. Lackner, W. Schwinger, P. Sovinz, and C. UrbanProcalcitonin-a marker of invasive fungal infection? Support Care Cancer2005, 13(5): 343-346

BDN 950 Christ-Crain M. & Muller B. Procalcitonin in bacterial infections –hype, hope, more or less? Swiss Med Wkly 2005, 135: 451-460

BDN 951 Masia, M., F. Gutierrez, C. Shum, S. Padilla, J. C. Navarro, E. Flores, and I. Hernandez Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index Chest 2005, 128(4): 2223-2229

BDN 952 De Mendonca-Filho, H. T., G. S. Gomes, P. M. Nogueira, M. A. Fernandes, B. R. Tura, M. Santos, and H. C. Castro-Faria-Neto Macrophage Migration Inhibitory Factor Is Associated With Positive Cultures In Patients With Sepsis After Cardiac Surgery Shock 2005, 24(4): 313-317

BDN 953 Pasnik, J., J. A. Moll, J. Moll, A. Cywinska-Bernas, W. Mazurowski, J. Arendarczyk, A. Sysa, M. Banasik, and K. Zeman Alterations of procalcitonin and interleukin 6 after cardiopulmonary bypass in children with congenital heart disease]. Pol Merkuriusz 2005 Lek 19(109): 20-23

BDN 954 Bota DP, van Nuffelen M, Zakariah N, Vincent JLSerum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver J Lab Clin Med December 2005, 146(6): 347-351

BDN 955 Dwolatzky T, Olshtain-Pops K, Yinnon AM, Raveh D, Rogowski O, Shapira I, Rotstein R, Berliner S, Rudensky B. Procalcitonin in the elderly: normal plasma concentrations and response to bacterial infections Eur J Clin Micribiol Infect Dis 2005, 24: 763-765

BDN 956 Torbe A., and Czajka R. Are vaginal fluid procalcitonin levels useful for the prediction of subclinial infection in patients with preterm premature rupture of membranes? J. Obstet Gynaecol Res, 2005, 31(5): 464-470

BDN 957 Meisner, M. Biomarkers of sepsis: clinically useful? Curr Opin Crit Care 2005 11(5): 473-480

BDN 958 Nagasaki, T., and M. Inaba. [Calcitonin, procalcitonin] Review [in Japanese] Nippon Rinsho, 2005, 63 Suppl 8: 295-299

BDN 959 Tavares, E., R. Maldonado, M. L. Ojeda, and F. J. Minano.Circulating inflammatory mediators during start of fever in differential diagnosis of gram-negative and gram-positive infections in leukopenic rats Clin Diagn Lab Immunol, 2005, 12(9): 1085-1093

BDN 960 Mahdi, A. D. Ventilator - associated pneumonia and the role of procalcitonin Acta Med Indones, 2005, 37(3):170-172

BDN 961 Kafetzis, D A, I. M. Velissariou, P. Nikolaides, M. Sklavos, M. Maktabi, G. Spyridis, D. D. Kafetzis, and E. Androulakakis Procalcitonin as a predictor of severe appendicitis in children Eur J Clin Microbiol Infect Dis, 2005, 24(7): 484-487


BDN 962 Scheingraber, S., D. Dobbert, P. Schmiedel, E. Seliger, and H. DralleGender-specific differences in sex hormones and cytokines in patients undergoing major abdominal surgery Surg Today, 2005, 35(10): 846-854

BDN 963 Casado-Flores, J., A. Blanco-Quiros, M. Nieto, J. Asensio, and C. Fernandez Prognostic utility of the semi-quantitative procalcitonin test, neutrophil count and C-reactive protein meningococcal infection in children Eur J Pediatr 2006, 165: 26-29

BDN 964 Al-Bahrani, A. Z., and B. J. Ammori Clinical laboratory assessment of acute pancreatitis Clin Chim Acta 2005, 362: 26-48

BDN 965 Czerwionka-Szaflarska M, Parzecka M.[Role of procalcitonin concentration in clinical diagnosis.] [in Polish] Pol Merk Lek Oct. 2005, 19(112): 584-586

BDN 966 Beloborodova, N. V., and D. A. Popov[Diagnostic value of some markers of infection in cardiosurgical patients in the early postoperative period.] [in Russian] Anesteziol Reanimatol(3), 2005 : 45-49.

BDN 968

Chevalier, I., and M. Gauthier. Procalcitonin and vesicoureteral reflux in children with urinary tract infection Pediatrics, 2005, 116(5): 1261-1262; author reply 1262-1263

BDN 969 Ricci Z. and Ronco C. Year in review: Critical Care 2004 – nephrology Critical Care 2005, 9: 523-527

BDN 970 Beovic B., Kreft S., Osredkar J., Kese D., Bonac-Tuma B.Serum procalcitonin levels in patients with mild community-acquired pneumonia Clin. Microbiol. Infection 2005, 11(12):1048-1054

BDN 971 Meisner M., Adina H., Schmidt J.Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients Crit Care. 2006 Feb;10(1):R1

BDN 972 Beloborodova N.V. et al., Immunotherapy guided by procalcitonin- a new approach to prevent development of infectious complication in children with hereditary heart failure Chlidren’s heart and vascular diseases 2005, 3: 62-68

BDN 973 Christ-Crain M. and Muller B. Procalcitonin on the Dusty Way to the Holy Grail: A Progress Report Yearbook of Intensive Care and Emergency Medicine 2005, 461-476

BDN 974 Arkader R, Troster EJ, Lopes MR, Junior RR, Carcillo J, Leoni C, Okay TS. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome. Arch Dis Child. 2006, 91: 117-120

BDN 975 Trow Terence K. Clinical Year in Review II: Pulmonary Infections Proc Am Thorac Soc. 2005;2(3):175-8

BDN 976 Christ-Crain M., Morgenthaler N., Struck J., Harbarth S., Bergmann A., Muller B. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study Crit Care 2005, 9(6): R816-R824

BDN 977 Joram N, Boscher C, Denizot S, Loubersac V, Winer N, Roze JC, Gras-Le Guen C Umbilical cord blood procalcitonin and C reactive protein concentrations as markers for early diagnosis of very early onset neonatal infection Arch Dis Child Fetal Neonatal Ed 2006, 91: F65-F66

BDN 978 Clec’h C, Fosse J-P, Karoubi P, Vincent F, Chouahi I, Hamza L, Cupa M, Cohen Y. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock Crit Care 2006, 34 (1): 102-107


BDN 980 Goossens H, Ferech M, Stichele RV, Elseviers M.Outpatient antibiotic use in Europe and association with resistance: a cross-national database study Lancet. 2005 Feb 12-18;365(9459):579-87

BDN 981 Venet C, Tardy B, Zéni F. [Biological markers of infection in critically ill adult patients: role of procalcitonin.] [in French] Réanimation 2002, 11: 1-16

BDN 982 Lotric-Furlan S, Rojko T, Strle F.

Concentration of procalcitonin and C-reactive protein in patients with human granulocytic anaplasmosis and the initial phase of tick-borne encephalitis. Ann N Y Acad Sci. 2005 Dec; 1063: 439-441

BDN 983 Castelli GP, Pognani C, Cita M, Stuani A, Sgarbi L, Paladini R. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiol. 2006 Jan-Feb;72(1-2): 69-80

BDN 985 Pincikova T, Bucova M, Slobodnikova L. [Influrence of recombinant human procalcitonin on phagocytic and candidacidal ability of polymorphonuclear leukocytes and on killing mechanisms of serum and blood aganist bacteria Staphylococcus aureus and Escherichia coli.] [Czech] VNITR LEK. 2005 DEC;51(12): 1365-1370.

BDN 987 Pindak D, Parrak V, Pechan J, Vavrecka A, Kuzela L, Fuchs D, Irsakova J.

The clinical value of the procalcitonin in prediction of severity and outcome in acute pancreatitis. Hepatogastroenterology, 2003 Dec, 50(2): ccviii-ccix

BDN 988 Kepa L, Oczko-Grzesik B, Bledowski D. [Procalcitonin (PCT) concentration in cerebrospinal fluid and plasma of patients with purulent and lymphocytic meningoencephalitis--own observations.] [Polish] Przegl Epidemiol, 2005; 59(3): 703-709

BDN 989 Butbul-Aviel Y, Koren A, Halevy R, Sakran W. Procalcitonin as a diagnostic aid in osteomyelitis and septic arthritis. Pediatr Emerg Care. 2005 Dec; 21(12): 828-832

BDN 990 Reinhart WH. [Erythrocyte sedimentation rate--just an old fashion?] [German] Ther Umsch, 2006 Jan;63(1): 108-112

BDN 991

Kern WV. Risk assessment and treatment of low-risk patients with febrile neutropenia Clin Infect Dis 2006 Feb 15,42(4), 533-540

BDN 992 Ortega M, Rovira M, Fillela X, Matinez JA, Almela M, Puig J, Carreras E, Mensa J. Prospective evaluation of procalcitonin in adults with non-neutropenic fever after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant, 2006 March, 37(5): 499-502

BDN 994 Opatrna S., Klaboch J., Opatrny K. Jr., Holubec L., Tomsu M., Sefrna F., Topolcan O. Procalcitonin levels in peritoneal dialysis patients. Perit Dial Int. 2005 Sep-Oct;25(5): 470-472

BDN 995 Boussekey N, Leroy O, Alfandari S, Devos P, Georges H, Guery B. Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia. Intensive Care Med. 2006 Mar; Epub 2006 Feb 14, 32(3): 469-472

BDN 996 Pihusch M, Pihusch R, Fraunberger P, Pihusch V, Andreesen R, Kolb HJ, Holler E. Evaluation of C-reactive protein interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients. Eur J Haematol. 2006 Feb;76(2):93-101

BDN 997 Madhi SA, Kohler M, Kuwanda L, Cutland C, Klugman KP. Usefulness of C-reactive protein to define pneumococcal conjugate vaccine efficacy in the prevention of pneumonia. Pediatr Infect Dis J. 2006 Jan; 25(1): 30-36


BDN 998 Level C, Chauveau P, Guisset U, Cazin MC, Lasseur C, Gabinsky C, Winnock S, Montaudon D, Bedry R, Nouts C, Pillet O, Benissan GG, Favarel-Guarrigues JC, Castaing Y. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure. Crit Care 2003, 7(6): 160-166

BDN 999 Verboon-Maciolek MA, Thijsen S, Hemels MA, Menses M, Van Loon AM, Krediet TG, Gerhards LJ, Fleer A, Voorbij AM, Rijers GT. Inflammatory mediators for the diagnosis and treatment of sepsis in early infancy. Pediatric Res. 2006, 59(3): 457-461

BDN 1000 Viallon A, Guyomarc’h S, Zeni F, Piteaud I, Lucht F, Levy M, Cotte L, Aubert G, Bertrand JC.Serum procalcitonin and cerebrospinal fluid lactate levels in emergency room differential diagnosis of acute meningites with a negative Gram stain. JEUR 2003, 16: 4-12

BDN 1001 Bogar L, Molnar Z, Kenyeres P, Tarsoly P. Sedimentation characteristics of leukocytes can predict bacteremia in critical care patients. J Clin Pathol. 2006 May;59(5):523-5

BDN 1002 Turner D, Hammerman C, Rudensky B, Schlesinger Y, Goia C, Schimmel MS. Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch Dis Child Fetal Neonatal Ed. 2006 Jul;91(4):F283-6

BDN 1003 Ge QG, Yin CH, Wen Y, Lu JQ, Wang YB. [Clinical study of relationship between serum procalcitonin and severity of multiple organ dysfunction syndrome.] [Chinese] Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005 Dec ;17(12) :729-731

BDN 1004 Gibot S. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia and severe sepsis. Semin Respir Crit Care Med. 2006 Feb; 27(1): 29-33

BDN 1005 Chromik AM, Endter F, Uhl W, Thiede A, Reith HB, Mittelkotter U. Pre-emptive antibiotic treatment vs ‘standard’ treatment in patients with elevated serum procalcitonin levels after elective colorectal surgery: a prospective randomised pilot study. Langenbecks Arch Surg. 2006 Jun;391(3):187-94

BDN 1006 Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004 Jan 29; 350(5): 451-458

BDN 1007 Pindak D, Pechan J, Parrak V, Vavrecka A, Mifkovic A, Lutter I. The correlation of procalcitonin serum levels with the presence of biliary obstruction. Bratisl Lek Listy. 2005; 106(11): 373-374.

BDN 1008 Leroy S et al. Predictive value of procalcitonin for vesicoureteral reflux. Nat Clin Pract Urol. 2005 Jul 14; 2(7): 314-315 [Comment to BDN 899]

BDN 1009 Kusnierz-Cabala B, Naskalski JW, Galicka-Latala D. [Role of neopterin in clinical diagnostics.] [Polish] Przegl Lek. 2005, 62(7): 716-719

BDN 1010 Desideri-Vaillant C, Rouby Y, Cardon N, Vinsonneau U, Laborde JP. [Analytical interference in determination of procalcitonin by PCT-Q® (Brahms®).] [French] Pathol Biol (Paris). 2006 May;54(5):293-5

BDN 1011 Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Muller B. Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia: A Randomized Trial. Am J Respir Crit Care Med. 2006 Jul 1;174(1): 84-93.

BDN 1012 Dubos F, Lamotte B, Bibi-Triki F, Moulin F, Raymond J, Gendrel D, Breart G and Chalumeau M.Clinical decision rules to distinguish between bacterial and aseptic meningitis. Arch Dis Child. 2006 Aug;91(8):647-50

BDN 1013 Celebi S, Koner O, Menda F, Balci H, Hatemi A, Korkut K, Esen F. Procalcitonin kinetics in pediatric patients with systemic inflammatory response after open heart surgery. Intensive Care Med. 2006, 32: 881-887


BDN 1014 Chakhunashvili L, Inasaridze A, Svanidze S, Samkharadze J, Chkhaidze I. Procalcitonin as the biomarker of inflammation in diagnostics of pediatric appendicular peritonitis and for the prognosis of early postoperative complications. Georgian Med News. 2005 Dec; (129): 78-81

BDN 1015 Elefsiniotis IS, Skounakis M, Vezali E, Pantazis KD, Petrocheilou A, Pirounaki M, Papatsibas G, Kontou-Kastellanou C, Moulakakis A. Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease. Eur J Gastroenterol Hepatol. 2006 May; 18(5): 525-530

BDN 1016 Yasmin D, Bulut G, Yildiz M. [Can procalcitonin be used for the diagnosis and follow-up of postoperative complications after fracture surgery?] [Turkish] Acta Orthop Traumatol Turc. 2006; 40(1): 15-21

BDN 1017 Bülbüller N, Dogru O, Ayten R, Akbulut H, Ilhan YS, Cetinkaya Z. Procalcitonin is a predictive marker for severe acute pancreatitis. Ulus Travma Acil Cerrahi Derg. 2006 Apr ; 12(2) : 115-120

BDN 1018 Zhang YT, Ding GJ, Fang Q. [Clinical study of serum lipopolysaccharide-binding protein and soluble CD14 in severe sepsis patients.] [Chinese] Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006 Feb; 18(2): 78-81

BDN 1019 Liu CF, Cai XX, Xu W. [Serum procalcitonin levels in children with bacterial or viral meningitis.] [in Chinese] Zhongguo Dang Dai Er Ke Za Zhi. 2006 Feb; 8(1): 17-20

BDN 1020 Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis. Crit Care Med. 2006 May 17: 1-8

BDN 1020a Tang BM and Eslick GD. Procalcitonin for sepsis: Methodological issues in meta-analysis lead to further uncertainty. Crit Care Med 2007;35 (2): 679.

BDN 1020b Uzzan B, Cohen R, Nicolas P, Cucherat M and Perret GY. Procalcitonin for sepsis: Methodological issues in meta-analysis lead to further uncertainty. Crit Care Med 2007;35 (2): 679-80.

BDN 1021 Guz G, Colak B, Hizel K, Reis KA, Erten Y, Bali M, Sindel S. Procalcitonin and conventional markers of inflammation in peritoneal dialysis patients and peritonitis. Perit Dial Int. 2006 Mar-Apr; 26(2): 240-248

BDN 1022 Perez Solis D, Lopez Sastre JB, Coto Cotallo GD, Dieguez Junquera MA, Deschamps Mosquera EM, Crespo Hernandez M. [Procalcitonin for the diagnosis of neonatal sepsis of vertical transmission.] [Spanish] An Pediatr (Barc). 2006 Apr; 64(4): 341-348.

BDN 1023 Perez Solis D, Lopez Sastre JB, Coto Cotallo GD, Dieguez Junquera MA, Deschamps Mosquera EM, Crespo Hernandez M. [Procalcitonin for the diagnosis of nosocomial neonatal sepsis.] [Spanish] An Pediatr (Barc). 2006 Apr; 64(4): 349-353

BDN 1023a Bustos Betanzo RO. [Procalcitonin, C-reactive protein and leukocyte count in very-low birth weight infants with late neonatal sepsis.]. An Pediatr (Barc) 2007;66 (5): 541-2.

BDN 1024 Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett ED. Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care. 2006 Apr 13; 10(2): R60, 1-7

BDN 1025 Chopin N, Floccard B, Sobas F, Illinger J, Boselli E, Benatir F, Levrat A,Guillaume C, Crozon J, Negrier C, Allaouchiche B. Activated partial thromboplastin time waveform analysis: a new tool to detect infection? Crit Care Med. 2006 Jun; 34(6):1654-1660

BDN 1026 Lopez Sastre JB, Perez Solis D, Roques Serradilla V, Fernandez Colomer B, Coto Cotallo GD, Krauel Vidal X, Narbona Lopez E, Garcia Del Rio M, Sanchez Luna M, Belaustegui Cueto A, Moro Serrano M, Urbon Artero A, Alvaro Iglesias E, Cotero Lavin A, Martinez Villalta E, Jimenez Cobos B. Procalcitonin is not sufficiently reliable to be the sole marker of neonatal sepsis of nosocomial origin. BMC Pediatr. 2006 May 18; 6(1):16, 1-24


BDN 1027 Beloborodova NV, Arkhipova AS, Beloborodov DM, Boiko NB, Mel’ko AI, Olenin Aiu. [Chromatographic mass spectrometric determination of low-molecular-weight aromatic compounds of microbial origin in the serum from patients with sepsis.] [Russian] Klin Lab Diagn. 2006 Feb; (2): 3-6

BDN 1028 Kitanovski L, Jazbec J, Hojker S, Gubina M, Derganc M. Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer. Eur J Clin Microbiol Infect Dis. 2006 May 20: 413-415

BDN 1029 Gentili A, Iannella E, Giuntoli L, Baroncini S. System for predicting outcome and for clinical evaluation in sepsis and septic shock: could scores and biochemical markers be of greater help in the future? Comment to: Septic shock: current pathogenic concept from a clinical perspective. Med Sci Monit. 2006 May 29;12(6): LE11-12

BDN 1030 von Lilienfeld-Toal M, Schneider A, Orlopp K, Hahn-Ast C, Glasmacher A, Stuber F. Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies. Support Care Cancer 2006;14 (12): 1241-5.

BDN 1031 Ten Boekel E, Vroonhof K, Huisman A, van Kampen C, de Kieviet W. Clinical laboratory findings associated with in-hospital mortality. Clin Chim Acta. 2006 May 11: 1-13

BDN 1032 Pusterla N, Magdesian KG, Mapes S, Leutenegger CM. Expression of molecular markers in blood of neonatal foals with sepsis. Am J Vet Res. 2006 Jun; 67(6): 1045-1049

BDN 1033 Gouya G, Hartmann G, Fae P, Tauber M, Holzmuller H, Benzer W, Lang A, Schuster A, Drexel H, Offner FA. A case of fulminant post-transplant lymphoproliferative disorder and septicemia. Clin Transplant. 2006 Mar-Apr; 20(2): 261-264

BDN 1034 Bianchi RA, Haedo AS, Romero MC. [Role of plasma procalcitonin determination in the postoperative follow-up of cephalic pancreatoduodenectomy.] [Spanish] Cir Esp. 2006 Jun; 79(6): 356-360

BDN 1035 Martinot A, Dubos F, Hue V. [Diagnostic tests value at the emergency room: interpretation of results.] [French] Arch Pediatr. 2005 Jun; 12(6):700-702

BDN 1036 Stolz D, Christ-Crain M, Gencay M, Bingisser R, Huber P, Muller B, Tamm M. Diagnostic value of signs, symptoms and laboratory values in lower respiratory tract infection. Swiss Med Wkly. 2006 Jul 8; 136(27-28): 434-440

BDN 1037 Dubos F, Moulin F, Gajdos V, De Suremain N, Biscardi S, Lebon P, Raymond J, Breart G, Gendrel D, Chalumeau M. Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. J Pediatr. 2006 Jul; 149(1): 72-76

BDN 1038 Rinaldi S, Adembri C, Grechi S, De Gaudio AR. Low-dose hydrocortisone during severe sepsis: Effects on microalbuminuria. Crit Care Med. 2006 Sep;34(9):2334-9

BDN 1039 Schüttrumpf S, Binder L, Hagemann T, Berkovic D, Trumper L, Binder C. Utility of procalcitonin concentration in the evaluation of patients with malignant diseases and elevated C-reactive protein plasma concentrations. Clin Infect Dis. 2006 Aug 15; 43(4): 468-473

BDN 1040 Dambrauskas Z, Pundzius J, Barauskas G. Predicting development of infected necrosis in acute necrotizing pancreatitis. Medicina (Kaunas). 2006; 42(6): 441-449

BDN 1041 Christ-Crain M, Morgenthaler NG, Stolz D, Muller C, Bingisser R, Harbarth S, Tamm M, Struck J, Bergmann A, Muller B. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit Care. 2006 Jun 28; 10(3): R96

BDN 1042 Baylan O, Balkan A, Inal A, Kisa O, Albay A, Doganci L, Acikel CH. The predictive value of serum procalcitonin levels in adult patients with active pulmonary tuberculosis. Jpn J Infect Dis. 2006 Jun; 59(3): 164-167


BDN 1043 Jereb M, Kotar T. Usefulness of procalcitonin to differentiate typical from atypical community-acquired pneumonia. Wien Klin Wochenschr. 2006 Apr; 118(5-6): 170-174

BDN 1045 Fraunberger P, Wang Y, Holler E, Parhofer KG, Nagel D, Walli AK, Seidel D. Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever. Shock. 2006 Jul; 26(1): 10-12

BDN 1046 Kordek A, Podraza W, Czajka R. Reliability of semiquantitative determination of procalcitonin serum concentrations in neonates. Diagn Microbiol Infect Dis. 2006 Sep;56(1):31-4

BDN 1047 Bogar L, Molnar Z, Tarsoly P, Kenyeres P, Marton S. Serum procalcitonin level and leukocyte antisedimentation rate as early predictors of respiratory dysfunction after oesophageal tumour resection. Crit Care. 2006 Jul 19; 10(4): R110

BDN 1048 Gurlich R, Maruna P, Spicak J. [Prediction and monitoring of severe acute pancreatitis.] [Czech] Cas Lek Cesk. 2006; 145(6): 437-41; discussion 442

BDN 1049 Jebali MA, Jaber H, Shimi N, Guermazi M, Ferjani M. [Procalcitonin as a prognosis and diagnosis aid in post-operative cardiac surgery] [Frenc] Tunis Med. 2006 Apr; 84(4): 213-217

BDN 1050 Nguyen HB, Rivers EP, Abrahamian FM, Moran GJ, Abraham E, Trzeciak S, Huang DT, Osborn T, Stevens D, Talan DA. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med. 2006 Jul; 48(1): 28-54.

BDN 1051 Danai PA, Moss M, Mannino DM, Martin GS. The epidemiology of sepsis in patients with malignancy. Chest. 2006 Jun; 129(6): 1432-1440

BDN 1052 Laupland KB, Lee H, Gregson DB, Manns BJ. Cost of intensive care unit-acquired bloodstream infections. J Hosp Infect. 2006 Jun; 63(2): 124-32.

BDN 1053 Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D; Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006 Feb;34(2):344-353

BDN 1054 Angus DC, Pereira CA, Silva E. Epidemiology of severe sepsis around the world. Endocr Metab Immune Disord Drug Targets. 2006 Jun; 6(2): 207-12. Review.

BDN 1055 Zhou CD, Lu ZY, Ren NZ, Zhang GC. [Diagnostic value of procalcitonin in ventilator associated pneumonia.] [Chinese] Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006 Jun; 18(6): 370-372.

BDN 1056 Hryckiewicz K, Juszczyk J, Samet A, Arlukowicz E, Sledzinska A, Bolewska B. [Procalcitonin as a diagnostic marker in systemic inflammatory response syndrome (SIRS) and sepsis.] [Polish] Przegl Epidemiol. 2006; 60(1): 7-15

BDN 1057 Bauer M, Brunkhorst F, Welte T, Gerlach H, Reinhart K. [Sepsis : Update on pathophysiology, diagnostics and therapy.] [German] Anaesthesist. 2006 Jun 30: 835-845

BDN 1058 Moerer O, Burchardi H. [The cost of sepsis.] [German] Anaesthesist. 2006 May 10: S36-42

BDN 1060 Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortalit Crit Care Med. 2006 Oct; 34(10): 2596-2602

BDN 1061 Andrejaitiene, J.[The diagnostic value of procalcitonin in severe sepsis]. [In Lithuanien] Medicina (Kaunas) 42(1): 69-78.


BDN 1062 Dahaba A. A., B. Hagara, A. Fall, P. H. Rehak, W. F. List and H. Metzler. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth. 2006 Oct;97(4):503-8.

BDN 1064 Alscher, D. M. and T. Mettang Procalcitonin in peritoneal dialysis--a useful marker of inflammation? Perit Dial Int 25(5): 441-4.

BDN 1066 Bignardi GE, R. Dhar, R. Heycock, S. Bansal and N. Majmudar. Can procalcitonin testing reduce antibiotic prescribing for respiratory infections? Age Ageing 2006;35 (6): 625-6.

BDN 1069 Charles PE, F. Dalle, S. Aho, J. P. Quenot, J. M. Doise, H. Aube, N. O. Olsson and B. Blettery. Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients. Intensive Care Med 2006;32 (10): 1577-83.

BDN 1070 Chang C, W. Z. Yao, Y. H. Chen, Z. Y. Liu and X. W. Zhang. [The changes and clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease]. Zhonghua Jie He He Hu Xi Za Zhi 2006;29 (7): 444-7.

BDN 1071 Chapman KR, D. M. Mannino, J. B. Soriano, P. A. Vermeire, A. S. Buist, M. J. Thun, C. Connell, A. Jemal, T. A. Lee, M. Miravitlles, S. Aldington and R. Beasley. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006;27 (1): 188-207

BDN 1072 Chastre J, C. E. Luyt, J. L. Trouillet and A. Combes. New diagnostic and prognostic markers of ventilator-associated pneumonia. Curr Opin Crit Care 2006;12 (5): 446-51

BDN 1075 Elsammak M, H. Hanna, A. Ghazal, F. B. Edeen and M. Kandil. Diagnostic value of serum procalcitonin and C-reactive protein in Egyptian children with streptococcal tonsillopharyngitis. Pediatr Infect Dis J 2006;25 (2): 174-6.

BDN 1076 Emmanuel K, H. Weighardt, H. Bartels, J. R. Siewert and B. Holzmann. Current and future concepts of abdominal sepsis. World J Surg 2005;29 (1): 3-9.

BDN 1077 Ertugrul BM, A. Yilmabasar, O. Ertugrul, H. B. Ayabakan, S. Kizilirmak and S. Turkmen. Do C-reactive protein and procalcitonin predict hospital-acquired infection in patients with trauma? Saudi Med J 2006;27 (4): 560-2.

BDN 1078 Fang XL, Q. Fang and J. J. Luo. [Effects of raw rhubarb on plasma D-lactate and procalcitonin expressions in patients with sepsis]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2006;26 (2): 128-30.

BDN 1079 Gaini S, O. G. Koldkjaer, C. Pedersen and S. S. Pedersen. Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care 2006;10 (2): R53.

BDN 1080 Guven AG, H. Z. Kazdal, M. Koyun, F. Aydn, F. Gungor, S. Akman and Y. E. Baysal. Accurate diagnosis of acute pyelonephritis: How helpful is procalcitonin? Nucl Med Commun 2006;27 (9): 715-21.

BDN 1081 Han YY, J. A. Carcillo, R. A. Ruppel, P. D. Adelson, S. R. Wisniewski, M. J. Bell, K. L. Janesko, D. W. Marion and P. M. Kochanek. Cerebrospinal fluid procalcitonin and severe traumatic brain injury in children. Pediatr Crit Care Med 2002;3 (1): 39-44.

BDN 1082 Heper Y, E. H. Akalin, R. Mistik, S. Akgoz, O. Tore, G. Goral, B. Oral, F. Budak and S. Helvaci. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis 2006;25 (8): 481-91.

BDN 1083 Kollef MH, L. E. Morrow, M. S. Niederman, K. V. Leeper, A. Anzueto, L. Benz-Scott and F. J. Rodino. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006;129 (5): 1210-8


BDN 1084 Korczowski B. Serum procalcitonin concentration in children with liver disease. Pediatr Infect Dis J 2006;25 (3): 268-9.

BDN 1085 Kuderer NM, D. C. Dale, J. Crawford, L. E. Cosler and G. H. Lyman. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 2006;106 (10): 2258-66.

BDN 1086 Lorton F, F. Veinberg, D. Ielsch, G. Deschenes, A. Bensman and T. Ulinski. Procalcitonin serum levels in children undergoing chronic haemodialysis. Pediatr Nephrol 2007 Mar;22(3):430-5

BDN 1088 Makhoul IR, A. Yacoub, T. Smolkin, P. Sujov, I. Kassis and H. Sprecher. Values of C-reactive protein, procalcitonin, and Staphylococcus-specific PCR in neonatal late-onset sepsis. Acta Paediatr 2006;95 (10): 1218-23.

BDN 1089 Michalik DE, B. W. Duncan, R. B. Mee, S. Worley, J. Goldfarb, L. A. Danziger-Isakov, S. J. Davis, A. M. Harrison, E. Appachi and C. Sabella. Quantitative analysis of procalcitonin after pediatric cardiothoracic surgery. Cardiol Young 2006;16 (1): 48-53.

BDN 1090 Mills GD, H. M. Lala, M. R. Oehley, A. B. Craig, K. Barratt, D. Hood, C. N. Thornley, A. Nesdale, N. E. Manikkam and P. Reeve. Elevated procalcitonin as a diagnostic marker in meningococcal disease. Eur J Clin Microbiol Infect Dis 2006;25 (8): 501-9.

BDN 1091 Molnar Z and Bogar L. Let's go dynamic with procalcitonin! Crit Care Med 2006;34 (10): 2687-8.

BDN 1093 Naeini AE and Montazerolghaem S. Procalcitonin marker for sepsis diagnosis. Evaluating a rapid immuno-chromatografic test. Saudi Med J 2006;27 (3): 422-4.

BDN 1094 Nathan BR and Scheld WM. The potential roles of C-reactive protein and procalcitonin concentrations in the serum and cerebrospinal fluid in the diagnosis of bacterial meningitis. Curr Clin Top Infect Dis 2002;22 155-65.

BDN 1095 Nowak D, K. Berger, B. Lippert, K. Kilgert, M. Caeser and R. Sandtmann. Epidemiology and health economics of COPD across Europe: a critical analysis. Treat Respir Med 2005;4 (6): 381-95.

BDN 1096 Nyamande K and Lalloo UG. Serum procalcitonin distinguishes CAP due to bacteria, Mycobacterium tuberculosis and PJP. Int J Tuberc Lung Dis 2006;10 (5): 510-5.

BDN 1097 Ojeda ML, J. Ambrosiani, E. Tavares, R. Maldonado and F. J. Minano. Identification and localization of procalcitonin-like immunoreactivity in the rat hypothalamus. Neurosci Lett 2006;408 (1): 40-5.

BDN 1098 Picard KM, S. C. O'Donoghue, D. A. Young-Kershaw and K. J. Russell. Development and implementation of a multidisciplinary sepsis protocol. Crit Care Nurse 2006;26 (3): 43-54.

BDN 1099 Ploder M, L. Pelinka, C. Schmuckenschlager, B. Wessner, H. J. Ankersmit, W. Fuerst, H. Redl, E. Roth and A. Spittler. Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients. Shock 2006;25 (2): 129-34.

BDN 1100 Purkayastha S, A. Chow, T. Athanasiou, A. Cambaroudis, S. Panesar, J. Kinross, P. Tekkis and A. Darzi. Does serum procalcitonin have a role in evaluating the severity of acute pancreatitis? A question revisited. World J Surg 2006;30 (9): 1713-21.

BDN 1101 Reinhart K, M. Meisner and F. M. Brunkhorst. Markers for sepsis diagnosis: what is useful? Crit Care Clin 2006;22 (3): 503-19, ix-x.

BDN 1102 Scire CA, L. Cavagna, C. Perotti, E. Bruschi, R. Caporali and C. Montecucco. Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases. Clin Exp Rheumatol 2006;24 (2): 123-8.


BDN 1103 Seligman R, M. Meisner, T. C. Lisboa, F. T. Hertz, T. B. Filippin, J. M. Fachel and P. J. Teixeira. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 2006;10 (5): R125.

BDN 1104 Sethi S and Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev 2001;14 (2): 336-63.

BDN 1105 Sponholz C, Y. Sakr, K. Reinhart and F. Brunkhorst. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care 2006;10 (5): R145.

BDN 1107 Tan HN and Lim WS. Procalcitonin in older people: an unresolved problem. J Am Geriatr Soc 2006;54 (3): 544-5; author reply 545-6.

BDN 1108 Thuemer O, Huttemann E and Sakka SG. [Procalcitonin as an early marker of sepsis]. Anaesthesist 2006;55 (6): 650-4.

BDN 1109 Müller B and Tamm M. Biomarkers in acute exacerbation of chronic obstructive pulmonary disease. Among the blind, the one-eyed is king Am J of Respiratory and Critical Care Medicine 2006, 174: 848-849

BDN 1110 Yoshihara T, T. Imamura, K. Yokoi, M. Shibata, G. Kano, S. Osone, K. Yagi, S. Todo, Y. Murakami, Y. Yamada, H. Yamada, S. Satomura and H. Ishida. Potential use of procalcitonin concentrations as a diagnostic marker of the PFAPA syndrome. Eur J Pediatr 2007;166 (6): 621-2.

BDN 1111 Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D, Muller C, Huber P, Muller B and Tamm M. Antibiotic Treatment of Exacerbations of COPD: A Randomized, Controlled Trial Comparing Procalcitonin-Guidance With Standard Therapy. Chest 2007;131 (1): 9-19.

BDN 1111a Martinez FJ and Curtis JL. Procalcitonin-Guided Antibiotic Therapy in COPD Exacerbations: Closer But Not Quite There. Chest 2007;131 (1): 1-2.

BDN 1111b Niewoehner DE. Procalcitonin level-guided treatment reduced antibiotic use in exacerbations of COPD. ACP J Club 2007;146 (3): 57.

BDN 1113 Beloborodova NV, Nonikov VE and Bachinskaia EN. [Diagnostic and therapeutic aspects of pneumonias after cardiosurgical operations associated with artificial ventilation]. Anesteziol Reanimatol 2006;(3): 83-7.

BDN 1114 Chang C, Yao WZ, Chen YH, Liu ZY and Zhang XW. [Value of serum procalcitonin in diagnosing bacterial lower respiratory tract infections in people with exacerbation of Chronic Obstructive Pulmonary Disease][in Chinese]. Beijing Da Xue Xue Bao 2006;38 (4): 389-92.

BDN 1116 Elefsiniotis IS, Petrocheilou A, Scarmeas N, Ketikoglou I, Pantazis KD, Toutouza M and Tsianos EV. Serum procalcitonin levels in chronic hepatitis C patients under pegylated interferon-alpha plus ribavirin treatment. J Clin Virol. 2006;37 (4): 329-31.

BDN 1117 Kordek A, Torbe A and Czajka R. Maternal venous procalcitonin levels do not correlate with umbilical cord blood and venous blood concentrations in the neonate. J Perinat Med 2006;34 (6): 462-5.

BDN 1118 Müller B, Suess E, Schuetz P, Muller C, Bingisser R, Bergmann A, Stolz D, Tamm M, Morgenthaler NG and Christ-Crain M. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections. J Intern Med 2006;260 (6): 568-76.

BDN 1120 Novotny A, Emmanuel K, Bartels H, Siewert JR and Holzmann B. [Indicators for early prediction of outcome in sepsis]. Chirurg 2005;76 (9): 837-44.


BDN 1121 Peters PG, Twisk JWR, van Agtmael MA and Groeneveld ABJ. The role of procalcitonin in a decision tree for prediction of bloodstream infection in febrile patients. Clin Microbiol Infect. 2006;12 (12): 1207-13.

BDN 1122 Popov DA, Beloborodova NV and Iarustovskii MB. [Systemic inflammation after operations on the open heart: significance of a microbial factor]. Anesteziol Reanimatol 2006;(3): 79-83.

BDN 1123 Reith HB, Rauchschwalbe SK and Mittelkotter U. Nosocomial pneumonia: third-group chinolone versus clindamycin/ceftriaxone in modulation of the acute phase reaction and outcome and cost efficacy. Int Surg 2006;91 (5): 272-5.

BDN 1124 Spapen HD, Hachimi-Idrissi S, Corne L and Huyghens LP. Diagnostic markers of sepsis in the emergency department. Acta Clin Belg 2006;61 (3): 138-42.

BDN 1125 Turner D, Hammerman C, Rudensky B, Schlesinger Y and Schimmel MS. The role of procalcitonin as a predictor of nosocomial sepsis in preterm infants. . Acta Paediatr. 2006;95 (12): 1571-6.

BDN 1126 Gomez-Rivera N, Molina-Moreno F, Garcia-Zarate M, Castillo-Ramos J, García-Hernández R, Vázquez-Pizana E, Cano-Rangel MA and Fonseca-Chon I. [Semiquantitative procalcitonin (PCT-Q) as a diagnostic tool and prognostic marker in children with bacterial sepsis] [in Spanish]. Bol Med Hosp Infant Mex 2006;63 (1): 8-17.

BDN 1127 Annane D, Bellissant E and Cavaillon JM. Septic shock. Lancet 2005;365 (9453): 63-78.

BDN 1128 Uzzan B, Izri A, Durand R, Deniau M, Bouchaud O and Perret GY. Serum procalcitonin in uncomplicated falciparum malaria: a preliminary study. Travel Med Infect Dis 2006;4 (2): 77-80.

BDN 1129 Decaluwe H, Harrison LM, Mariscalco MM, Gendrel D, Bohuon C, Tesh VL and Proulx F. Procalcitonin in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome. Pediatr Res 2006;59 (4 Pt 1): 579-83.

BDN 1130 Dorizzi RM, Polati E, Sette P, Ferrari A, Rizzotti P and Luzzani A. Procalcitonin in the diagnosis of inflammation in intensive care units. Clin Biochem 2006;39 (12): 1138-43.

BDN 1131 Leroy S, Romanello C, Galetto-Lacour A, Smolkin V, Korczowski B, Rodrigo C, Tuerlinckx D, Gajdos V, Moulin F, Contardo M, Gervaix A, Halevy R, Duhl B, Prat C, Borght TV, Foix-l'Helias L, Dubos F, Gendrel D, Breart G and Chalumeau M. Procalcitonin to reduce the number of unnecessary cystographies in children with a urinary tract infection: a European validation study. J Pediatr 2007;150 (1): 89-95.

BDN 1132 Kaufmann I, Hoelzl A, Schliephake F, Hummel T, Chouker A, Peter K and Thiel M. Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity. Shock 2006;26 (3): 254-61.

BDN 1133 Hellerstein S. Acute urinary tract infection--evaluation and treatment. Curr Opin Pediatr 2006;18 (2): 134-8.

BDN 1134 Pecile P and Romanello C. Procalcitonin and pyelonephritis in children. Curr Opin Infect Dis 2007;20 (1): 83-7.

BDN 1135 Müller B, Morgenthaler N, Stolz D, Schuetz P, Muller C, Bingisser R, Bergmann A, Tamm M and Christ-Crain M. Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Eur J Clin Invest 2007;37 (2): 145-52

BDN 1136 Muller B and Prat C. Markers of acute inflammation in assessing and managing lower respiratory tract infections: focus on procalcitonin. Clin Microbiol Infect 2006;12 Suppl 9 8-16.


BDN 1140 Yaegashi Y, Shirakawa K, Sato N, Suzuki Y, Kojika M, Imai S, Takahashi G, Miyata M, Furusako S andEndo S. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother 2005;11 (5): 234-8.

BDN 1142 Chawes BL, Rechnitzer C, Schmiegelow K and Tvede M. [Procalcitonin for early diagnosis of bacteraemia in children with cancer]. Ugeskr Laeger 2007;169 (2): 138-42.

BDN 1143 Bottner F, Wegner A, Winkelmann W, Becker K, Erren M and Gotze C. Interleukin-6, procalcitonin and TNF-{alpha}: MARKERS OF PERI-PROSTHETIC INFECTION FOLLOWING TOTAL JOINT REPLACEMENT. J Bone Joint Surg Br 2007;89 (1): 94-9.

BDN 1144 Ray P, Badarou-Acossi G, Viallon A, Boutoille D, Arthaud M, Trystram D and Riou B. Accuracy of the cerebrospinal fluid results to differentiate bacterial from non bacterial meningitis, in case of negative gram-stained smear. Am J Emerg Med 2007;25 (2): 179-84.

BDN 1144a Steichen O and Martinez-Almoyna L. Comments on "Accuracy of the cerebrospinal fluid results to differentiate bacterial from non bacterial meningitis, in case of negative gram-stained smear". Am J Emerg Med 2008;26 (2): 237.

BDN 1145 Secmeer G, Devrim I, Kara A, Ceyhan M, Cengiz B, Kutluk T, Buyukpamukcu M, Yetgin S, Tuncer M, Uludag AK, Tezer H and Yildirim I. Role of Procalcitonin and CRP in Differentiating a Stable From a Deteriorating Clinical Course in Pediatric Febrile Neutropenia. J Pediatr Hematol Oncol 2007;29 (2): 107-111.

BDN 1146 Catalano-Pons C, Andre MC, Chalumeau M, Guerin S and Gendrel D. Lack of Value of Procalcitonin for Prediction of Coronary Aneurysms in Kawasaki Disease. Pediatr Infect Dis J 2007;26 (2): 179-180.

BDN 1147 Oberhofer D, Rumenjak V, Lazic J and Vucic N. [Procalcitonin concentrations after major abdominal surgery measured by semiquantitative PCT-Q test]. Acta Med Croatica 2006;60 (5): 429-33.

BDN 1148 Ukaszewski M, Durek G and Mierzchala M. [Severe sepsis or clinical view of autoaggressive disease. Wegener's granulomatosis--case report]. Pol Merkur Lekarski 2006;21 (124): 351-3.

BDN 1149 Engelmann L. Die Diagnose der Sepsis. Diagnostik und Intensivtherapie bei Sepsis und Multiorganversagen., Steinkopff Verlag,2006;1-12

BDN 1150 Rau BM, Frigerio I, Buchler MW, Wegscheider K, Bassi C, Puolakkainen PA, Beger HG and Schilling MK. Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. Arch Surg 2007;142 (2): 134-42.

BDN 1150a Rau BM. Blood marker helps predict prognosis among those with abdominal infection. 2007

BDN 1150b Paugam-Burtz C, Mantz J, Dupont H and Dehoux M. Procalcitonin levels and sequential organ failure assessment scores in secondary peritonitis. Arch Surg 2007;142 (8): 803; author reply 803-4.

BDN 1151 Rey C, Los Arcos M, Concha A, Medina A, Prieto S, Martinez P and Prieto B. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive Care Med 2007; 33 (3): 477-84.

BDN 1151a Rey C, Los Arcos M, Concha A, Medina A, Prieto S, Martinez P and Prieto B. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive Care Med. 2007 Jun;33(6):1108-9.

BDN 1152 Biban P, Santuz, P. Il Ruolo della Procalcitonina nelle emergenze infettive pediatriche. Rivista Italiana di Emergenze Urgenze pediatrica;p. 27-32.


BDN 1153 Müller B. La PCT peut-elle influencer la durée du traitement des pneumopathies communautaires? Réanimation 2006;15 S281-285.

BDN 1154 Luyts L. Procalcitonine et pneumonie sous ventilation mécanique. Réanimation 2006;15 S286-S290.

BDN 1155 Annane D. Place de la Procalcitonine dans la stratégie diagnostique et thérapeutique du sepsis. Réanimation 2006;15 S291-S294.

BDN 1156 Tang BM, Eslick GD, Craig JC and McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007;7 (3): 210-7.

BDN 1156a Tang BM, Eslick GD, Craig JC and McLean AS. Meta-analysis of procalcitonin for sepsis detection - Authors' reply. Lancet Infect Dis 2007;7 (8): 502-3.

BDN 1156b Muller B, Christ-Crain M and Schuetz P. Meta-analysis of procalcitonin for sepsis detection. Lancet Infect Dis 2007;7 (8): 498-9.

BDN 1156c Jensen JU, Lundgren B and Lundgren JD. Meta-analysis of procalcitonin for sepsis detection. Lancet Infect Dis 2007;7 (8): 499-500.

BDN 1156d Reinhart K and Brunkhorst FM. Meta-analysis of procalcitonin for sepsis detection. Lancet Infect Dis 2007;7 (8): 500-2.

BDN 1157 Briel M, Langewitz W, Tschudi P, Young J, Hugenschmidt C and Bucher HC. Communication training and antibiotic use in acute respiratory tract infections. A cluster randomised controlled trial in general practice. Swiss Med Wkly 2006;136 (15-16): 241-7.

BDN 1158 Müller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, Nusbaumer C, Tamm M and Christ-Crain M. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 2007;7 10.

BDN 1159 Tavares E, Maldonado R and Minano FJ. N-procalcitonin: central effects on feeding and energy homeostasis in rats. Endocrinology 2007;148 (4): 1891-901.

BDN 1160 Zoccali C, Maas R, Cutrupi S, Pizzini P, Finocchiaro P, Cambareri F, Panuccio V, Martorano C, Schulze F, Enia G, Tripepi G and Boger R. Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections. Nephrol Dial Transplant 2007;22 (3): 801-6.

BDN 1161 Lemiale V, Renaud B, Moutereau S, N'Gako A, Salloum M, Calmettes MJ, Herve J, Boraud C, Santin A, Grego JC, Braconnier F and Roupie E. A single procalcitonin level does not predict adverse outcomes of women with pyelonephritis. Eur Urol 2007;51 (5): 1394-401.

BDN 1162 Herd D. In children under age three does procalcitonin help exclude serious bacterial infection in fever without focus? Arch Dis Child 2007;92 (4): 362-4.

BDN 1163 Soto GJ. Diagnostic strategies for nosocomial pneumonia. Curr Opin Pulm Med 2007;13 (3): 186-91.

BDN 1164 Lopez Sastre JB, Solis DP, Serradilla VR, Colomer BF and Cotallo GD. Evaluation of procalcitonin for diagnosis of neonatal sepsis of vertical transmission. BMC Pediatr 2007;7 9.

BDN 1165 Masia M, Gutierrez F, Padilla S, Soldan B, Mirete C, Shum C, Hernandez I, Royo G and Martin-Hidalgo A. Clinical characterisation of pneumonia caused by atypical pathogens combining classic and novel predictors. Clin Microbiol Infect 2007;13 (2): 153-61.


BDN 1166 Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, Eugen-Olsen J and Larsen K. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 2007;11 (2): R38.

BDN 1167 Gaini S, Pedersen SS, Koldkjaer OG, Pedersen C and Moller HJ. High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study. Crit Care 2007;11 (2): R32.

BDN 1168 Rau BM. Predicting severity of acute pancreatitis. Curr Gastroenterol Rep 2007;9 (2): 107-15.

BDN 1169 Stolz D, Christ-Crain M, Morgenthaler NG, Leuppi J, Miedinger D, Bingisser R, Muller C, Struck J, Muller B and Tamm M. Copeptin, C-Reactive Protein, and Procalcitonin as Prognostic Biomarkers in Acute Exacerbation of COPD. Chest 2007;131 (4): 1058-67.

BDN 1170 Guen CG, Delmas C, Launay E, Caillon J, Loubersac V, Picherot G and Roze JC. Contribution of procalcitonin to occult bacteraemia detection in children. Scand J Infect Dis 2007;39 (2): 157-9.

BDN 1171 Don M, Valent F, Korppi M, Falleti E, De Candia A, Fasoli L, Tenore A and Canciani M. Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood. Scand J Infect Dis 2007;39 (2): 129-37.

BDN 1172 Lavrentieva A, Kontakiotis T, Lazaridis L, Tsotsolis N, Koumis J, Kyriazis G and Bitzani M. Inflammatory markers in patients with severe burn injury. What is the best indicator of sepsis? Burns 2007;33 (2): 189-94.

BDN 1173 Matzaraki V, Alexandraki KI, Venetsanou K, Piperi C, Myrianthefs P, Malamos N, Giannakakis T, Karatzas S, Diamanti-Kandarakis E and Baltopoulos G. Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis. Clin Biochem 2007;40 (5-6): 336-42.

BDN 1174 Jemli B, Aouni Z, Lebben I, Mazigh C, Ferjani M, Machgoul M and Gargouri S. [Procalcitonin in invasive candidosis]. Ann Biol Clin (Paris) 2007;65 (2): 169-73.

BDN 1175 Lekmanov AU, Erpuleva Iu V and Soshkina VV. [Inflammatory markers in critically ill children during nutritive therapy]. Anesteziol Reanimatol 2006;(6): 24-6.

BDN 1176 Lisboa T and Rello J. De-escalation in lower respiratory tract infections. Curr Opin Pulm Med 2006;12 (5): 364-8.

BDN 1177 Krzanowski M, Stompor T, Kusnierz-Cabala B, Ignacak E, Sulowicz W and Naskalski JW. [Analysis of selected inflammatory markers in patients with stable renal graft (RTx) 36 months after transplantation]. Przegl Lek 2006;63 (8): 597-601.

BDN 1178 Nicolcescu P, Badulescu F and Schenker M. [Diagnosis of nosocomial pneumonia: conventional and new indicators]. Pneumologia 2006;55 (2): 52-7.

BDN 1179 Piechota M, Banach M, Irzmanski R, Misztal M, Rysz J, Barylski M, Piechota-Urbanska M, Kowalski J and Pawlicki L. N-terminal brain natriuretic propeptide levels correlate with procalcitonin and C-reactive protein levels in septic patients. Cell Mol Biol Lett 2007;12 (2): 162-75.

BDN 1180 Vuilliez A, Floccard B, Sobas F, Chopin N and Allaouchiche B. [The abnormal activated partial thromboplastin time biphasic waveform: a red flag in the sepsis? Technique and interest as marker of the sepsis]. Ann Fr Anesth Reanim 2007;26 (3): 259-62.

BDN 1181 van Oers JAH, Tulleken JE, Ligtenberg JJM, Meertens JHJM and Zijlstra JG. Can procalcitonin guide therapy in newly admitted critically ill patients? Neth J Crit Care 2007;11 (2): 81-86.


BDN 1182 Christ-Crain M and Muller B. Procalcitonin and Pneumonia: Is it a Useful Marker? Curr Infect Dis Rep 2007;9 (3): 233-40.

BDN 1183 Maniaci V, Weiss S, Dauber A, Nylen E and Bachur R. Utility of procalcitonin to identify young febrile infants at low risk of serious bacterial infections. Acad Emerg Med 2007;14 (5 Suppl 1): S88.

BDN 1184 Livaditi O, Kotanidou A, Psarra A, Dimopoulou I, Sotiropoulou C, Augustatou K, Papasteriades C, Armaganidis A, Roussos C, Orfanos SE and Douzinas EE. Neutrophil CD64 expression and serum IL-8: Sensitive early markers of severity and outcome in sepsis. Cytokine 2006;36 (5-6): 283-90.

BDN 1185 Lee BE and Davies HD. Aseptic meningitis. Curr Opin Infect Dis 2007;20 (3): 272-7.

BDN 1186 Koksal N, Harmanci R, Cetinkaya M and Hacimustafaoglu M. Role of procalcitonin and CRP in diagnosis and follow-up of neonatal sepsis. Turk J Pediatr 2007;49 (1): 21-9.

BDN 1187 Fluckiger U, Battegay M and Laifer G. [Diagnostic procedures for patients with community acquired pneumonia.]. Internist (Berl) 2007;48 (5): 468-75.

BDN 1188 Madershahian N, Wittwer T, Franke UF, Wippermann J, Strauch J, Groetzner J and Wahlers T. Effect of induction therapy on kinetic of procalcitonin following uncomplicated heart transplantation. J Card Surg 2007;22 (3): 199-202.

BDN 1189 Kocabas E, Sarikcioglu A, Aksaray N, Seydaoglu G, Seyhun Y and Yaman A. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis. Turk J Pediatr 2007;49 (1): 7-20.

BDN 1190 Rau BM, Kemppainen EA, Gumbs AA, Buchler MW, Wegscheider K, Bassi C, Puolakkainen PA and Beger HG. Early Assessment of Pancreatic Infections and Overall Prognosis in Severe Acute Pancreatitis by Procalcitonin (PCT): A Prospective International Multicenter Study. Ann Surg 2007;245 (5): 745-754.

BDN 1191 Mandi Y, Farkas G, Takacs T, Boda K and Lonovics J. Diagnostic relevance of procalcitonin, IL-6, and sICAM-1 in the prediction of infected necrosis in acute pancreatitis. Int J Pancreatol 2000;28 (1): 41-9.

BDN 1192 Hausfater P. [Procalcitonin measurement in adult clinical practice.]. Rev Med Interne 2007;28 (5): 296-305.

BDN 1193 Christ-Crain M and Müller B. Diagnostic and Prognostic Value of Hormokines as Biomarkers in Severe Infections. Yearbook of Intensive Care and Emergency Medicine 2007;22-31.

BDN 1194 Jensen JU. Procalcitonin: Nice to Know, Need to know, or Needs Further Research? Yearbook of Intensive Care and Emergency Medicine 2007;10-21.

BDN 1195 McLean AS, Tang B and Huang SJ. The Diagnosis of Sepsis: The Present and the Future. Yearbook of Intensive Care and Emergency Medicine 2007;1-9.

BDN 1196 Dubos F, Moulin F, Raymond J, Gendrel D, Breart G and Chalumeau M. [Distinction between bacterial and aseptic meningitis in children: refinement of a clinical decision rule.]. Arch Pediatr 2007;14 (5): 434-438.

BDN 1197 Hausfater P, Juillien G, Madonna-Py B, Haroche J, Bernard M and Riou B. Serum Procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department. Crit Care 2007;11 (3): R60.

BDN 1197a van Oers JA, Tulleken JE and Zijlstra JG. Does serum procalcitonin have a diagnostic value in febrile adult patients presenting to the emergency department? Crit Care 2007;11 (6): 422


BDN 1198 Novotny A, Emmanuel K, Matevossian E, Kriner M, Ulm K, Bartels H, Holzmann B, Weighardt H and Siewert JR. Use of procalcitonin for early prediction of lethal outcome of postoperative sepsis. Am J Surg 2007;194 (1): 35-9.

BDN 1199 Sato N, Endo S, Kasai T, Inoue Y, Fujino Y, Onodera M, Imai S, Takahashi G, Miyata M, Kitamura M and Wakabayashi G. Relationship of the serum procalcitonin level with the severity of acute pancreatitis. Res Commun Mol Pathol Pharmacol 2004;115-116 243-9.

BDN 1200 Senturk T, Cordan J, Baran I, Ozdemir B, Gullulu S, Aydinlar A and Goral G. Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease. Acta Cardiol 2007;62 (2): 135-41.

BDN 1201 Svoboda P, Kantorova I, Scheer P, Radvanova J and Radvan M. Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery? Hepatogastroenterology 2007;54 (74): 359-63.

BDN 1202 Michelow IC, Katz K, McCracken GH and Hardy RD. Systemic cytokine profile in children with community-acquired pneumonia. Pediatr Pulmonol 2007;42 (7): 640-5.

BDN 1203 Luthold S, Berneis K, Bady P and Muller B. Effects of infectious disease on plasma lipids and their diagnostic significance in critical illness. Eur J Clin Invest 2007;37 (7): 573-9.

BDN 1204 Jones AE, Fiechtl JF, Brown MD, Ballew JJ and Kline JA. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 2007;50 (1): 34-41.

BDN 1205 Chalumeau M, Leroy S, Gendrel D, Breart G, Moulin F and Dubos F. [Procalcitonin bedside testing in the pediatric emergency department.]. Arch Pediatr 2007;14 (6): 529-531.

BDN 1206 Muthiah KA, Rachakonda KS, Davis MJ, Simmons EG, Schier G and Gil FS. Prospective evaluation of procalcitonin in sepsis in the Illawarra area of Australia: PEPSIA study. Crit Care Resusc 2007;9 (2): 137-42.

BDN 1207 Mendes AV, Sapolnik R and Mendonca N. New guidelines for the clinical management of febrile neutropenia and sepsis in pediatric oncology patients. J Pediatr (Rio J) 2007;83 (2 Suppl): S54-S63.

BDN 1208 Voll K, Haase G, Fritz H, Riebe J, Huszka C and Kindler J. [Septic shock and purpura fulminans after a dog bite]. Dtsch Med Wochenschr 2007;132 (24): 1321-4.

BDN 1209 Wagenlehner FM, Weidner W and Naber KG. Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis. Clin Pharmacokinet 2007;46 (4): 291-305.

BDN 1210 Pavcnik-Arnol M, Hojker S and Derganc M. Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children. Intensive Care Med 2007;33 (6): 1025-32.

BDN 1211 Ziebolz D, Jager GC, Hornecker E and Mausberg RF. Periodontal findings and blood analysis of blood donors: a pilot study. J Contemp Dent Pract 2007;8 (5): 43-50.

BDN 1212 Kushimoto S, Shibata Y, Koido Y, Kawai M, Yokota H and Yamamoto Y. The Clinical Usefulness of Procalcitonin Measurement for Assessing the Severity of Bacterial Infection in Patients Requiring Corticosteroid Therapy - Abstracts of Outstanding Presentations of the 74th Annual Meeting of the Medical Association of Nippon Medical School J Nippon Med Sch 2006;73 (6): 354-6.

BDN 1213 Lommatzsch M, Niewerth A, Klotz J, Schulte-Herbruggen O, Zingler C, Schuff-Werner P and Christian Virchow J. Platelet and plasma BDNF in lower respiratory tract infections of the adult. Respir Med 2007;101 (7): 1493-9.


BDN 1214 Asselineau J, Thiebaut R, Perez P, Pinganaud G and Chene G. [Analysis of left-censored quantitative outcome: example of procalcitonin level.]. Rev Epidemiol Sante Publique 2007;55 (3): 213-220.

BDN 1215 Stolz D and Bingisser R. Procalcitonin test can reduce antibiotic use in COPD. J Fam Pract 2007;56 (4): 273.

BDN 1216 Schuetz P, Christ-Crain M, Wolbers M, Schild U, Thomann R, Falconnier C, Widmer I, Neidert S, Blum CA, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B and The Prohosp Study Group F. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. BMC Health Serv Res 2007;7 (1): 102.

BDN 1217 Gaini S, Koldkjaer OG, Moller HJ, Pedersen C and Pedersen SS. A comparison of high mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteremia: a prospective study. Crit Care 2007;11 (4): R76.

BDN 1218 Adib-Conquy M, Monchi M, Goulenok C, Laurent I, Thuong M, Cavaillon JM and Adrie C. Increased Plasma Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 1 and Procalcitonin after Cardiac Surgery and Cardiac Arrest without Infection. Shock 2007;28 (4): 406-10.

BDN 1219 Gibot S, Cravoisy A, Dupays R, Barraud D, Nace L, Levy B and Bollaert PE. Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis. Scand J Infect Dis 2007;39 (6): 604-8.

BDN 1220 Knudsen TB, Larsen K, Kristiansen TB, Moller HJ, Tvede M, Eugen-Olsen J and Kronborg G. Diagnostic value of soluble CD163 serum levels in patients suspected of meningitis: Comparison with CRP and procalcitonin. Scand J Infect Dis 2007;39 (6): 542-53.

BDN 1222 Topolcan O, Holubec L, Polivkova V, Svobodova S, Pesek M, Treska V, Safranek J, Hajek T, Bartunek L, Rousarova M and Finek J. Tumor markers in pleural effusions. Anticancer Res 2007;27 (4A): 1921-4.

BDN 1223 Christ-Crain M. [Procalcitonin as a biomarker in infections]. Schweiz Rundsch Med Prax 2007;96 (25-26): 1017-21.

BDN 1224 Ip M, Rainer TH, Lee N, Chan C, Chau SS, Leung W, Leung MF, Tam TK, Antonio GE, Lui G, Lau TK, Hui DS, Fuchs D, Renneberg R and Chan PK. Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections. Diagn Microbiol Infect Dis 2007;59 (2): 131-6.

BDN 1225 Jebali MA, Hausfater P, Abbes Z, Aouni Z, Riou B and Ferjani M. Assessment of the Accuracy of Procalcitonin to Diagnose Postoperative Infection after Cardiac Surgery. Anesthesiology 2007;107 (2): 232-238.

BDN 1226 Hoksch B, Fahrner R and Alexander Schmid R. Procalcitonin and brain natriuretic peptide as parameters in the postoperative course of patients with major pulmonary resection. Interact Cardiovasc Thorac Surg 2007;6 (2): 155-9.

BDN 1227 Fioretto JR, Borin FC, Bonatto RC, Ricchetti SM, Kurokawa CS, de Moraes M, Carpi MF, Padovani CR and Martin JG. Procalcitonin in children with sepsis and septic shock. J Pediatr (Rio J) 2007;83 (4): 323-8.

BDN 1228 Jankovic B, Veljkovic D, Pasic S, Rakonjac Z, Jevtic D and Martic J. [C-reactive protein and cytokines in the diagnosis of neonatal sepsis]. Med Pregl 2006;59 (11-12): 545-9.

BDN 1230 Zuppa AA, Calabrese V, D'Andrea V, Fracchiolla A, Scorrano A, Orchi C and Romagnoli C. Evaluation of C reactive protein and others immunologic markers in the diagnosis of neonatal sepsis. Minerva Pediatr 2007;59 (3): 267-274.


BDN 1231 George A, Coulson C and De R. Procalcitonin: A bacterial specific marker of infection. Clin Otolaryngol 2007;32 (4): 310.

BDN 1232 Parrak V, Secnik P, Greksova K, Venczelova Z, Mistrik M, Stencl P, Scholz E and Fuchs D. High-sensitive procalcitonin (PCT) in the diagnosis of neonatal infection. Abstracts: 26th International Winter-Workshop on Clinical, Chemical and Biochemical Aspects of Pteridines 2007;54.

BDN 1233 Maruna P, Frasko R and Gurlich R. Plasma procalcitonin in patients with ileus. Relations to other inflammatory parameters. Physiol Res. 2008;57(3):481-6

BDN 1234 Bargues L, Chancerelle Y, Catineau J, Jault P and Carsin H. Evaluation of serum procalcitonin concentration in the ICU following severe burn. Burns 2007;33 (7): 860-864.

BDN 1235 Isidor B, Caillaux G, Gilquin V, Loubersac V, Caillon J, Roze JC and Guen GL. The use of procalcitonin in the diagnosis of late-onset infection in neonatal intensive care unit patiens. Scand J Infect Dis. 2007;39(11-12):1063-6

BDN 1236 Morath C, Sis J, Haensch GM, Zeier M, Andrassy K and Schwenger V. Procalcitonin as marker of infection in patients with Goodpasture's syndrome is misleading. Nephrol Dial Transplant 2007;22 (9): 2701-4.

BDN 1237 Volk HD, Reinke P and Docke WD. Immunological monitoring of the inflammatory process: Which variables? When to assess? Eur J Surg Suppl 1999;(584): 70-2.

BDN 1238 Watkin RW, Harper LV, Vernallis AB, Lang S, Lambert PA, Ranasinghe AM and Elliott TS. Pro-inflammatory cytokines IL6, TNF-alpha, IL1beta, procalcitonin, lipopolysaccharide binding protein and C-reactive protein in infective endocarditis. J Infect 2007;55 (3): 220-5.

BDN 1239 Gombocz K, Beledi A, Alotti N, Kecskes G, Gabor V, Bogar L, Koszegi T and Garai J. Influence of dextran-70 on systemic inflammatory response and myocardial ischaemia - reperfusion following cardiac operations. Crit Care 2007;11 (4): R87.

BDN 1240 Bhatia BD and Basu S. Newer diagnostic tests for bacterial diseases. Indian J Pediatr 2007;74 (7): 673-7.

BDN 1241 Torbe A. Maternal plasma procalcitonin concentrations in pregnancy complicated by preterm premature rupture of membranes. Mediators Inflamm 2007;2007 (1): 35782.

BDN 1242 Schneider HG and Lam QT. Procalcitonin for the clinical laboratory: a review. Pathology 2007;39 (4): 383-90.

BDN 1244 Lee CC, Chen SY, Tsai CL, Wu SC, Chiang WC, Wang JL, Sun HY, Chen SC, Chen WJ and Hsueh PR. Prognostic Value of Mortality in Emergency Department Sepsis Score, Procalcitonin, and C-Reactive Protein in Patients with Sepsis at the Emergency Department. Shock. 2008 Mar;29(3):322-327

BDN 1245 Ernst A, Morgenthaler NG, Buerger K, Dodel R, Noelker C, Sommer N, Schwarz M, Koehrle J, Bergmann A and Hampel H. Procalcitonin is elevated in the cerebrospinal fluid of patients with dementia and acute neuroinflammation. J Neuroimmunol 2007;189 (1-2): 169-74.

BDN 1246 Kisacik B, Kalyoncu U, Erol MF, Karadag O, Yildiz M, Akdogan A, Kaptanoglu B, Hayran M, Ureten K, Ertenli I, Kiraz S and Calguneri M. Accurate diagnosis of acute abdomen in FMF and acute appendicitis patients: how can we use procalcitonin? Clin Rheumatol 2007;26 (12): 2059-62.;

BDN 1247 Kuuliala A, Takala A, Siitonen S, Leirisalo-Repo M and Repo H.Cellular and humoral markers of systemic inflammation in acute reactive arthritis and early rheumatoid arthritis. Scand J Rheumatol 2004;33 (1): 13-8.


BDN 1248 Magadle R, Weiner P, Sotzkover A, Mizrahi-Reuveni M and Yanay NB. Fever in a medical intensive care unit. Clinical Intensive Care 2003,14(1-2):31-35

BDN 1249 Christ-Crain M and Muller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription prognostic markers and mediators. Eur Respir J 2007;556-573.

BDN 1250 Christ-Crain M, Stolz D, Jutla S, Couppis O, Mueller C, Bingisser R, Schuetz P, Tamm M, Edwards R, Muller B and Grossman AB. Free and Total Cortisol Levels as Predictors of Severity and Outcome in Community-Acquired Pneumonia. Am J Respir Crit Care Med 2007;176 (9): 913-20.

BDN 1251 Hatzistilianou M, Rekleity A, Athanassiadou F, Delutils MA, Conti P and Catriu D. Serial procalcitonin responses in infection of children with secondary immunodeficiency. Clin Invest Med 2007;30 (2): E75-85.

BDN 1252 Phua J, Koay ES and Lee KH. Lactate, Procalcitonin, and Amino-Terminal Pro-B-Type Natriuretic Peptide Versus Cytokine Measurements and Clinical Severity Scores for Prognostication in Septic Shock. Shock. 2008 Mar;29(3):328-333

BDN 1253 Schuetz P, Christ-Crain M and Muller B. Biomarkers to improve diagnostic and prognostic accuracy in systemic infections. Curr Opin Crit Care 2007;13 (5): 578-85.

BDN 1254 Prat C, Lacoma A, Dominguez J, Papassotiriou J, Morgenthaler NG, Andreo F, Tudela P, Ruiz-Manzano J and Ausina V. Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia. J Infect 2007;55 (5): 400-7.

BDN 1255 Holm A, Pedersen SS, Nexoe J, Obel N, Nielsen LP, Koldkjaer O and Pedersen C. Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care. Br J Gen Pract 2007;57 (540): 555-60.

BDN 1256 Beger HG and Rau BM. Severe acute pancreatitis: Clinical course and management. World J Gastroenterol 2007;13 (38): 5043-51.

BDN 1257 Becker KL, Nylen ES, White JC, Muller B and Snider RH, Jr. Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004;89 (4): 1512-25.

BDN 1258 Piechota M, Banach M, Irzmanski R, Barylski M, Piechota-Urbanska M, Kowalski J and Pawlicki L. Plasma endothelin-1 levels in septic patients. J Intensive Care Med 2007;22 (4): 232-9.

BDN 1259 Mentula P, Kylanpaa ML, Kemppainen E, Repo H and Puolakkainen P. Early inflammatory response in acute pancreatitis is little affected by body mass index. Scand J Gastroenterol 2007 Nov;42(11):1362-8

BDN 1260 Andreola B, Bressan S, Callegaro S, Liverani A, Plebani M and Da Dalt L. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr Infect Dis J 2007;26 (8): 672-7.

BDN 1261 Schuetz P, Mueller B and Trampuz A. Serum Procalcitonin for Discrimination of Blood Contamination from Bloodstream Infection due to Coagulase-Negative Staphylococci. Infection 2007;35 (5): 352-5.

BDN 1262 Muller B, Schuetz P and Trampuz A. Circulating biomarkers as surrogates for bloodstream infections. Int J Antimicrob Agents 2007;30S S16-23.

BDN 1263 Llorente E, Prieto B, Cardo L, Avello N and Alvarez FV. Umbilical cord blood serum procalcitonin by Time-Resolved Amplified Cryptate Emission (TRACE) technology: reference values of a potential marker of vertically transmitted neonatal sepsis. Clin Chem Lab Med 2007;45 (11): 1531-5.


BDN 1264 Werner J and Buchler MW. [Infectious complications in necrotizing pancreatitis.]. Zentralbl Chir 2007;132 (5): 433-7.

BDN 1265 Dayer E, Dayer JM and Roux-Lombard P. Primer: the practical use of biological markers of rheumatic and systemic inflammatory diseases. Nat Clin Pract Rheumatol 2007;3 (9): 512-20.

BDN 1266 Kafkas N, Venetsanou K, Patsilinakos S, Voudris V, Antonatos D, Kelesidis K, Baltopoulos G, Maniatis P and Cokkinos DV. Procalcitonin in acute myocardial infarction. Acute Card Care 2008;10(1):30-6

BDN 1267 Huang DT, Weissfeld LA, Kellum JA, Yealy DM, Kong L, Martino M and Angus DC. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 2008;52 (1): 48-58 e2.

BDN 1267a Menchine MD, Barrett TW and Schriger DL. Huang DT, Weissfeld LA, Kellum JA, et al Risk Prediction With Procalcitonin and Clinical Rules in Community-Acquired Pneumonia. Ann Emerg Med 2008;52 (1): 59-60.

BDN 1267b Jones AE and Kline JA. Risk stratification of community-acquired pneumonia: what does all of this mean? Ann Emerg Med 2008;52 (1): 61-2.

BDN 1268 Rosmarakis ES, Prapas SN, Rellos K, Michalopoulos A, Samonis G and Falagas ME. Nosocomial infections after off-pump coronary artery bypass surgery: frequency, characteristics, and risk factors. Interact Cardiovasc Thorac Surg 2007;6 (6): 759-67.

BDN 1269 Amour J, Langeron, Riou B and Coriat P. Usefullness of procalcitonin measurements in subrenal aortic surgery for the etiological diagnosis of postoperative febricule. 2007;1-5.

BDN 1270 Gerlach H. Sepsis. 25 Years of Progress and Innovation in Intensive Care Medicine 2007;141-153.

BDN 1271 Uys A, Rapoport BL, Fickl H, Meyer PW and Anderson R. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10. Eur J Cancer Care (Engl) 2007;16 (6): 475-83.

BDN 1272 Muller B. Endocrine aspects of critical illness. Ann Endocrinol (Paris) 2007;68 (4): 290-298.

BDN 1273 Kruger S, Papassotiriou J, Marre R, Richter K, Schumann C, von Baum H, Morgenthaler NG, Suttorp N and Welte T. Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia : Results from the German competence network CAPNETZ. Intensive Care Med 2007;33 (12): 2069-78.

BDN 1274 Theilla M, Singer P, Cohen J and Dekeyser F. A diet enriched in eicosapentanoic acid, gamma-linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: A randomized, prospective, controlled study. Clin Nutr 2007;Aug 8

BDN 1275 Masia M, Papassotiriou J, Morgenthaler NG, Hernandez I, Shum C and Gutierrez F. Midregional ProA-Type Natriuretic Peptide and Carboxy-Terminal Provasopressin May Predict Prognosis in Community-Acquired Pneumonia. Clin Chem. 2007 Dec;53(12):2193-201

BDN 1276 Ivancevic N, Radenkovic D, Bumbasirevic V, Karamarkovic A, Jeremic V, Kalezic N, Vodnik T, Beleslin B, Milic N, Gregoric P and Zarkovic M. Procalcitonin in preoperative diagnosis of abdominal sepsis. Langenbecks Arch Surg 2008 May;393(3):397-403

BDN 1277 Cate CC, Pettengill OS and Sorenson GD. Biosynthesis of procalcitonin in small cell carcinoma of the lung. Cancer Res 1986;46 (2): 812-8.


BDN 1278 Yilmaz FM, Yilmaz G, Akay H, Duranay M and Yucel D. Evaluation of a card test for procalcitonin in continuous ambulatory peritoneal dialysis peritonitis. Ann Clin Biochem 2007;44 (Pt 5): 482-4.

BDN 1279 Snider RH, Jr., Nylen ES and Becker KL. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Investig Med 1997;45 (9): 552-60.

BDN 1280 Jeandrot A, Richard JL, Combescure C, Jourdan N, Finge S, Rodier M, Corbeau P, Sotto A and Lavigne JP. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study. Diabetologia 2008;51 (2): 347-52.

BDN 1281 Schmidt N, Palma J, King A and Santolaya ME. [C reactive protein and procalcitonin levels for the diagnosis of invasive bacterial infections in allogenic hematopoietic stem cell transplantation recipients.]. Rev Med Chil 2007;135 (8): 982-9.

BDN 1282 Kruger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, Suttorp N and Welte T. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J. 2008 Feb;31(2):349-55

BDN 1283 Yamada H, Matsuda S, Ushio Y, Nakamura K, Kobatake S, Satomura S and Matsuura S. Determination of procalcitonin concentration using the SphereLight 180 clinical auto-analyzer. Clin Chim Acta 2008;388 (1-2): 38-40.

BDN 1284 Myers C and Gervaix A. Streptococcus pneumoniae bacteraemia in children. Int J Antimicrob Agents 2007;30 Suppl 1 S24-8.

BDN 1285 Sfia M, Boeckler P and Lipsker D. High procalcitonin levels in patients with severe drug reactions. Arch Dermatol 2007;143 (12): 1591.

BDN 1286 Fendler WM and Piotrowski AJ. Procalcitonin in the early diagnosis of nosocomial sepsis in preterm neonates. J Paediatr Child Health 2008 Mar;44(3):114-8

BDN 1287 Massaro KS, Costa SF, Leone C and Chamone DA. Procalcitonin (PCT) and C-reactive Protein (CRP) as severe systemic infection markers in febrile neutropenic adults. BMC Infect Dis 2007;7 (1): 137.

BDN 1288 Pharma Report Biomarker ermöglicht gezielte Antibiose. Der Pneumologe 2007;6 (4)

BDN 1289 Tamaki K, Kogata Y, Sugiyama D, Nakazawa T, Hatachi S, Kageyama G, Nishimura K, Morinobu A and Kumagai S. Diagnostic Accuracy of Serum Procalcitonin Concentrations for Detecting Systemic Bacterial Infection in Patients with Systemic Autoimmune Diseases. J Rheumatol. 2008 Jan;35(1):114-9

BDN 1290 de Kruif MD, Lemaire LC, Giebelen IA, Struck J, Morgenthaler NG, Papassotiriou J, Elliott PJ and van der Poll T. The influence of corticosteroids on the release of novel biomarkers in human endotoxemia. Intensive Care Med. 2008 Mar;34(3):518-522

BDN 1291 Green Y, Petignat PA and Perrier A. [Procalcitonin and diagnosis of infection in non-icu patients]. Rev Med Suisse 2007;3 (129): 2330-2, 2334.

BDN 1292 Pastor Peidró JA GdDJ, Urán Moreno MM, García Avilés B, de la Morena Campillo A, Moya Benavent M. [Usefulness of procalcitonin as an early diagnostic test of neonatal sepsis in newborns with risk factors for infection.]. An Pediatr (Barc). 2007;67 (6): 530-5.

BDN 1293 Uzun G, Solmazgul E, Curuksulu H, Turhan V, Ardic N, Top C, Yildiz S and Cimsit M. Procalcitonin as a diagnostic aid in diabetic foot infections. Tohoku J Exp Med 2007;213 (4): 305-12.

BDN 1294 Schuetz P, Christ-Crain M, Morgenthaler NG, Struck J, Bergmann A and Muller B. Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Endothelium 2007;14 (6): 345-51.


BDN 1295 Zazula R, Prucha M, Tyll T and Kieslichova E. Induction of procalcitonin in liver transplant patients treated with anti-thymocyte globulin. Crit Care 2007;11 (6): R131.

BDN 1296 Viallon A, Guyomarc'h S, Marjollet O, Berger C, Carricajo A, Robert F, Laporte S, Lambert C, Page Y, Zeni F and Bertrand JC. Can emergency physicians identify a high mortality subgroup of patients with sepsis: role of procalcitonin. Eur J Emerg Med 2008;15 (1): 26-33.

BDN 1297 Rangeard O, Audibert G, Perrier JF, Loos-Ayav C, Lalot JM, Agavriloaie M, Meistelman C, Gregoire H, Mertes PM and Longrois D. Relationship between procalcitonin values and infection in brain-dead organ donors. Transplant Proc 2007;39 (10): 2970-4.

BDN 1298 Nobre V, Harbarth S, Graf JD, Rohner P and Pugin J. Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients. A Randomized Trial. Am J Respir Crit Care Med. 2008 Mar 1;177(5):498-505

BDN 1298a Simon P, Milbrandt EB and Emlet LL. Procalcitonin-guided antibiotics in severe sepsis. Crit Care 2008;12 (6): 309.

BDN 1299 Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008 Jan;36(1):296-327

BDN 1300 Schuetz P, Christ-Crain M and Mueller B. Procalcitonin for Diagnosis and Monitoring of Therapy of Bacterial Infections. European Infectious Disease 2007;1-4

BDN 1301 Gaini S, Pedersen SS, Koldkaer OG, Pedersen C, Moestrup SK and Moller HJ. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis. Clin Exp Immunol 2008;151 (3): 423-31.

BDN 1302 Cosentini R, Piffer F, Arioli M and Tardini F. Fever and confusion in the emergency department. Breathe 2007;4 (2): 173-182.

BDN 1303 Jung DY, Park JB, Lee EN, Lee HA, Joh JW, Kwon CH, Ki CS, Lee SY and Kim SJ. Combined use of myeloid-related protein 8/14 and procalcitonin as diagnostic markers for acute allograft rejection in kidney transplantation recipients. Transpl Immunol 2008;18 (4): 338-43.

BDN 1304 Morgenthaler NG, Muller B, Struck J, Bergmann A, Redl H and Christ-Crain M. Copeptin, a Stable Peptide of the Arginine Vasopressin Precursor, Is Elevated in Hemorrhagic and Septic Shock. Shock 2007;28 (2): 219-226.

BDN 1305 Ramirez P, Garcia MA, Ferrer M, Aznar J, Valencia M, Sahuquillo JM, Menendez R, Asenjo MA and Torres A. Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J 2008;31 (2): 356-62.

BDN 1306 Streit G, Alber D, Toubin MM, Toussirot E and Wendling D. Procalcitonin, C-reactive protein, and complement-3a assays in synovial fluid for diagnosing septic arthritis: preliminary results. Joint Bone Spine 2008;75 (2): 238-9.

BDN 1307 Vogel Y, Bous JC, Winnekendonk G and Henning BF. Tuberculous peritonitis in a German patient with primary biliary cirrhosis: a case report. J Med Case Reports 2008;2 (1): 32.

BDN 1308 Klinkhammer MA, Weber F, Wappler F and Sakka SG. Uncertain usefulness of procalcitonin as reliable marker of sepsis? Anesth Analg 2008;106 (2): 675-6.

BDN 1309 Fottner A, Birkenmaier C, von Schulze Pellengahr C, Wegener B and Jansson V. Can serum procalcitonin help to differentiate between septic and nonseptic arthritis? Arthroscopy 2008;24 (2): 229-33.


BDN 1310 Menendez R, Cavalcanti M, Reyes S, Mensa J, Martinez R, Marcos MA, Filella X, Niederman M and Torres A. Markers of treatment failure in hospitalised community acquired pneumonia. Thorax 2008;63 (5): 447-52.

BDN 1312 Schutte K and Malfertheiner P. Markers for predicting severity and progression of acute pancreatitis. Best Pract Res Clin Gastroenterol 2008;22 (1): 75-90.

BDN 1313 Gendrel D and Moulin F. [Community-acquired pneumonia in children]. Rev Prat 2007;57 (17): 1883-94.

BDN 1314 De La Rosa GD, Valencia ML, Arango CM, Gomez CI, Garcia A, Ospina S, Osorno S, Henao A and Jaimes FA. Toward an operative diagnosis in sepsis: a latent class approach. BMC Infect Dis 2008;8 (1): 18.

BDN 1315 Lam HS and Ng PC. Biochemical markers of neonatal sepsis. Pathology 2008;40 (2): 141-8.

BDN 1316 Franke A, Lante W, Kupser S, Becker HP, Weinhold C and Markewitz A. Procalcitonin levels after different types of conventional thoracic surgery. Thorac Cardiovasc Surg 2008;56 (1): 46-50.

BDN 1317 Schuetz P, Stolz D, Mueller B, Morgenthaler N, Struck J, Mueller C, Bingisser R, Tamm M and Christ-Crain M. Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia. BMC Infect Dis 2008;8 (1): 22.

BDN 1318 Yucel T, Gonullu D, Guclu S, Sit M, Adaleti R, Tetikkurt S, Ozcan A and Koksoy FN. [The therapeutic effect of normobaric oxygen in experimental peritonitis and the efficiency of rectal fever, WBC, CRP and procalcitonin in monitoring response of the therapy.]. Ulus Travma Acil Cerrahi Derg 2008;14 (1): 14-20.

BDN 1319 Forsberg JA, Elster EA, Andersen RC, Nylen E, Brown TS, Rose MW, Stojadinovic A, Becker KL and McGuigan FX. Correlation of procalcitonin and cytokine expression with dehiscence of wartime extremity wounds. J Bone Joint Surg Am 2008;90 (3): 580-8.

BDN 1321 Xu K, Kang FX, Wang RL and Yu KL. [Evaluation of value of procalcitonin determination in assessing the severity of bacterial infection in critically ill patients requiring anti-coagulant therapy.]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2008;20 (1): 52-3.

BDN 1322 Xing YB, Dai LM, Zhao ZH, Li ZW and Li C. [Diagnostic and prognostic value of procalcitonin and common inflammatory markers combining SOFA score in patients with sepsis in early stage.]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2008;20 (1): 23-8.

BDN 1323 Skrak P, Kovacikova L and Kunovsky P. Procalcitonin, neopterin and C-reactive protein after pediatric cardiac surgery with cardiopulmonary bypass. Bratisl Lek Listy 2007;108 (12): 501-5.

BDN 1324 Colak B, Gurlek B, Yegin ZA, Deger SM, Elbek S, Pasaoglu H, Dogan I, Ozturk MA, Unal S and Guz G. The Relationship between the MEFV Genotype, Clinical Features, and Cytokine-Inflammatory Activities in Patients with Familial Mediterranean Fever. Ren Fail 2008;30 (2): 187-91.

BDN 1325 Povoa P. Serum markers in community-acquired pneumonia and ventilator-associated pneumonia. Curr Opin Infect Dis 2008;21 (2): 157-62.

BDN 1326 Lisboa T and Rello J. Diagnosis of ventilator-associated pneumonia: is there a gold standard and a simple approach? Curr Opin Infect Dis 2008;21 (2): 174-8.

BDN 1327 Nagata J, Kobayashi M, Nishikimi N and Komori K. Serum Procalcitonin (PCT) as a Negative Screening Test for Colonic Ischemia after Open Abdominal Aortic Surgery. Eur J Vasc Endovasc Surg Eur J Vasc Endovasc Surg. 2008 Jun;35(6):694-7


BDN 1329 Papassotiriou I, Alexiou VG, Tsironi M, Skenderi K, Spanos A and Falagas ME. Severe aseptic inflammation caused by long distance running (246 km) does not increase procalcitonin. Eur J Clin Invest 2008;38 (4): 276-9.

BDN 1329a Lippi G, Schena F, Montagnana M, Salvagno GL and Guidi GC. Acute influence of aerobic physical exercise on procalcitonin. Eur J Clin Invest 2008;38 (10): 784-5.

BDN 1330 Stiefelhagen P. [Patient with cough and fever. Does he need an antibiotic?]. MMW Fortschr Med 2008;150 (1-2): 18-9.

BDN 1331 Kalocheretis P, Revela I, Spanou E, Drouzas A, Makriniotou I and Iatrou C. Strong correlation of B2-microglobulin (B2-m) with procalcitonin (PCT) in the serum of chronic hemodialysis patients: a role for infections in the dialysis-related amyloidosis? Ren Fail 2008;30 (3): 261-5.

BDN 1332 Becker KL, Snider RH and Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations. Crit Care Med 2008;36 (3): 941-952.

BDN 1333 Amour J, Birenbaum A, Langeron O, Le Manach Y, Bertrand M, Coriat P, Riou B, Bernard M and Hausfater P. Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med 2008;36 (4): 1147-54.

BDN 1334 Boo NY, Nor Azlina AA and Rohana J. Usefulness of a semi-quantitative procalcitonin test kit for early diagnosis of neonatal sepsis. Singapore Med J 2008;49 (3): 204-8.

BDN 1333a De Waele JJ, Hoste E, Blot S and Vogelaers D. The value of procalcitonin to diagnose infection in critically ill patient: caveat emptor! Crit Care Med 2008;36 (11): 3121; author reply 3121-2.

BDN 1333b Amour J, Langeron O and Hausfater P. The authors reply Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med 2008;36 (11): 1321-22.

BDN 1335 Didebulidze K, Manjavidze N, Ubiria I and Gogberashvili K. [Procalcitonin - marker of severe infection and sepsis.]. Georgian Med News 2007;(153): 22-7.

BDN 1336 Charles PE, Ladoire S, Aho S, Quenot JP, Doise JM, Prin S, Olsson NO and Blettery B. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria. BMC Infect Dis 2008;8 38.

BDN 1337 Hausfater P, Hurtado M, Pease S, Juillien G, Lvovschi VE, Salehabadi S, Lidove O, Wolff M, Bernard M, Chollet-Martin S and Riou B. Is procalcitonin a marker of critical illness in heatstroke? Intensive Care Med 2008 Aug;34(8):1377-83

BDN 1338 Procalcitonin: Gezielte Therapie durch innovative Diagnostik. Med Review - Die Zeitschrift für ärztliche Fortbildungskongresse 2007;(5):

BDN 1339 Skipworth JR and Pereira SP. Acute pancreatitis. Curr Opin Crit Care 2008;14 (2): 172-178.

BDN 1340 Jensen JU and Lundgren JD. Procalcitonin in liver transplant patients - yet another stone turned. Crit Care 2008;12 (1): 108.

BDN 1341 Pelosi P, Barassi A, Severgnini P, Gomiero B, Finazzi S, Merlini G, Melzi d'Eril G, Chiaranda M and Niederman MS. Prognostic Role of Clinical and Laboratory Criteria to Identify Early Vap in Brain Injury. Chest 2008 Jul;134(1):101-8


BDN 1342 Herzum I and Renz H. Inflammatory markers in SIRS, sepsis and septic shock. Curr Med Chem 2008;15 (6): 581-7.

BDN 1343 Wei JX, Verity A, Garle M, Mahajan R and Wilson V. Examination of the effect of procalcitonin on human leucocytes and the porcine isolated coronary artery. Br J Anaesth 2008;100 (5): 612-21.

BDN 1344 Perren A, Cerutti B, Lepori M, Senn V, Capelli B, Duchini F and Domenighetti G. Influence of Steroids on Procalcitonin and C-reactive Protein in Patients with COPD and Community-acquired Pneumonia. Infection 2008;36 (2): 163-6.

BDN 1345 Luyt CE, Combes A, Reynaud C, Hekimian G, Nieszkowska A, Tonnellier M, Aubry A, Trouillet JL, Bernard M and Chastre J. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008 Aug;34(8):1434-40

BDN 1346 Sirvinskas E, Veikutiene A, Benetis R, Grybauskas P, Andrejaitiene J, Veikutis V and Surkus J. Influence of early re-infusion of autologous shed mediastinal blood on clinical outcome after cardiac surgery. Perfusion 2007;22 (5): 345-52.

BDN 1347 Rea-Neto A, Youssef N, Tuche F, Brunkhorst F, Ranieri M, Reinhart K and Sakr Y. Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care 2008;12 (2): R56.

BDN 1348 Yilmaz Z, Ilcol YO and Ulus IH. Endotoxin increases plasma leptin and ghrelin levels in dogs. Crit Care Med 2008;36 (3): 828-33.

BDN 1349 Mussap M, Degrandi R, Cataldi L, Fanos V and Plebani M. Biochemical markers for the early assessment of neonatal sepsis: the role of procalcitonin. J Chemother 2007;19 Suppl 2 35-8.

BDN 1350 Sexton PM, Christopoulos G, Christopoulos A, Nylen ES, Snider RH, Jr. and Becker KL. Procalcitonin has bioactivity at calcitonin receptor family complexes: Potential mediator implications in sepsis*. Crit Care Med 2008;36 (5): 1637-40.

BDN 1351 Zakariah AN, Cozzi SM, Nuffelen MV, Clausi CM, Pradier O and Vincent JL. Combination of biphasic transmittance waveform with blood procalcitonin levels for diagnosis of sepsis in acutely ill patients. Crit Care Med 2008;36 (5): 1507-12.

BDN 1352 Carboni GL, Fahrner R, Gazdhar A, Printzen G, Schmid RA and Hoksch B. Comparison of procalcitonin and CrP in the postoperative course after lung decortication. Eur J Cardiothorac Surg 2008;33 (5): 777-80.

BDN 1352a Apostolakis EE, Prokakis C and Dougenis D. Are procalcitonin levels sufficient for the follow up of patients undergoing lung decortication for pleural empyema? Eur J Cardiothorac Surg 2009;35 (1): 193; author reply 194.

BDN 1353 Thia KT, Chan ES, Ling KL, Ng WY, Jacob E and Ooi CJ. Role of Procalcitonin in Infectious Gastroenteritis and Inflammatoryfever and . Dig Dis Sci. 2008 Nov;53(11):2960-8

BDN 1354 Song LO, Yinglong LI and Jinping LI. Effects of zero-balanced ultrafiltration on procalcitonin and respiratory function after cardiopulmonary bypass. Perfusion 2007;22 (5): 339-43.

BDN 1355 Korppi M, Don M, Valent F and Canciani M. The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children. Acta Paediatr. 2008 Jul;97(7):943-7

BDN 1357 Cardelli P, Ferraironi M, Amodeo R, Tabacco F, De Blasi RA, Nicoletti M, Sessa R, Petrucca A, Costante A and Cipriani P. Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis. Int J Immunopathol Pharmacol 2008;21 (1): 43-49.

BDN 1358 O'Grady NP, Barie PS, Bartlett JG, Bleck T, Carroll K, Kalil AC, Linden P, Maki DG, Nierman D, Pasculle W and Masur H. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med 2008;36 (4): 1330-49.


BDN 1359 Tasabehji WR, Al-Quobaili FA and Al-Daher NA. Usefulness of procalcitonin and some inflammatory parameters in septic patients. Saudi Med J 2008;29 (4): 520-5.

BDN 1360 Cheung YB, Zaman SM, Ruopuro ML, Enwere G, Adegbola RA, Greenwood B and Cutts FT. C-reactive protein and procalcitonin in the evaluation of the efficacy of a pneumococcal conjugate vaccine in Gambian children. Trop Med Int Health 2008;13 (5): 603-11.

BDN 1361 Los Arcos M, Rey C, Concha A, Medina A and Prieto B. Acute-phase reactants after paediatric cardiac arrest. Procalcitonin as marker of immediate outcome. BMC Pediatr 2008;8 (1): 18.

BDN 1362 Hochreiter M, Kohler T, Schweiger AM, Keck FS, Bein B, von Spiegel T and Schroder S. [Antibiotic treatment of surgical intensive care patients : Procalcitonin to guide duration of therapy.]. Anaesthesist 2008;57 (6): 571-7.

BDN 1363 Christ-Crain M and Muller B. Calcitonin peptides--the mediators in sepsis or just another fairy tale? Crit Care Med 2008;36 (5): 1684-7.

BDN 1364 Christ-Crain M, Breidthardt T, Stolz D, Zobrist K, Bingisser R, Miedinger D, Leuppi J, Tamm M, Mueller B and Mueller C. Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia. J Intern Med. 2008 Aug;264(2):166-76

BDN 1365 Frasko R, Maruna P, Gurlich R and Trca S. Transcutaneous Electrogastrography in Patients with Ileus. Relations to Interleukin-1beta, Interleukin-6, Procalcitonin and C-Reactive Protein. Eur Surg Res 2008;41 (2): 197-202.

BDN 1366 Dornbusch HJ, Strenger V, Sovinz P, Lackner H, Schwinger W, Kerbl R and Urban C. Non-infectious causes of elevated procalcitonin and C-reactive protein serum levels in pediatric patients with hematologic and oncologic disorders. Support Care Cancer 2008;16 (9): 1035-40.

BDN 1367 Mussap M, Molinari MP, Senno E, Gritti P, Soro B, Mannelli S and Fabris C. New diagnostic tools for neonatal sepsis: the role of a real-time polymerase chain reaction for the early detection and identification of bacterial and fungal species in blood samples. J Chemother 2007;19 Suppl 2 31-4.

BDN 1368 Santolaya ME, Alvarez AM, Aviles CL, Becker A, King A, Mosso C, O'Ryan M, Paya E, Salgado C, Silva P, Topelberg S, Tordecilla J, Varas M, Villarroel M, Viviani T and Zubieta M. Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: a prospective, multicenter trial. Pediatr Infect Dis J 2008;27 (6): 538-43.

BDN 1369 Kallio R, Surcel HM, Bloigu A and Syrjala H. C-reactive protein, procalcitonin and interleukin-8 in the primary diagnosis of infections in cancer patients. Eur J Cancer 2000;36 (7): 889-94.

BDN 1370 Stolz D, Christ-Crain M, Morgenthaler NG, Miedinger D, Leuppi J, Muller C, Bingisser R, Struck J, Muller B and Tamm M. Plasma Pro-Adrenomedullin But Not Plasma Pro-Endothelin Predicts Survival in Exacerbations of COPD. Chest 2008;134 (2): 263-72.

BDN 1371 Tseng JS, Chan MC, Hsu JY, Kuo BI and Wu CL. Procalcitonin is a valuable prognostic marker in ARDS caused by community-acquired pneumonia. Respirology 2008;13 (4): 505-9.

BDN 1372 Linssen CF, Bekers O, Drent M and Jacobs JA. C-reactive protein and procalcitonin concentrations in bronchoalveolar lavage fluid as a predictor of ventilator-associated pneumonia. Ann Clin Biochem 2008;45 (Pt 3): 293-8.

BDN 1373 Moertl D, Hammer A, Huelsmann M, Pacher R and Berger R. Prognostic value of sequential measurements of amino-terminal prohormone of B-type natriuretic peptide in ambulatory heart failure patients. Eur J Heart Fail 2008;10 (4): 404-11.


BDN 1374 Simon L, Saint-Louis P, Amre DK, Lacroix J and Gauvin F. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome*. Pediatr Crit Care Med. 2008 Jul;9(4):407-13

BDN 1374a Watson RS. Is it time to put procalcitonin to the (randomized, controlled) test?*. Pediatr Crit Care Med. 2008 Jul;9(4):446-7

BDN 1375 Stolz D, Breidthardt T, Christ-Crain M, Bingisser R, Miedinger D, Leuppi J, Mueller B, Tamm M and Mueller C. Use of B-Type Natriuretic Peptide in the Risk Stratification of Acute Exacerbations of COPD. Chest 2008;133 (5): 1088-94.

BDN 1376 Zjevikova A, Lukacova L and Kielkowska I. [Large vessel vasculitis as a cause of fever of unknown origin and increase of inflammatory markers.]. Klin Mikrobiol Infekc Lek 2008;14 (3): 109-114.

BDN 1377 Chatzimavroudis G, Pavlidis TE, Koutelidakis I, Giamarrelos-Bourboulis EJ, Atmatzidis S, Kontopoulou K, Marakis G and Atmatzidis K. CO(2) Pneumoperitoneum Prolongs Survival in an Animal Model of Peritonitis Compared to Laparotomy. J Surg Res 2008

BDN 1378 Hirakata Y, Yanagihara K, Kurihara S, Izumikawa K, Seki M, Miyazaki Y and Kohno S. Comparison of usefulness of plasma procalcitonin and C-reactive protein measurements for estimation of severity in adults with community-acquired pneumonia. Diagn Microbiol Infect Dis 2008;61 (2): 170-4.

BDN 1379 Indino P, Lemarchand P, Bady P, de Torrente A, Genne L and Genne D. Prospective study on procalcitonin and other systemic infection markers in patients with leukocytosis. Int J Infect Dis 2008;12 (3): 319-24.

BDN 1380 Barati M, Alinejad F, Bahar MA, Tabrisi MS, Shamshiri AR, Bodouhi NO and Karimi H. Comparison of WBC, ESR, CRP and PCT serum levels in septic and non-septic burn cases. Burns 2008;34 (6): 770-4.

BDN 1381 Cuculi F, Toggweiler S, Auer M, Auf der Maur C, Zuber M and Erne P. Serum procalcitonin has the potential to identify Staphylococcus aureus endocarditis. Eur J Clin Microbiol Infect Dis. 2008 Nov;27(11):1145-9

BDN 1382 Groeneveld AB and Hack CE. The role of the innate immune response in hospital- versus community-acquired infection in febrile medical patients. Int J Infect Dis. 2008 Nov;12(6):660-670

BDN 1383 Ramsthaler F, Kettner M, Mall G and Bratzke H. The use of rapid diagnostic test of Procalcitonin serum levels for the postmortem diagnosis of sepsis. Forensic Sci Int 2008;178 (2-3): 139-45.

BDN 1384 Lam MF, Leung JC, Lam CW, Tse KC, Lo WK, Lui SL, Chan TM, Tam S and Lai KN. Procalcitonin fails to differentiate inflammatory status or predict long-term outcomes in peritoneal dialysis-associated peritonitis. Perit Dial Int 2008;28 (4): 377-84.

BDN 1385 Sakr Y, Burgett U, Nacul FE, Reinhart K and Brunkhorst F. Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis? Crit Care Med 2008;36 (7): 2014-22.

BD N 1386 Quintana G, Medina YF, Rojas C, Fernandez A, Restrepo JF, Rondon F and Iglesias A. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus. J Clin Rheumatol 2008;14 (3): 138-42.

BDN 1387 Shehabi Y and Seppelt I. Pro/Con debate: Is procalcitonin useful for guiding antibiotic decision making in critically ill patients? Crit Care 2008;12 (3): 211.

BDN 1388 Bassim CW, Redman RS, Denucci DJ, Becker KL and Nylen ES. Salivary procalcitonin and periodontitis in diabetes. J Dent Res 2008;87 (7): 630-4.


BDN 1389 Endo S, Aikawa N, Fujishima S, Sekine I, Kogawa K, Yamamoto Y, Kushimoto S, Yukioka H, Kato N, Totsuka K, Kikuchi K, Ikeda T, Ikeda K, Yamada H, Harada K and Satomura S. Usefulness of procalcitonin serum level for the discrimination of severe sepsis from sepsis: a multicenter prospective study. J Infect Chemother 2008;14 (3): 244-9.

BDN 1390 Pramod J and Singh A. Sepsis biomarkers. Am J Med 2008;121 (6): e11.

BDN 1391 Kordek A, Halasa M and Podraza W. Early detection of an early onset infection in the neonate based on measurements of procalcitonin and C-reactive protein concentrations in cord blood. Clin Chem Lab Med 2008;46 (8): 1143-8.

BDN 1392 Ewig S and Welte T. Biomarkers in the diagnosis of pneumonia in the critically ill: don't shoot the piano player. Intensive Care Med 2008;34 (6): 981-4.

BDN 1393 Hawk M. C-reactive protein in neonatal sepsis. Neonatal Netw 2008;27 (2): 117-20.

BDN 1394 Reinhart K, Brunkhorst M, Bone HG, Gerlach H, Gründling M, Kreymann G, Kujath P, Marggraf G, Mayer K, Meier-Hellmann A, Peckelsen C, Putensen C, Quintel M, Ragaller M, Rossaint R, Stüber F, Weiler N, Welte T and Werdan K. Diagnosis und Therapie der Sepsis: S-2 Leitlinien der Deutschen Sepsis-Gesellschaft e.V. (DGS) und der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin (DIVI). Intensiv - News 2006;10 Suppl 2 (3)

BDN 1395 Gerard Y, Hober D, Petitjean S, Assicot M, Bohuon C, Mouton Y and Wattre P. High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis. Infection 1995;23 (5): 310-1.

BDN 1396 Hugle T, Schuetz P, Mueller B, Laifer G, Tyndall A, Regenass S and Daikeler T. Serum procalcitonin for discrimination between septic and non-septic arthritis. Clin Exp Rheumatol 2008;26 (3): 453-6.

BDN 1397 Lacour AG, Zamora SA and Gervaix A. A score identifying serious bacterial infections in children with Fever without source. Pediatr Infect Dis J 2008;27 (7): 654-6.

BDN 1398 Clodi M, Vila G, Geyeregger R, Riedl M, Stulnig TM, Struck J, Luger TA and Luger A. Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men. Am J Physiol Endocrinol Metab. 2008 Sep;295(3):E686-91

BDN 1399 Eyraud D, Ben Ayed S, Tanguy ML, Vezinet C, Siksik JM, Bernard M, Fratea S, Movschin M, Vaillant JC, Coriat P and Hannoun L. Procalcitonin in liver transplantation: are high levels due to donors or recipients? Crit Care 2008;12 (4): R85.

BDN 1400 Santuz P, Soffiati M, Dorizzi RM, Benedetti M, Zaglia F and Biban P. Procalcitonin for the diagnosis of early-onset neonatal sepsis: A multilevel probabilistic approach. Clin Biochem. 2008 Oct;41(14-15):1150-5

BDN 1401 Don M, Valerio G, Korppi M and Canciani M. Hyponatremia in pediatric community-acquired pneumonia. Pediatr Nephrol. 2008 Dec;23(12):2247-53

BDN 1402 Cosentini R, Tarsia P, Canetta C, Graziadei G, Brambilla AM, Aliberti S, Pappalettera M, Tantardini F and Blasi F. Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection. Respir Res 2008 May 30;9:48

BDN 1403 Bordon J, Peyrani P, Brock GN, Blasi F, Rello J, File T and Ramirez J. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Chest 2008;133 (3): 618-24.

BDN 1405 Blasi F, Iori I, Bulfoni A, Corrao S, Costantino S and Legnani D. Can CAP Guideline Adherence Improve Patient Outcome in Internal Medicine Departments? Eur Respir J. 2008 Oct;32(4):902-10


BDN 1406 Aliberti S, Amir A, Peyrani P, Mirsaeidi M, Allen M, Moffett BK, Myers J, Shaib F, Cirino M, Bordon J, Blasi F and Ramirez JA. Incidence, Etiology, Timing and Risk Factors for Clinical Failure in Hospitalized Patients with Community-Acquired Pneumonia. Chest. 2008 Nov;134(5):955-62

BDN 1407 Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S and Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J 2007;30 (5): 993-1013.

BDN 1408 Jensen JU, Lundgren B, Hein L, Mohr TT, Petersen PL, Andersen LH, Lauritsen AO, Hougaard S, Mantoni T, Bomler B, Thornberg KJ, Thormar K, Loken J, Steensen M, Carl P, Petersen JA, Tousi H, Soe-Jensen P, Bestle M, Hestad S, Andersen MH, Fjeldborg P, Larsen KM, Rossau CD, Thomsen CB, Ostergaard C, Kjaer J, Grarup J and Lundgren JD. The Procalcitonin And Survival Study (PASS) - A Randomised multi-center trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients. BMC Infect Dis 2008;8 (1): 91.

BDN 1409 Procalitonin stellt die Weichen: Neue Studienergebnisse: Für mehr Diagnose-Sicherheit und ein erfolgreiches Antibiotika-Management in Klinik und Praxis. MedReview 2008;6 1-4.

BDN 1410 Zhang D, Lavaux T, Voegeli AC, Lavigne T, Castelain V, Meyer N, Sapin R, Aunis D, Metz-Boutigue MH and Schneider F. Prognostic value of chromogranin A at admission in critically ill patients: a cohort study in a medical intensive care unit. Clin Chem 2008;54 (9): 1497-503.

BDN 1411 Prat C, Sancho JM, Dominguez J, Xicoy B, Gimenez M, Ferra C, Blanco S, Lacoma A, Ribera JM and Ausina V. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. Leuk Lymphoma 2008;1-10.

BDN 1412 Gendrel D, Leroy S, Breart G and Chalumeau M. [Procalcitonin and prediction of vesico-ureteral reflux in pediatric urinary tract infection]. Bull Acad Natl Med 2007;191 (8): 1731-43; discussion 1743-4.

BDN 1417 Weiss M. [Risk assessment in community acquired pneumonia. Who should be hospitalized, who can be managed at home?] Wer muss ins Krankenhaus, wer kann zu Hause versorgt werden? MMW Fortschr Med 2008;150 (12): 18.

BDN 1418 Loebinger M, Shoemark A, Berry M, Kemp M and Wilson R. Procalcitonin in stable and unstable patients with bronchiectasis. Chron Respir Dis 2008;5 (3): 155-60.

BDN 1419 Haeuptle J, Zaborsky R, Fiumefreddo R, Trampuz A, Steffen I, Frei R, Christ-Crain M, Muller B and Schuetz P. Prognostic value of procalcitonin in Legionella pneumonia. Eur J Clin Microbiol Infect Dis. 2009 Jan;28(1):55-60.

BDN 1420 Bulut C, Ozturk R, Yilmaz GR, Parpucu H, Irmak H, Kinikli S, Duranay M and Demiroz AP. [Evaluation of the epidemiological, clinical and laboratory findings in continuous ambulatory peritoneal dialysis related peritonitis attacks]. Mikrobiyol Bul 2008;42 (2): 255-64.

BDN 1421 Maniaci V, Dauber A, Weiss S, Nylen E, Becker KL and Bachur R. Procalcitonin in young febrile infants for the detection of serious bacterial infections. Pediatrics 2008;122 (4): 701-10.

BDN 1421a Bachur RG. New test could help catch serious infections in babies: Blood test may spare infants invasive diagnostic tests and antibiotics Children's Hospital Boston 2008;

BDN 1422 Sakr Y, Sponholz C, Tuche F, Brunkhorst F and Reinhart K. The Role of Procalcitonin in Febrile Neutropenic Patients: Review of the Literature. Infection. 2008 Oct;36(5):396-407


BDN 1423 El Hage F, Stroobant V, Vergnon I, Baurain JF, Echchakir H, Lazar V, Chouaib S, Coulie PG and Mami-Chouaib F. Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathway. Proc Natl Acad Sci U S A 2008;105 (29): 10119-24.

BDN 1424 Zhang D, Lavaux T, Sapin R, Lavigne T, Castelain V, Aunis D, Metz-Boutigue MH and Schneider F. Serum concentration of chromogranin A at admission: An early biomarker of severity in critically ill patients. Ann Med 2008;1-7.

BDN 1425 Ebell M. Procalcitonin-guided treatment of respiratory tract infections. Am Fam Physician 2008;78 (6): 756-7.

BDN 1427 Christ-Crain M, Schuetz P, Huber AR and Muller B. [Procalcitonin - importance for the diagnosis of bacterial infections.]. Ther Umsch 2008;65 (9): 559-68.

BDN 1428 Kuzi S, Aroch I, Peleg K, Karnieli O, Klement E and Dank G. Canine procalcitonin messenger RNA expression. J Vet Diagn Invest 2008;20 (5): 629-33.

BDN 1429 Sakha K, Husseini MB and Seyyedsadri N. The role of the procalcitonin in diagnosis of neonatal sepsis and correlation between procalcitonin and C-reactive protein in these patients. Pak J Biol Sci 2008;11 (14): 1785-90.

BDN 1430 Prieto B, Llorente E, Gonzalez-Pinto I and Alvarez FV. Plasma procalcitonin measured by time-resolved amplified cryptate emission (TRACE) in liver transplant patients. A prognosis marker of early infectious and non-infectious postoperative complications. Clin Chem Lab Med 2008;46 (5): 660-6.

BDN 1431 Kramer PM, Gouzy MF, Kess M, Kleinschmidt U and Kremmer E. Development and characterization of new rat monoclonal antibodies for procalcitonin. Anal Bioanal Chem 2008;392 (4): 727-36.

BDN 1432 Tsilina SV, Govorova NV, Dolgikh VT, Lukach VN, Maksimishin SV and Glushchenko AV. [Clinical significance of the parameters of a systemic inflammatory response, leukocytic intoxication index, and procalcitonin test in the diagnosis of pyodestructive pyelonephritis of pregnant women]. Anesteziol Reanimatol 2008;(3): 29-31.

BDN 1433 Dubos F, Moulin F, Gendrel D, Breart G and Chalumeau M. [Distinguishing between bacterial and aseptic meningitis in children in the emergency department]. Arch Pediatr 2008;15 (5): 724-5.

BDN 1434 Briel M, Schuetz P, Mueller B, Young J, Schild U, Nusbaumer C, Periat P, Bucher HC and Christ-Crain M. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008;168 (18): 2000-7; discussion 2007-8.

BDN 1435 Daubin C, Parienti JJ, Vabret A, Ramakers M, Fradin S, Terzi N, Freymuth F, Charbonneau P and du Cheyron D. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study. BMC Infect Dis 2008;8 145.

BDN 1436 Dauber A, Weiss S, Maniaci V, Nylen E, Becker KL and Bachur R. Procalcitonin levels in febrile infants after recent immunization. Pediatrics 2008;122 (5): e1119-22.

BDN 1438 Atemwegsinfekte: PCT-Test klärt, wer Antibiose braucht. Ärztezeitung 2008;(4 Nov):

BDN 1439 Madershahian N, Wittwer T, Strauch J, Wippermann J, Rahmanian P, Franke UF and Wahlers T. Kinetic of procalcitonin in the early postoperative course following heart transplantation. J Card Surg 2008;23 (5): 468-73.

BDN 1440 Dahaba AA and Metzler H. Procalcitonin's role in the sepsis cascade. Is procalcitonin a sepsis marker or mediator? Minerva Anestesiol 2008 Nov 6

BDN 1441 Schneider CP, Yilmaz Y, Kleespies A, Jauch KW and Hartl WH. Accuracy of procalcitonin for outcome prediction in unselected postoperative critically ill patients. Shock. 2009 Jun;31(6):568-73


BDN 1442 Gurda-Duda A, Kusnierz-Cabala B, Nowak W, Naskalski JW and Kulig J. Assessment of the prognostic value of certain acute-phase proteins and procalcitonin in the prognosis of acute pancreatitis. Pancreas 2008;37 (4): 449-53.

BDN 1443 Tan TQ. Procalcitonin in young febrile infants for the detection of serious bacterial infections: is this the "holy grail"? Pediatrics 2008;122 (5): 1117-8.

BDN 1444 Molnar T, Peterfalvi A, Szereday L, Pusch G, Szapary L, Komoly S, Bogar L and Illes Z. Deficient leucocyte antisedimentation is related to post-stroke infections and outcome. J Clin Pathol 2008;61 (11): 1209-13.

BDN 1445 Mueller B, Schuetz P and Christ-Crain M. Procalcitonin. Schweiz Med Forum 2008;8 (21): 388-390.

BDN 1446 Stolzel F, Babatz J, Thiede C, Siegert G, Illmer T, Ehninger G and Schaich M. Cyclic severe elevated procalcitonin serum levels in a patient with post polycythemic myelofibrosis carrying a V617F-JAK2 mutation. Ann Hematol 2008;87 (12): 1021-2.

BDN 1448 Nseir S, Cavestri B, Di Pompeo C, Diarra M, Brisson H, Lemyze M, Roussel-Delvallez M and Durocher A. Factors predicting bacterial involvement in severe acute exacerbations of chronic obstructive pulmonary disease. Respiration 2008;76 (3): 253-60.

BDN 1448a Miravitlles M. Is it possible to reduce the use of antibiotics in severe exacerbations of chronic obstructive pulmonary disease? Respiration 2008;76 (3): 249-50.

BDN 1449 Kulabukhov VV. Use of an endotoxin adsorber in the treatment of severe abdominal sepsis. Acta Anaesthesiol Scand 2008;52 (7): 1024-5.

BDN 1450 Savagner C, Hoppe A, Montcho Y, Leboucher B, Le Bouedec S, Lemarie C, Boux de Casson F and Bouderlique C. Interest of Procalcitonin in neonatal intensive care unit for patients suspected of nosocomial sepsis: Retrospective study on 40 children. Journal de pédiatrie et de puériculture 2008;21 292-298.

BDN 1453 Burkhardt O, Evcümen S, Hummers-Pradier E, Wegscheider K, Giersdorf S and Welte T. Procalcitonin in Primary Care Patients with Upper and Lower Respiratory Tract Infections. Poster: American Thoracic Society International Conference 2008;May 16 - 21, 2008, Toronto

BDN 1454 Zaffanello M, Brugnara M, Franchini M and Fanos V. Is serum procalcitonin able to predict long-term kidney morbidity from urinary tract infections in children? Clin Chem Lab Med 2008;46 (10): 1358-63.

BDN 1455 Zilkens C, Friese J, Koller M, Muhr G and Schinkel C. Hepatic failure after injury - a common pathogenesis with sclerosing cholangitis? Eur J Med Res 2008;13 (7): 309-13.

BDN 1456 Ferns T. PROCALCITONIN AS A MARKER OF SEPSIS IN PATIENTS ON ECMO. Pediatric Critical Care Medicine 2005;6 393.

BDN 1457 Procalcitonin-Test hilft bei Entscheidung für Antibiose. Ärzte Zeitung 2008;

BDN 1458 Barclay L and Murata P. Procalcitonin Levels May Help Guide Antibiotic Use for Acute Respiratory Tract Infections Medscape 2008;

BDN 1459 Klugman KP, Madhi SA and Albrich WC. Novel approaches to the identification of Streptococcus pneumoniae as the cause of community-acquired pneumonia. Clin Infect Dis 2008;47 Suppl 3 S202-6.

BDN 1460 Niederman MS. Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin. Clin Infect Dis 2008;47 Suppl 3 S127-32.


BDN 1461 Wang C. Role of Serum Procalcitonin in the Differentiation between Septic and Nonseptic Arthritis. BestBets 2008;

BDN 1462 Prat C, Ricart P, Ruyra X, Dominguez J, Morillas J, Blanco S, Tomasa T, Torres T, Camara L, Molinos S and Ausina V. Serum Concentrations of Procalcitonin After Cardiac Surgery. J Card Surg 2008;23 (6): 627-632.

BDN 1463 Vennewald I, Arnhold A, Dürig E, Prinz M and Demant T. Procalcitonin (PCT) im Verlauf einer disseminierten Aspergillus-Infektion bei einem Intensivstationspatienten - Ein Fallbericht. Intensivmed 2008;45 330-336.

BDN 1464 Ventetuolo CE and Levy MM. Biomarkers: diagnosis and risk assessment in sepsis. Clin Chest Med 2008;29 (4): 591-603.

BDN 1465 Phua J, Koay ES, Zhang D and Lee KH. How well do serum sTREM-1 measurements prognosticate in septic shock? Anaesth Intensive Care 2008;36 (5): 654-8.

BDN 1466 Fraunberger P, Holler E, Parhofer KG, Walli AK and Seidel D. Interleukin 6, procalcitonin and CRP levels during first increase of fever in intensive care patients. Haben die Konzentrationen von Interleukin 6, Procalcitonin und CRP bei Intensivpatienten während des ersten Fieberanstieges eine prognostische Bedeutung? J Lab Med 2008;32 (6): 434-437.

BDN 1467 Rudensky B, Sirota G, Erlichman M, Yinnon AM and Schlesinger Y. Neutrophil CD64 expression as a diagnostic marker of bacterial infection in febrile children presenting to a hospital emergency department. Pediatr Emerg Care 2008;24 (11): 745-8.

BDN 1468 Schultz MJ and Determann RM. PCT and sTREM-1: The markers of infection in critically ill patients? Med Sci Monit 2008;14 (12): RA241-247.

BDN 1469 Menchine MD, Schriger DL and Barrett TW. Annals of Emergency Medicine Journal Club. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia answers to the July 2008 Journal Club questions. Ann Emerg Med 2008;52 (6): 754-63.

BDN 1470 Zambon M, Ceola M, Almeida-de-Castro R, Gullo A and Vincent JL. Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: we could go faster. J Crit Care 2008;23 (4): 455-60.

BDN 1471 Bender L, Thaarup J, Varming K, Krarup H, Ellermann-Eriksen S and Ebbesen F. Early and late markers for the detection of early-onset neonatal sepsis. Dan Med Bull 2008;55 (4): 219-23.

BDN 1472 Cuesta MP, Llorente JL, Gomez JR, Lopez F and Suarez C. [Procalcitonin plasma levels do not alter after uncomplicated skull base surgery.]. Acta Otorrinolaringol Esp 2008;59 (7): 341-4.

BDN 1473 Dubos F, Korczowski B, Aygun DA, Martinot A, Prat C, Galetto-Lacour A, Casado-Flores J, Taskin E, Leclerc F, Rodrigo C, Gervaix A, Leroy S, Gendrel D, Breart G and Chalumeau M. Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study. Arch Pediatr Adolesc Med 2008;162 (12): 1157-63.

BDN 1474

Schroeder S, Hochreiter M, Koehler T, Schweiger AM, Bein B, Keck FS and von Spiegel T. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg 2009;394 (2): 221-6.

BDN 1475 Biomarker bei bakeriellen Infektionen: Procalcitonin und MR-pro-Adrenomedullin erleichtern ärztliche Entscheidungen. PNEUMO-News 2008;6

BDN 1476 Algeciras-Schimnich A, Preissner CM, Theobald JP, Finseth MS and Grebe SK. Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 2009;94 (3): 861-8.


BDN 1477 Shapiro NI, Trzeciak S, Hollander JE, Birkhahn R, Otero R, Osborn TM, Moretti E, Nguyen HB, Gunnerson KJ, Milzman D, Gaieski DF, Goyal M, Cairns CB, Ngo L and Rivers EP. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med 2009;37 (1): 96-104.

BDN 1478 Nakamura A, Wada H, Ikejiri M, Hatada T, Sakurai H, Matsushima Y, Nishioka J, Maruyama K, Isaji S, Takeda T and Nobori T. Efficacy of Procalcitonin in the Early Diagnosis of Bacterial Infections in a Critical Care Unit. Shock. 2009 Jun;31(6):586-91

BDN 1479 Mira JP, Max A and Burgel PR. The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy. Crit Care 2008;12 Suppl 6 S5.

BDN 1480 Mendonca Coelho MC, Tannuri U, Aoun Tannuri AC, Reingenheim C and Troster EJ. Is procalcitonin useful to differentiate rejection from bacterial infection in the early post-operative period of liver transplantation in children? Pediatr Transplant 2008 Nov 18

BDN 1481 Ames PR, Walker E, Aw D, Marshall D, de Villiers F and Staber M. Multi-organ failure in adult onset Still's disease: a septic disguise. Clin Rheumatol. 2009 Jun;28 Suppl 1:S3-6

BDN 1482 McMaster P, Park DY, Shann F, Cochrane A, Morris K, Gray J, Cottrell S and Belcher J. Procalcitonin versus C-reactive protein and immature-to-total neutrophil ratio as markers of infection after cardiopulmonary bypass in children. Pediatr Crit Care Med 2009;10 (2): 217-221.

BDN 1483 Novotny AR, Emmanuel K, Hueser N, Knebel C, Kriner M, Ulm K, Bartels H, Siewert JR and Holzmann B. Procalcitonin ratio indicates successful surgical treatment of abdominal sepsis. Surgery 2009;145 (1): 20-6.

BDN 1484 Maier M, Wutzler S, Lehnert M, Szermutzky M, Wyen H, Bingold T, Henrich D, Walcher F and Marzi I. Serum procalcitonin levels in patients with multiple injuries including visceral trauma. J Trauma 2009;66 (1): 243-9.

BDN 1485 Menendez R, Martinez R, Reyes S, Mensa J, Filella X, Marcos MA, Martinez A, Esquinas C, Ramirez P and Torres A. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax 2009;

BDN 1487 Baldini F, Bolzoni L, Giannetti A, Kess M, Kramer PM, Kremmer E, Porro G, Senesi F and Trono C. A new procalcitonin optical immunosensor for POCT applications. Anal Bioanal Chem 2009;393 (4): 1183-90.

BDN 1488 Ruiz-Alvarez MJ, Garcia-Valdecasas S, De Pablo R, Sanchez Garcia M, Coca C, Groeneveld TW, Roos A, Daha MR and Arribas I. Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis. J Intensive Care Med 2009;24 (1): 63-71.

BDN 1489 Pfafflin A and Schleicher E. Inflammation markers in point-of-care testing (POCT). Anal Bioanal Chem 2009;393 (5): 1473-80.

BDN 1490 Berres ML, Schnyder B, Yagmur E, Inglis B, Stanzel S, Tischendorf JJ, Koch A, Winograd R, Trautwein C and Wasmuth HE. Longitudinal monocyte Human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis. Liver Int. 2009 Apr;29(4):536-43

BDN 1491 Charles PE, Ladoire S, Snauwaert A, Prin S, Aho S, Pechinot A, Olsson NO, Blettery B, Doise JM and Quenot JP. Impact of previous sepsis on the accuracy of procalcitonin for the early diagnosis of blood stream infection in critically ill patients. BMC Infect Dis 2008;8 163.

BDN 1492 Faix JD. Using procalcitonin to diagnose sepsis and the potential for improved antibiotic stewardship. MLO Med Lab Obs 2008;40 (11): 25-6.

BDN 1493 Damoiseaux RA. [Should antibiotics be used for acute rhinosinusitis? The argument is not yet settled]. Ned Tijdschr Geneeskd 2008;152 (43): 2319-21.


BDN 1494 Schutzle H, Forster J, Superti-Furga A and Berner R. Is serum procalcitonin a reliable diagnostic marker in children with acute respiratory tract infections? A retrospective analysis. Eur J Pediatr 2008;

BDN 1495 Schmidt J, Duhaut P, Bourgeois AM, Salle V, Smail A, Chatelain D, Betsou F, Maziere JC and Ducroix JP. Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: the GRACG prospective study. Rheumatology (Oxford) 2009;48 (2): 158-9.

BDN 1496 Shimizu T, Hanasawa K, Sato K, Umeki M, Koga N, Naganuma T, Sato S, Shimonishi T, Ikeda T, Matsuno N, Ono S, Saitoh H, Satoh K, Otani Y, Endo Y, Eguchi Y and Tani T. The Clinical Significance of Serum Procalcitonin Levels following Direct Hemoperfusion with Polymyxin B-Immobilized Fiber Column in Septic Patients with Colorectal Perforation. Eur Surg Res 2008;42 (2): 109-117.

BDN 1497 Tavares E and Minano FJ. Procalcitonin N-terminal peptide causes catabolic effects via the hypothalamus and prostaglandin-dependent pathways. Neuroendocrinology 2008;88 (4): 316-26.

BDN 1499 Sandri MT, Passerini R, Leon ME, Peccatori FA, Zorzino L, Salvatici M, Riggio D, Cassatella C, Cinieri S and Martinelli G. Procalcitonin as a useful marker of infection in hemato-oncological patients with fever. Anticancer Res 2008;28 (5B): 3061-5.

BDN 1500 Strassburg A, Rupp J, Herth FJ, Magnussen H, Zabel P and Lange C. [Infection diagnostics in pneumology. Part 1. Survey and methods]. Pneumologie 2008;62 (12): 730-43.

BDN 1501 Sherwin C, Broadbent R, Young S, Worth J, McCaffrey F, Medlicott NJ and Reith D. Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis. Am J Perinatol 2008;25 (10): 629-36.

BDN 1502 Apiwattanakul N, Wanitkun S, Chongtrakool P and Sirinavin S. A patient with penicillin-resistant viridans group streptococcal endocarditis and unusual reactions to vancomycin. Southeast Asian J Trop Med Public Health 2008;39 (6): 1088-91.

BDN 1503 Feld R. Bloodstream infections in cancer patients with febrile neutropenia. Int J Antimicrob Agents 2008;32 Suppl 1 S30-3.

BDN 1504 Brunkhorst FM. [Sepsismarker--what is useful?]. Dtsch Med Wochenschr 2008;133 (48): 2512-5.

BDN 1505 Venkatesh B, Kennedy P, Kruger PS, Looke D, Jones M, Hall J and Barruel GR. Changes in serum procalcitonin and C-reactive protein following antimicrobial therapy as a guide to antibiotic duration in the critically ill: a prospective evaluation. Anaesth Intensive Care 2009;37 (1): 20-6.

BDN 1506 Pugin J and Nobre V. Strategies to shorten antibiotic therapy duration in the ICU. ICU Management 2008;(4): 32-33.

BDN 1507 Kotoula A, Gardikis S, Tsalkidis A, Mantadakis E, Zissimopoulos A, Kambouri K, Deftereos S, Tripsianis G, Manolas K, Chatzimichael A and Vaos G. Procalcitonin for the early prediction of renal parenchymal involvement in children with UTI: preliminary results. Int Urol Nephrol. 2009;41(2):393-9

BDN 1507a Kapoor S. The rapidly expanding role of procalcitonin as a diagnostic and prognostic assay besides in UTIs. Int Urol Nephrol. 2009;41(2):435-6

BDN 1508 Robson-Ansley P, Barwood M, Canavan J, Hack S, Eglin C, Davey S, Hewitt J, Hull J and Ansley L. The effect of repeated endurance exercise on IL-6 and sIL-6R and their relationship with sensations of fatigue at rest. Cytokine 2009;45 (2): 111-6.

BDN 1509 Billeter A, Turina M, Seifert B, Mica L, Stocker R and Keel M. Early Serum Procalcitonin, Interleukin-6, and 24-Hour Lactate Clearance: Useful Indicators of Septic Infections in Severely Traumatized Patients. World J Surg 2009;33 (3): 558-566.

BDN 1510 Polverino E and Torres A. Diagnostic strategies for healthcare-associated pneumonia. Semin Respir Crit Care Med 2009;30 (1): 36-45.


BDN 1511 Uettwiller-Geiger DL and Denise L. Clinical Application of Procalcitonin (PCT). Journal of Clinical Ligand Assay 2007;30 (Number 1-2 Spring-Summer): 20-28.

BDN 1512 Bressan S, Andreola B, Zucchetta P, Montini G, Burei M, Perilongo G and Da Dalt L. Procalcitonin as a predictor of renal scarring in infants and young children. Pediatr Nephrol 2009;

BDN 1513 Caliskan Y, Oflaz H, Pusuroglu H, Boz H, Yazici H, Tamer S, Karsidag K and Yildiz A. Hepatitis C virus infection in hemodialysis patients is not associated with insulin resistance, inflammation and atherosclerosis. Clin Nephrol 2009;71 (2): 147-57.

BDN 1514 Chen N, Li H, Zhao LY, Liu JB, Huang Q, Wang TH and Hao XM. [Therapy for clearing heat and resolving phlegm in treatment of systemic inflammatory response syndrome in acute deterioration stage of chronic obstructive pulmonary disease: a randomized controlled trial.]. Zhong Xi Yi Jie He Xue Bao 2009;7 (2): 105-9.

BDN 1515 Oruc N, Ozutemiz O, Yuce G, Akarca US, Ersoz G, Gunsar F and Batur Y. Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study. BMC Gastroenterol 2009;9 (1): 16.

BDN 1516 Zycinska K, Wardyn KA, Zielonka TM, Tyszko P and Straburzynski M. Procalcitonin as an indicator of systemic response to infection in active pulmonary Wegener's granulomacytosis. J Physiol Pharmacol 2008;59 Suppl 6 839-44.

BDN 1517 Suzuki N, Mizuno H, Nezu M, Takai Y, Misu T, Kuroda H, Aoki M, Nakashima I and Itoyama Y. Procalcitonin might help in discrimination between meningeal neuro-Behcet disease and bacterial meningitis. Neurology 2009;72 (8): 762-3.

Documents

PCT Bibliography March 2009 - pingxiti.com · PCT_Bibliography_March_2009.doc, page 4 of 80 BDN 005 Nylen ES et al. And Becker KL. Serum procalcitonin as an index of inhalation injury